
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Different Derivatives of Plumbagin Analogue: Bioavailability and Their Toxicity Studies - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15254CBA8AF3C943054CBA001C2C9A64.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="fsn">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365397/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Food Science &amp; Nutrition">
<meta name="citation_title" content="Different Derivatives of Plumbagin Analogue: Bioavailability and Their Toxicity Studies">
<meta name="citation_author" content="Souparnika Thekkumkara">
<meta name="citation_author_institution" content="Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Mangaluru, Karnataka, India">
<meta name="citation_author" content="Arenbenla Longchar">
<meta name="citation_author_institution" content="Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Mangaluru, Karnataka, India">
<meta name="citation_author" content="Baskar Venkidasamy">
<meta name="citation_author_institution" content="Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India">
<meta name="citation_author" content="Benod Kumar Kondapavuluri">
<meta name="citation_author_institution" content="Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune, India">
<meta name="citation_author" content="Muthu Thiruvengadam">
<meta name="citation_author_institution" content="Department of Applied Bioscience, College of Life and Environmental Science, Konkuk University, Seoul, Republic of Korea">
<meta name="citation_author_institution" content="Centre for Research Impact &amp; Outcome, Chitkara University, Rajpura, Punjab, India">
<meta name="citation_author" content="Mansour Ghorbanpour">
<meta name="citation_author_institution" content="Arak University, Arak, Iran">
<meta name="citation_author" content="Sathianarayanan Sankaran">
<meta name="citation_author_institution" content="Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Mangaluru, Karnataka, India">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="13">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e70720">
<meta name="citation_doi" content="10.1002/fsn3.70720">
<meta name="citation_pmid" content="40842665">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365397/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365397/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365397/pdf/FSN3-13-e70720.pdf">
<meta name="description" content="The roots of the Plumbago genus, specifically Plumbago zeylanica and related species, contain natural plumbagin. Because of its possible medicinal benefits, naphthoquinone has been the subject of several studies. Ongoing research aims to better ...">
<meta name="og:title" content="Different Derivatives of Plumbagin Analogue: Bioavailability and Their Toxicity Studies">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The roots of the Plumbago genus, specifically Plumbago zeylanica and related species, contain natural plumbagin. Because of its possible medicinal benefits, naphthoquinone has been the subject of several studies. Ongoing research aims to better ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365397/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12365397">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/fsn3.70720"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/FSN3-13-e70720.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365397%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12365397/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12365397/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365397/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-fsn.gif" alt="Food Science &amp; Nutrition logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Food Science &amp; Nutrition" title="Link to Food Science &amp; Nutrition" shape="default" href="http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%292048-7177" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Food Sci Nutr</button></div>. 2025 Aug 19;13(8):e70720. doi: <a href="https://doi.org/10.1002/fsn3.70720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/fsn3.70720</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Food%20Sci%20Nutr%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Food%20Sci%20Nutr%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Food%20Sci%20Nutr%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Food%20Sci%20Nutr%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Different Derivatives of Plumbagin Analogue: Bioavailability and Their Toxicity Studies</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thekkumkara%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Souparnika Thekkumkara</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Souparnika Thekkumkara</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Mangaluru, Karnataka, India</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thekkumkara%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Souparnika Thekkumkara</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Longchar%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Arenbenla Longchar</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Arenbenla Longchar</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Mangaluru, Karnataka, India</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Longchar%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Arenbenla Longchar</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Venkidasamy%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Baskar Venkidasamy</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Baskar Venkidasamy</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Venkidasamy%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Baskar Venkidasamy</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kondapavuluri%20BK%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Benod Kumar Kondapavuluri</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Benod Kumar Kondapavuluri</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune, India</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kondapavuluri%20BK%22%5BAuthor%5D" class="usa-link"><span class="name western">Benod Kumar Kondapavuluri</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thiruvengadam%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Muthu Thiruvengadam</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Muthu Thiruvengadam</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Applied Bioscience, College of Life and Environmental Science, Konkuk University, Seoul, Republic of Korea</div>
<div class="p">
<sup>
<sup>5</sup>
</sup>Centre for Research Impact &amp; Outcome, Chitkara University, Rajpura, Punjab, India</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thiruvengadam%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Muthu Thiruvengadam</span></a>
</div>
</div>
<sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghorbanpour%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Mansour Ghorbanpour</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Mansour Ghorbanpour</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Arak University, Arak, Iran</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghorbanpour%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mansour Ghorbanpour</span></a>
</div>
</div>
<sup>6,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sankaran%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Sathianarayanan Sankaran</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Sathianarayanan Sankaran</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Mangaluru, Karnataka, India</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sankaran%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sathianarayanan Sankaran</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="fsn370720-aff-0001">
<sup>
<sup>1</sup>
</sup>Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Mangaluru, Karnataka, India</div>
<div id="fsn370720-aff-0002">
<sup>
<sup>2</sup>
</sup>Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India</div>
<div id="fsn370720-aff-0003">
<sup>
<sup>3</sup>
</sup>Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune, India</div>
<div id="fsn370720-aff-0004">
<sup>
<sup>4</sup>
</sup>Department of Applied Bioscience, College of Life and Environmental Science, Konkuk University, Seoul, Republic of Korea</div>
<div id="fsn370720-aff-0005">
<sup>
<sup>5</sup>
</sup>Centre for Research Impact &amp; Outcome, Chitkara University, Rajpura, Punjab, India</div>
<div id="fsn370720-aff-0006">
<sup>
<sup>6</sup>
</sup>Arak University, Arak, Iran</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Mansour Ghorbanpour (<span>m-ghorbanpour@araku.ac.ir</span>), 
Sathianarayanan Sankaran (<span>ssnvij@yahoo.co.in</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 16; Received 2025 Mar 6; Accepted 2025 Jul 18; Collection date 2025 Aug.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Food Science &amp; Nutrition</em> published by Wiley Periodicals LLC.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12365397  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40842665/" class="usa-link">40842665</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>The roots of the <em>Plumbago</em> genus, specifically 
<em>Plumbago zeylanica</em>
 and related species, contain natural plumbagin. Because of its possible medicinal benefits, naphthoquinone has been the subject of several studies. Ongoing research aims to better understand the mechanisms underlying the actions of plumbagin, optimize its distribution and formulation, assess its efficacy and safety in clinical trials. Plumbagin is a bioactive compound that has several possible therapeutic uses; however, further studies are required to completely understand its advantages and disadvantages in clinical settings. The roots, leaves, and stem of the plant contain plumbagin, which possesses antimalarial, antiobese, antidiabetic, antimicrobial, antiulcer, anti‐inflammatory, antioxidant, and anticancer properties, and has been traditionally used to treat various disorders, including dysmenorrhea, leprosy, anemia, rheumatic pain, colds, coughs, and arthritis. Plumbagin has low bioavailability owing to its poor solubility, metabolic instability, and efflux by transporters. Although plumbagin has promising therapeutic properties, it is also poisonous, which limits its clinical applications, cytotoxicity, organ toxicity, oxidative stress, and genotoxicity. Plumbagin and its derivatives have high therapeutic potential, particularly in oncology and antibacterial applications. However, issues such as bioavailability and toxicity must be addressed. Advances in drug delivery technologies, chemical changes, and combination therapy are interesting approaches for increasing the therapeutic viability of plumbagin and its derivatives. To completely comprehend their therapeutic potential and guarantee human safety, further clinical investigations are needed.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> bio‐availability, pharmacological action, plumbagin, plumbagin derivatives, toxicity</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p>Plumbagin, discovered in 
<em>Plumbago zeylanica</em>
, has potential therapeutic effects such as anticancer, antimicrobial, and anti‐inflammatory characteristics. It has traditionally been used to treat anemia and rheumatic pain, but its therapeutic application is limited because of low bioavailability and toxicity risk factors. Chemical modifications and combination medicines are being studied to improve delivery, reduce toxicity, and increase efficacy. More research and clinical trials are required to verify its safety and therapeutic potential.</p>
<section class="bt xbox font-sm" id="fsn370720-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/46286b1ccdc0/FSN3-13-e70720-g008.jpg" loading="lazy" id="jats-graphic-1" height="289" width="390" alt="graphic file with name FSN3-13-e70720-g008.jpg"></p></section></section><section id="fsn370720-sec-0001"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>A naphthoquinone, plumbagin (PB), is generated from the roots of various families of medicinal plants, including Droseraceae, Ebenaceae, and Plumbaginaceae. 
<em>Plumbago zeylanica</em>
 L. (Badwaik et al. <a href="#fsn370720-bib-0008" class="usa-link" aria-describedby="fsn370720-bib-0008">2019</a>; Galal et al. <a href="#fsn370720-bib-0037" class="usa-link" aria-describedby="fsn370720-bib-0037"><sup>2013</sup></a>; Ganesan and Gani <a href="#fsn370720-bib-0038" class="usa-link" aria-describedby="fsn370720-bib-0038"><sup>2013</sup></a>) is often regarded as the best‐known medicinal plant that contains PB. PB has a very short half‐life; however, it is structurally identical to vitamin K. More significantly, PB has a limited oral bioavailability, mild toxicity, and low water solubility. Regardless, it appears to be a viable option for the development of new therapeutic medications. The biological activities of molecules, which include anti‐inflammatory, antifungal, antibacterial, antioxidant, and anticancer (Jiang et al. <a href="#fsn370720-bib-0058" class="usa-link" aria-describedby="fsn370720-bib-0058">2018</a>; Yin et al. <a href="#fsn370720-bib-0144" class="usa-link" aria-describedby="fsn370720-bib-0144"><sup>2020</sup></a>; Titiwattanakarn et al. <a href="#fsn370720-bib-0133" class="usa-link" aria-describedby="fsn370720-bib-0133"><sup>2025</sup></a>) qualities, have been shown in numerous studies (Nazeem et al. <a href="#fsn370720-bib-0088" class="usa-link" aria-describedby="fsn370720-bib-0088">2009</a>). The effects of PB on cancer have been thoroughly studied in the literature, and PB has promising therapeutic properties. It is also poisonous, which limits its clinical applications, cytotoxicity, organ toxicity, oxidative stress, and genotoxicity. PB and its derivatives have high therapeutic potential, particularly in oncology and antibacterial applications. However, issues such as bioavailability and toxicity must be addressed. Plumbagin, a natural substance with a variety of biological functions including anti‐inflammatory properties, is a good alternative for future medical research. Nevertheless, additional research is necessary to improve its clinical usefulness owing to its toxicity and absorption (Petrocelli et al. <a href="#fsn370720-bib-0095" class="usa-link" aria-describedby="fsn370720-bib-0095">2023</a>). Advances in drug delivery technologies, chemical changes, and combination therapy are interesting approaches for increasing the therapeutic viability of PB and its derivatives. Plumbagin is a naphthoquinone with important pharmacological properties. Progress in the understanding of its biosynthesis and biotechnological manufacturing presents encouraging opportunities for long‐term and extensive medicinal applications. Although more research is required to address its pharmacokinetic and toxicity issues, plumbagin has varied therapeutic qualities, making it a fascinating prospect for future pharmaceutical research and development (Thakor and Janathia <a href="#fsn370720-bib-0131" class="usa-link" aria-describedby="fsn370720-bib-0131">2022</a>). To guarantee human safety and complete comprehension of their therapeutic potential, further clinical investigations are needed. PB is a secondary metabolite found in several families, including Droseraceae, Drosophyllaceae, Ebenaceae, Nepenthaceae, and Plumbaginaceae. The primary component is 1,4‐napthoquinone. It is composed of a hydroxyl group at position five and a methyl substituent at position two. It contains a vivid yellow pigment. PB was disregarded in 1928 until Roy and Dutt looked into it; nonetheless, they were unable to derive the appropriate empirical formula. Madinaveitia and Gallego (<a href="#fsn370720-bib-0152" class="usa-link" aria-describedby="fsn370720-bib-0152">1928</a>) later elucidated the correct formula. The novelty of the review primarily provides a broad yet cohesive synopsis of the pharmacological potential of plumbagin. Plumbagin is a naphthoquinone produced by 
<em>P. zeylanica</em>
 and related species. It links modern pharmacological discoveries with various pathways to the traditional medicinal applications of plumbagin. This review emphasizes drawbacks, including toxicity, metabolic instability, and limited bioavailability. This highlights the need for improved delivery methods, chemical alterations, and improved clinical research. Further clinical investigations are needed to completely comprehend the therapeutic potential and guarantee human safety. Through the modulation of NF‐κB, PI3K/Akt, and STAT3, as well as ROS‐mediated mitochondrial pathways, plumbagin causes apoptosis and cell cycle arrest, and inhibits metastasis in a variety of cancer types, including breast, prostate, and lung cancer. It downregulates pro‐inflammatory cytokines and COX‐2 and NF‐κB signaling; therefore, it may be used as an anti‐inflammatory, antioxidant, and anti‐inflammatory agent that is beneficial in models of neurodegenerative diseases. Plumbagin shows potent activity against microorganisms, such as bacteria, fungi, and viruses. Plumbagin lowers glucose levels and protects heart tissue from ischemic damage in preclinical models. Plumbagin targets several important regulators including topoisomerases, Bcl‐2, STAT3, and p53. It is a multi‐target agent, which is a recent trend in contemporary drug research owing to its capacity to interact with several signaling cascades. To improve bioavailability, solubility, and target specificity, as well as address its intrinsic low water solubility and systemic toxicity, research is moving forward with nanoparticle‐based delivery, liposomal formulations, and prodrug designs. In cancer treatment, plumbagin works in concert with common chemotherapeutics (such as doxorubicin and cisplatin) to overcome drug resistance. Mechanistic research on immune response control, autophagy, and epigenetic modification is ongoing. Although it is currently in preclinical or early clinical stages, clinical translation is being studied. Owing to its broad‐spectrum biological activity, distinct mode of action, and intriguing therapeutic potential in areas where drug resistance or toxicity is an issue, plumbagin is a multipurpose phytochemical. Its uniqueness in contemporary biomedical research has been increased by continuous innovation in its formulation and molecular targeting.</p></section><section id="fsn370720-sec-0002"><h2 class="pmc_sec_title">2. Extraction of Plumbagin</h2>
<p>The roots of 
<em>P. zeylanica</em>
 and 
<em>P. scandens</em>
 L. were believed to be the richest known sources of plumbagin(PB) when it was originally discovered. Grevenstuk et al. (<a href="#fsn370720-bib-0043" class="usa-link" aria-describedby="fsn370720-bib-0043">2012</a>) conducted the quantification analysis using n‐hexane as a solvent in a Soxhlet extraction process because it consistently produces a high yield, according to several studies. The PB in the plant roots, bark, leaves, aerial parts, etc., could not be quantified, even though the complete plant was used at the time of extraction. Despite its high yield, the Soxhlet method has several drawbacks. Specifically, the yield decreased as the extraction duration increased, showing that PB degraded after exposure to heat for longer than five hours. Therefore, to solve this issue, additional techniques for extraction were identified. As a result, other extraction techniques, such as hot and cold maceration (Sundari et al. <a href="#fsn370720-bib-0127" class="usa-link" aria-describedby="fsn370720-bib-0127">2017</a>), were used to solve this issue. These results provide a full account of the extraction and isolation methods used in different studies (Badwaik et al. <a href="#fsn370720-bib-0008" class="usa-link" aria-describedby="fsn370720-bib-0008">2019</a>). Tables <a href="#fsn370720-tbl-0001" class="usa-link">1</a> and <a href="#fsn370720-tbl-0002" class="usa-link">2</a> show the plumbagin spectroscopic and physical data, respectively.</p>
<section class="tw xbox font-sm" id="fsn370720-tbl-0001"><h3 class="obj_head">TABLE 1.</h3>
<div class="caption p"><p>Plumbagin spectroscopic and physical data.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">S. No</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Biological source</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Plant part</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Green plant or dried powder</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Method of extraction</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Solvent used</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>Dionea muscipula</em> Ellis</td>
<td align="center" valign="top" rowspan="1" colspan="1">Whole plant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Soxhlet</td>
<td align="center" valign="top" rowspan="1" colspan="1">Methanol</td>
<td align="center" valign="top" rowspan="1" colspan="1">Kreher et al. (<a href="#fsn370720-bib-0069" class="usa-link" aria-describedby="fsn370720-bib-0069">1990</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>Ceratostigma minus</em> Stapf Prain</td>
<td align="center" valign="top" rowspan="1" colspan="1">Whole plant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Maceration room temp</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ethanol</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yue et al. (<a href="#fsn370720-bib-0146" class="usa-link" aria-describedby="fsn370720-bib-0146">1994</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>Plumbago zeylanica</em>
 and other <em>Plumbago</em> spp.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Whole plant and their root</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder of whole plant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cold maceration</td>
<td align="center" valign="top" rowspan="1" colspan="1">Toluene, glacial acetic acid and ethyl acetate</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hazra et al. (<a href="#fsn370720-bib-0051" class="usa-link" aria-describedby="fsn370720-bib-0051">2004</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>P. zeylanica</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Root</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Soxhlet</td>
<td align="center" valign="top" rowspan="1" colspan="1">Methanol</td>
<td align="center" valign="top" rowspan="1" colspan="1">Kishore et al. (<a href="#fsn370720-bib-0067" class="usa-link" aria-describedby="fsn370720-bib-0067">2010</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>P. auriculata</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Root</td>
<td align="center" valign="top" rowspan="1" colspan="1">Shaded dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Soxhlet</td>
<td align="center" valign="top" rowspan="1" colspan="1">Chloroform</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sreelatha et al. (<a href="#fsn370720-bib-0120" class="usa-link" aria-describedby="fsn370720-bib-0120">2010</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>P. zeylanica</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Root</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cold maceration</td>
<td align="center" valign="top" rowspan="1" colspan="1">Chloroform: dichloromethane (1:1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bothiraja et al. (<a href="#fsn370720-bib-0016" class="usa-link" aria-describedby="fsn370720-bib-0016">2013</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>Drosera intermedia</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Whole plant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Soxhlet</td>
<td align="center" valign="top" rowspan="1" colspan="1">n‐Hexane</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grevenstuk et al. (<a href="#fsn370720-bib-0043" class="usa-link" aria-describedby="fsn370720-bib-0043">2012</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>P. zeylanica</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Root</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Soxhlet</td>
<td align="center" valign="top" rowspan="1" colspan="1">Methanol</td>
<td align="center" valign="top" rowspan="1" colspan="1">Pradeepa et al. (<a href="#fsn370720-bib-0098" class="usa-link" aria-describedby="fsn370720-bib-0098">2016</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">9</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>P. indica</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Root</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Static extraction (maceration at roomtemperature)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Methanol and chloroform</td>
<td align="center" valign="top" rowspan="1" colspan="1">Silja et al. (<a href="#fsn370720-bib-0114" class="usa-link" aria-describedby="fsn370720-bib-0114">2016</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">10</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>P. indica</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Whole plant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Maceration (hot)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ethanol</td>
<td align="center" valign="top" rowspan="1" colspan="1">Makchuchit et al. (<a href="#fsn370720-bib-0081" class="usa-link" aria-describedby="fsn370720-bib-0081">2017</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">11</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>D. anisandra</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Whole plant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ultrasonication</td>
<td align="center" valign="top" rowspan="1" colspan="1">n‐Hexane</td>
<td align="center" valign="top" rowspan="1" colspan="1">Juárez‐Méndez et al. (<a href="#fsn370720-bib-0059" class="usa-link" aria-describedby="fsn370720-bib-0059">2022</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">12</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>D. lusitanicum</em> L.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Leaves</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Soxhlet and Ultrasonication</td>
<td align="center" valign="top" rowspan="1" colspan="1">Methanol, chloroform and n‐Hexane</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grevenstuk et al. (<a href="#fsn370720-bib-0042" class="usa-link" aria-describedby="fsn370720-bib-0042">2008</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">13</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>D. intermedia</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Whole plant</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ultrasonication and supercritical fluid extraction</td>
<td align="center" valign="top" rowspan="1" colspan="1">Acetonitrile and water</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grevenstuk et al. (<a href="#fsn370720-bib-0043" class="usa-link" aria-describedby="fsn370720-bib-0043">2012</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>P. europaea</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Aerial parts (leaves, flowers)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Clavenger</td>
<td align="center" valign="top" rowspan="1" colspan="1">Water</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hasan et al. (<a href="#fsn370720-bib-0153" class="usa-link" aria-describedby="fsn370720-bib-0153">2025</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">

<em>P. zeylanica</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Root</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Microwave assisted extraction</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ethanol</td>
<td align="center" valign="top" rowspan="1" colspan="1">Katoch et al. (<a href="#fsn370720-bib-0061" class="usa-link" aria-describedby="fsn370720-bib-0061">2023</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>Juglans</em> spp.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Root, leaves</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Supercritical fluid extraction</td>
<td align="center" valign="top" rowspan="1" colspan="1">Carbon dioxide</td>
<td align="center" valign="top" rowspan="1" colspan="1">Zenk et al. (<a href="#fsn370720-bib-0147" class="usa-link" aria-describedby="fsn370720-bib-0147">1969</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">18</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>Triphyophyllum peltatum</em>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Stem, bark</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dried powder</td>
<td align="center" valign="top" rowspan="1" colspan="1">Soxhlet extraction</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dichloromethane and 5% ammoniumhydroxide</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bringmann et al. (<a href="#fsn370720-bib-0017" class="usa-link" aria-describedby="fsn370720-bib-0017">2008</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/fsn370720-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="fsn370720-tbl-0002"><h3 class="obj_head">TABLE 2.</h3>
<div class="caption p"><p>Plumbagin physical and spectroscopic data.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">S. No</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Particulars</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">Data</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">1</td>
<td align="center" rowspan="2" valign="top" colspan="1">Details about the molecular structure</td>
<td align="center" colspan="3" valign="top" rowspan="1">
<p>
<img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/3a898629ff9a/FSN3-13-e70720-g010.jpg" loading="lazy" alt="graphic file with name FSN3-13-e70720-g010.jpg">
</p>
<p>5‐hydroxy‐2‐methyl‐1,4‐napthaquinone</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bothiraja et al. (<a href="#fsn370720-bib-0014" class="usa-link" aria-describedby="fsn370720-bib-0014">2011</a>)</td>
</tr>
<tr>
<td align="center" colspan="3" valign="top" rowspan="1">Chemical formula: C<sub>11</sub>H<sub>8</sub>O<sub>3</sub> Mol Wt: 188.182 g/mol, Elemental analysis: C:70.21, H:4.29, O:25.51. Orange to yellow needles (daylight), reddish, and M.P. 76°C–79°C Soluble in benzene, chloroform, ethyl alcohol, and acetone</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">2</td>
<td align="center" rowspan="2" valign="top" colspan="1">Spectroscopic interpretation</td>
<td align="center" rowspan="2" valign="top" colspan="1">UV–Visible</td>
<td align="center" colspan="2" valign="top" rowspan="1">UV: <em>λ</em>
<sub>max</sub> (methanol): 254 nm</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cesari et al. (<a href="#fsn370720-bib-0019" class="usa-link" aria-describedby="fsn370720-bib-0019">2013</a>)</td>
</tr>
<tr>
<td align="center" colspan="2" valign="top" rowspan="1">Visible: <em>λ</em>
<sub>max</sub> (methanol): 416 nm</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">IR</td>
<td align="center" colspan="2" valign="top" rowspan="1">IR (KBr) peaks at 3321–3577 cm<sup>−1</sup> for OH stretching, 1645–1667 cm<sup>−1</sup> for carbonyl, 1609–1611 cm<sup>−1</sup> for aromatic C]C, and 751.7–765 cm<sup>−1</sup> for aromatic CH stretching</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bothiraja et al. (<a href="#fsn370720-bib-0014" class="usa-link" aria-describedby="fsn370720-bib-0014">2011</a>)</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1"></td>
<td align="center" rowspan="2" valign="top" colspan="1"></td>
<td align="center" rowspan="2" valign="top" colspan="1">NMR</td>
<td align="center" rowspan="2" valign="top" colspan="1">
<sup>1</sup>H NMR</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<sup>1</sup>H NMR (CDCl3, 300 MHz): 2.19 (3H, s, Me‐2), 6.81 (1H, s, H‐3), 7.26 (1H, m, H‐6), 7.62 (2H, m, H‐7, 8) and 11.97 (–OH)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>
<sup>1</sup>H NMR (CD3OD, 500 MHz): 2.15 (3H, d, J¼ 1.6 Hz, CH3), 6.85 (1H, q, J¼ 2.0 Hz, H‐3), 7.24 (1H, d, J¼ 8.3 Hz, H6), 7.59.</p>
<p>(1H, d, J¼ 7.4 Hz, H‐8), 7.65 (1H, dd, J¼ 8.3, 7.4 Hz, H‐7)</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cesari et al. (<a href="#fsn370720-bib-0019" class="usa-link" aria-describedby="fsn370720-bib-0019">2013</a>)</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1"></td>
<td align="center" rowspan="2" valign="top" colspan="1"></td>
<td align="center" rowspan="2" valign="top" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">
<sup>13</sup>C NMR</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<sup>13</sup>C NMR CDCl3 (75 MHz): 16.4 (2‐CH3), 114.9 (C‐4a), 119.1 (C‐8), 124.0 (C‐6), 131.8 (C‐8a), 135.3 (C‐3), 135.9 (C‐7), 149.5 (C‐2), 161.0 (C‐5), 184.6 (C‐1), and 190.1 (C‐4)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">
<sup>13</sup>C NMR CD3OD at 126 MHz: 192.5 (C‐4), 184.7 (C‐1), 161.1 (C‐5), 149.8 (C‐2), 136.1 (C‐7), 135.3 (C‐3), 132.4 (C‐9), 123.6 (C‐6), 118.8 (C‐8), 115.2 (C‐10), and 15.2 (C‐11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cesari et al. (<a href="#fsn370720-bib-0019" class="usa-link" aria-describedby="fsn370720-bib-0019">2013</a>)</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1"></td>
<td align="center" rowspan="2" valign="top" colspan="1"></td>
<td align="center" rowspan="2" colspan="2" valign="top">MS</td>
<td align="center" valign="top" rowspan="1" colspan="1">EI‐MS: <em>m/z</em> (intensity%): 188 (100), 173 (26), 160 (27), 131 (44), 120 (30), 92 (39), and 63 (43)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bothiraja et al. (<a href="#fsn370720-bib-0014" class="usa-link" aria-describedby="fsn370720-bib-0014">2011</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">LC‐ ESI‐ MS: <em>m/z</em> 187.2 [M‐H]+</td>
<td align="center" valign="top" rowspan="1" colspan="1">Singh et al. (<a href="#fsn370720-bib-0115" class="usa-link" aria-describedby="fsn370720-bib-0115">2015</a>)</td>
</tr>
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">3</td>
<td align="center" rowspan="3" valign="top" colspan="1">Chromatography</td>
<td align="center" rowspan="2" colspan="2" valign="top">TLC</td>
<td align="center" valign="top" rowspan="1" colspan="1">Rf (n‐hexane: benzene (1:9)) = 0.64</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cesari et al. (<a href="#fsn370720-bib-0019" class="usa-link" aria-describedby="fsn370720-bib-0019">2013</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Rf (n‐hexane:ethylformate (9:1)): 0.37</td>
<td align="center" valign="top" rowspan="1" colspan="1">Kapadia et al. (<a href="#fsn370720-bib-0060" class="usa-link" aria-describedby="fsn370720-bib-0060">2005</a>)</td>
</tr>
<tr>
<td align="center" colspan="2" valign="top" rowspan="1">HPTLC</td>
<td align="center" valign="top" rowspan="1" colspan="1">Rf (mobile phase: n‐hexane: benzene (1:9), stationary phase: silica gel 60 F254 plates with a CAMAG LINOMAT IV automatic spotter): 0.63</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bothiraja et al. (<a href="#fsn370720-bib-0014" class="usa-link" aria-describedby="fsn370720-bib-0014">2011</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">Thermogram</td>
<td align="center" colspan="2" valign="top" rowspan="1">DSC</td>
<td align="center" valign="top" rowspan="1" colspan="1">Thermogram showed a significant melting endothermic peak at 78.6°C</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bothiraja et al. (<a href="#fsn370720-bib-0014" class="usa-link" aria-describedby="fsn370720-bib-0014">2011</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/fsn370720-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section id="fsn370720-sec-0003"><h3 class="pmc_sec_title">2.1. Optimized Extraction Methods for Plumbagin</h3>
<section id="fsn370720-sec-0004"><h4 class="pmc_sec_title">2.1.1. Extraction With Microwave Assistance (MAE)</h4>
<p>Using microwave energy to heat solvents that come into contact with plant materials, MAE effectively extracts phytochemicals (Katoch et al. <a href="#fsn370720-bib-0061" class="usa-link" aria-describedby="fsn370720-bib-0061">2023</a>). Higher yields and shorter extraction times than traditional methods are the outcomes of this method's optimization for plumbagin extraction. The procedure is safe for the environment and appropriate for large‐scale operations.</p></section><section id="fsn370720-sec-0005"><h4 class="pmc_sec_title">2.1.2. Extraction of Gelucire Without Solvent</h4>
<p>Using the lipid‐based excipient Gelucire, this solvent‐free technique improves plumbagin intestinal absorption and solubility (Bothiraja et al. <a href="#fsn370720-bib-0015" class="usa-link" aria-describedby="fsn370720-bib-0015">2012</a>). This technique is a potential method for creating oral formulations because it increases not only extraction efficiency but also bioavailability.</p></section><section id="fsn370720-sec-0006"><h4 class="pmc_sec_title">2.1.3. Chloroform/Dichloromethane Cold Maceration</h4>
<p>Plumbagin is traditionally extracted by soaking the plant roots in a solution of chloroform and dichloromethane. Longer extraction durations and the use of hazardous solvents are significant disadvantages, despite the fact that it is efficient in producing pure chemicals (Bothiraja et al. <a href="#fsn370720-bib-0014" class="usa-link" aria-describedby="fsn370720-bib-0014">2011</a>). Plumbagin structures have been studied using spectroscopic methods, such as FT‐IR, NMR, and MS (Figure <a href="#fsn370720-fig-0001" class="usa-link">1</a>). Plumbagin is classified as a hydroxy‐1,4‐naphthoquinone because it has methyl and hydroxy groups in place of hydrogen atoms at Positions 2 and 5. It functions as an antineoplastic agent, adjuvant for the immune system, anticoagulant, and metabolite. It is a hydroxy‐1,4‐naphthoquinone and a member of the phenol family (Ding et al. <a href="#fsn370720-bib-0027" class="usa-link" aria-describedby="fsn370720-bib-0027">2005</a>).</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0001"><h5 class="obj_head">FIGURE 1.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/9d3c7f3702e5/FSN3-13-e70720-g009.jpg" loading="lazy" id="jats-graphic-3" height="614" width="669" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Structure of plumbagin.</p></figcaption></figure></section></section></section><section id="fsn370720-sec-0007"><h2 class="pmc_sec_title">3. Biological Activity of Plumbagin</h2>
<p>Since it was found to be the main component of several naphthalene species, plumbagin(PB) has been linked to several pharmacological activities, including anticancer, neuroprotective, pro‐cognitive, anti‐Alzheimer's, antimicrobial, antidiabetic, analgesic, anti‐inflammatory, and anti‐arthritic effects.</p>
<section id="fsn370720-sec-0008"><h3 class="pmc_sec_title">3.1. Anticancer</h3>
<p>Cancer is a major cause of disease and mortality worldwide. According to WHO figures from 2018, cancer caused over 8.8 million deaths in 2015, accounting for nearly one in every six fatalities. Recent studies have predicted a significant increase in cancer cases worldwide. From 2022 to 2050, the number of cancer cases is predicted to increase by approximately 77%, reaching approximately 35.3 million cases globally (Bizuayehu et al. <a href="#fsn370720-bib-0013" class="usa-link" aria-describedby="fsn370720-bib-0013">2024</a>). Low‐ and middle‐income nations are expected to see the largest increase in cancer incidence and death, and lung cancer continues to be the most prevalent and severe type of cancer in the world. Cancer incidence among those under 50 years of age has significantly increased, especially for cancers of the digestive system, which may be related to environmental and lifestyle factors. It is the world's second leading cause of death. Cancer is caused by various genetic and epigenetic changes that increase angiogenesis, metastasis, immune system malfunction, unregulated cell division, and resistance to apoptosis. In recent years, various treatments have been used to combat cancer evasion, including hormone therapy, surgery, radiation therapy, and chemotherapy. Chemotherapy is the most commonly used cancer treatment (Gomathinayagam et al. <a href="#fsn370720-bib-0040" class="usa-link" aria-describedby="fsn370720-bib-0040">2008</a>). The development of medication resistance and substantial side effects are the primary factors that limit its effectiveness. As a result, many research teams have focused on evaluating the anticancer potential of various phytoconstituents, either alone or in combination with currently approved chemotherapeutic tablets. The potential of PB as an anticancer agent has been the subject of numerous studies. PB has been proven to have antineoplastic activity in both in vitro and in vivo tests of various cancer types (Badwaik et al. <a href="#fsn370720-bib-0008" class="usa-link" aria-describedby="fsn370720-bib-0008">2019</a>). Figure <a href="#fsn370720-fig-0002" class="usa-link">2</a> shows the use of plumbagin for various types of cancers.</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/8dac242a3a37/FSN3-13-e70720-g005.jpg" loading="lazy" id="jats-graphic-5" height="454" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Therapeutic applications of plumbagin in various cancer types.</p></figcaption></figure><section id="fsn370720-sec-0009"><h4 class="pmc_sec_title">3.1.1. Breast Cancer</h4>
<p>HIF‐1α translation is regulated by the PI3K/Akt/mTOR pathway. Previous studies have shown that it blocks the PI3K/Akt/mTOR signaling pathway in MCF‐7 cells, resulting in cell cycle arrest and autophagy (Xie et al. <a href="#fsn370720-bib-0140" class="usa-link" aria-describedby="fsn370720-bib-0140">2019</a>). Suppressing the PI3K/Akt/mTOR signaling pathway reduces HIF‐1α synthesis in several cell types during hypoxia or CoCl<sub>2</sub>‐induced hypoxia, as shown in previous studies (Lee and Park <a href="#fsn370720-bib-0154" class="usa-link" aria-describedby="fsn370720-bib-0154">2011</a>; Li et al. <a href="#fsn370720-bib-0076" class="usa-link" aria-describedby="fsn370720-bib-0076"><sup>2015</sup></a>; Yang et al. <a href="#fsn370720-bib-0143" class="usa-link" aria-describedby="fsn370720-bib-0143"><sup>2015</sup></a>). It also demonstrated that PB does not affect the expression of phosphorylated Akt, mTOR, or total PI3K under hypoxic conditions. The data suggest that PB, which inhibits the PI3K/Akt/mTOR signaling pathway in MCF‐7 breast cancer cells, is unlikely to interfere with HIF‐1α signaling or its target genes; however, PB may reduce HIF‐1α through an alternative mechanism. On the other hand, it may inhibit HIF‐1α by inhibiting the signaling pathway that is dependent on ERK and MPK. The various molecular processes and targets of HIF‐1α need to be further investigated to fully comprehend its inhibitory effect on PB. Furthermore, it has been shown that MCF‐7 cell lines express significant amounts of HIF‐1α protein (Shi et al. <a href="#fsn370720-bib-0111" class="usa-link" aria-describedby="fsn370720-bib-0111">2010</a>). In numerous investigations, PB showed a potent anticancer effect on cell lines expressing the estrogen receptor (ER). Additionally, PB specifically targeted ERs that were highly expressed in MCF‐7 cells, while the opposite was true for MDA‐MB‐231 cells (Kilcar et al. <a href="#fsn370720-bib-0064" class="usa-link" aria-describedby="fsn370720-bib-0064">2016</a>). This study aimed to investigate the effect of PB on HIF‐1α‐associated ER‐positive MCF‐7 cells. The impact of PB on ER‐negative MDA‐MB‐231 cells, on the other hand, is an intriguing topic that warrants more investigation.</p></section><section id="fsn370720-sec-0010"><h4 class="pmc_sec_title">3.1.2. Prostate Cancer</h4>
<p>Prostate cancer is a severe disease that affects millions of people and is the second leading cause of cancer‐related deaths among males in the United States. Hormone‐refractory prostate cancer is particularly aggressive, difficult to treat, and accounts for the majority of prostate cancer‐related deaths. According to Aziz et al. (<a href="#fsn370720-bib-0007" class="usa-link" aria-describedby="fsn370720-bib-0007">2008</a>), PB can also prevent the invasive growth of prostate cancer cells. PB only causes cancer cells to undergo apoptosis, which is in line with our findings in BRCA cells (Ahmad et al. <a href="#fsn370720-bib-0003" class="usa-link" aria-describedby="fsn370720-bib-0003">2008</a>). The nontumorigenic prostate epithelial cell line, RWPE‐1, was unaffected by PB. Furthermore, PB (2 mg/kg body weight) delayed tumor growth in mice treated with DU145 cells for three weeks. Additionally, it reduced the tumor weight by 90%. It is interesting to note that the tumor did not develop more quickly for four weeks, even after quitting PB. This evidence suggests that PB suppresses hormone‐refractory prostate cancer cells. Furthermore, it effectively inhibited prostate cancer under both in vitro and in vivo conditions. (Powolny and Singh <a href="#fsn370720-bib-0097" class="usa-link" aria-describedby="fsn370720-bib-0097">2008</a>) discovered that exposure to PB can significantly reduce the viability of prostate cancer cells with different receptor status. Additionally, PB treatment promoted apoptosis, which was linked to the formation of ROS. N‐acetylcysteine (NAC) pre‐treatment of cells inhibited PB‐mediated ROS formation and apoptosis, indicating that ROS production is an important factor in PB‐induced apoptosis.</p></section><section id="fsn370720-sec-0011"><h4 class="pmc_sec_title">3.1.3. Ovarian Cancer</h4>
<p>Thasni et al. (<a href="#fsn370720-bib-0132" class="usa-link" aria-describedby="fsn370720-bib-0132">2008</a>) examined how different chemical capacities to suppress cell development in ER‐positive ovarian cancer cells (Powolny and Singh <a href="#fsn370720-bib-0097" class="usa-link" aria-describedby="fsn370720-bib-0097">2008</a>) depended on the BRCA1 (early onset) status of the cells. Plumbagin was the most effective of the chemicals studied. It induces apoptosis by attaching to and altering ER‐α in cells that have BRCA1 silenced. The cytotoxicity generated by PB was reduced upon silencing ER‐α. The chemotherapeutic potential of PB against ER‐positive tumors (Thasni et al. <a href="#fsn370720-bib-0132" class="usa-link" aria-describedby="fsn370720-bib-0132">2008</a>), which are deficient or have mutated BRCA1, was suggested in this report. The impact of tamoxifen, emodin, and PB on ER‐expressing (Srinivas, Annab, et al. <a href="#fsn370720-bib-0121" class="usa-link" aria-describedby="fsn370720-bib-0121"><sup>2004</sup></a>) and BRCA1‐silenced ovarian cancer cells was studied by Srinivas. The ratio was PB 4 tamoxifen 4 emodin; apoptosis induction was more effective in cells prevented by BRCA1. BRCA1‐blocked cells were nearly twice as susceptible to PB treatment as control cells, requiring a dosage of 2.68 mM to kill 50% of the cells. Accordingly, five milligrams of PB was required to destroy half of the BRCA1‐blocked cells, suggesting that PB may be a helpful therapeutic intervention for cancers caused by BRCA1 mutations.</p></section><section id="fsn370720-sec-0012"><h4 class="pmc_sec_title">3.1.4. Myeloma</h4>
<p>The known benefit of activating STAT‐3 is that it can slow down the development of cancer. Therefore, the inhibiting of STAT‐3 activation may be essential to stop the spread of the disease. Sandur et al. (<a href="#fsn370720-bib-0107" class="usa-link" aria-describedby="fsn370720-bib-0107">2010</a>) investigated the modulation of PB STAT‐3. Constitutively active STAT‐3 inhibited both constitutive and interleukin (IL)‐6‐inducible STAT‐3 phosphorylation, and this suppression was effective in plumbagin‐induced apoptosis. This study used the human multiple myeloma cell lines MM.1S and U266 to demonstrate that PB has a favorable effect. A prior study (Bringmann et al. <a href="#fsn370720-bib-0017" class="usa-link" aria-describedby="fsn370720-bib-0017">2008</a>), which examined the proliferation of the human multiple myeloma cell lines RPMI8226 and INA‐6 using Annexin V‐FITC/PI labeling, found no indication of PB impact. Dioncoquinone A and Dioncoquinone B, two naturally occurring naphthoquinones isolated from <em>Triphyophyllum peltatum</em>, were found to be effective against myeloma cell lines. Two naturally occurring naphthoquinones, dioncoquinone A and dioncoquinone B, isolated from 
<em>T. peltatum</em>
, were found to be effective against myeloma cell lines. According to these findings, PB may influence myeloma models in different ways, depending on the cell source. Further research is needed to fully understand the anticancer activity of PB in multiple myeloma.</p></section><section id="fsn370720-sec-0013"><h4 class="pmc_sec_title">3.1.5. Pancreating Cancer</h4>
<p>According to Chen et al. (<a href="#fsn370720-bib-0022" class="usa-link" aria-describedby="fsn370720-bib-0022">2009</a>), plumbagin possesses anticancer properties against pancreatic cancer and has the lowest chance of survival. The chemical had a dose‐dependent effect on the growth of Panc‐1 and BxPC‐3 pancreatic cancer cells. Plumbagin‐treated Panc‐1 cells showed morphological alterations that matched apoptosis, according to discoloration and transmission electron microscopy examinations. The number of apoptotic cells increased dramatically, and a variety of procedures have been utilized to assess apoptosis. Apoptosis‐inducing factor was overexpressed in the cytosol, mitochondrial transmembrane potential rapidly dropped, pro‐caspase‐9 and PARP (poly ADP‐ribose polymerase) were degraded, and Bax was increased following PB exposure. PB anticancer effects against prostate cancer have been studied by Chen and associates. It was shown that the fluorometric substrate assay activated caspase‐3 but not caspase‐8. In an orthotopic pancreatic tumor model, PB significantly reduced Panc‐1 xenograft development but had no discernible effect on body weight or leukocyte counts. Therefore, PB may be developed as a new treatment option for pancreatic cancer (Chen et al. <a href="#fsn370720-bib-0022" class="usa-link" aria-describedby="fsn370720-bib-0022">2009</a>).</p></section><section id="fsn370720-sec-0014"><h4 class="pmc_sec_title">3.1.6. Lung Cancer</h4>
<p>Currently, there is limited therapeutic success with various treatments for lung cancer. The cause of this is that non‐small‐cell lung cancer (NSCLC) develops resistance to regular treatment. PB dramatically reduced the proliferation of H460 cells compared to A549 cells, according to Gomathinayagam et al. (<a href="#fsn370720-bib-0040" class="usa-link" aria-describedby="fsn370720-bib-0040">2008</a>), who investigated the anticancer activities of PB against H460 and A549 NSCLC. EGFR‐mediated signaling was downregulated in these cells by 80% PB. Furthermore, activating caspase‐3 to induce apoptosis (Hsu et al. <a href="#fsn370720-bib-0053" class="usa-link" aria-describedby="fsn370720-bib-0053">2006</a>) and altering a number of cell cycle regulatory factors results in cell cycle arrest. PB has also been demonstrated to inhibit cell proliferation by inducing A549 cell death and cell cycle arrest and has been shown to alter the expression of numerous cell cycle‐regulating proteins, including p21, cyclin B1, Cdc2, Cdc25C, and others. Moreover, PB administration was found to trigger the mitochondrial apoptotic pathway, and a model employing naked mice further validated the anticancer impact. For PB, Acharya et al. (<a href="#fsn370720-bib-0001" class="usa-link" aria-describedby="fsn370720-bib-0001">2008</a>) evaluated its impact on cellular microtubules. Purified tubulin polymerization was effectively stopped by plumbagin, which also disrupted the interphase microtubule network in a dose‐dependent manner. The possible cause of the reported effects of PB was hypothesized to be the identification of the colchicine binding site of tubulin. Taken together, these results suggest that PB can be used to treat lung cancer as an anticancer drug. Further clinical research is needed to determine the therapeutic potential of this intriguing natural substance. PB was discovered to be an effective inhibitor of TPA‐induced invasion and migration in A549 cancer cells (Shieh et al. <a href="#fsn370720-bib-0112" class="usa-link" aria-describedby="fsn370720-bib-0112">2010</a>). PB's ability to decrease MMP and urokinase‐type plasminogen activator (uPA) expression has been connected to this activity.</p></section><section id="fsn370720-sec-0015"><h4 class="pmc_sec_title">3.1.7. Skin Carcinoma</h4>
<p>Plumbagin has been shown to have anticancer properties in human melanoma cells (Wang et al. <a href="#fsn370720-bib-0139" class="usa-link" aria-describedby="fsn370720-bib-0139">2008</a>). PB suppressed the growth of A375 cells by causing S‐G2/M cell cycle arrest and death of S2 cells. PB has the ability to prevent cancer and has been established in vivo. During PB therapy, cyclin B1, A, Cdc2, and Cdc25C levels decreased, while p21 levels increased. Activating caspase‐9 and changing Bax/Bcl‐2 ratio also caused apoptotic cell death. Additionally, PB suppresses cell growth (Nazeem et al. <a href="#fsn370720-bib-0088" class="usa-link" aria-describedby="fsn370720-bib-0088">2009</a>). Used A‐431 cells to examine the biological function of plumbagin in the redox recycling of copper, a transition metal, by employing ROS scavengers and neocuproine, a Cu(I)‐specific chelating agent, has demonstrated that PB anticancer actions are mediated via ROS and Cu(I). PB inhibits proliferation and induces death in SKBR3 BRCA cells, indicating its anticancer properties. Other researchers have also demonstrated the anticancer activity of PB against melanoma cells (Prasad et al. <a href="#fsn370720-bib-0099" class="usa-link" aria-describedby="fsn370720-bib-0099">1996</a>; Mandala Rayabandla et al. <a href="#fsn370720-bib-0082" class="usa-link" aria-describedby="fsn370720-bib-0082"><sup>2010</sup></a>).</p></section><section id="fsn370720-sec-0016"><h4 class="pmc_sec_title">3.1.8. Liver Cancer</h4>
<p>Plumbagin has been shown to reduce MMP‐2 and uPA (Jaiswal et al. <a href="#fsn370720-bib-0057" class="usa-link" aria-describedby="fsn370720-bib-0057">2002</a>; Shih et al. <a href="#fsn370720-bib-0113" class="usa-link" aria-describedby="fsn370720-bib-0113"><sup>2009</sup></a>) levels, preventing the migration and infiltration of HepG2 cells in liver cancer cells, it leads toinhibiting the growing liver cancer cells p300, located in close proximity to lysine acetyltransferase, is associated with numerous diseases due to its dysfunction, and it controls multiple genes. PB can inhibit p300‐mediated p53 acetylation and histone acetyltransferase activity in vivo (Ravindra et al. <a href="#fsn370720-bib-0103" class="usa-link" aria-describedby="fsn370720-bib-0103">2009</a>). PB, by inhibiting p300 histone acetyltransferase activity, may affect a number of genes associated with illnesses, such as cancer. The hydroxyl group of PB forms a hydrogen bond with the lysine 1358 residue of p300, according to the study. This functional group is important because PB derivatives with altered or replaced C‐5 hydroxyl groups lose their ability to inhibit acetyltransferase. PB administration increases gluconeogenic enzyme levels, indicating a mechanism for the anticarcinogenic effects of 3‐methyl‐4‐dimethylaminoazobenzene (3MeDAB) ‐induced hepatoma (Parimala and Sachdanandam <a href="#fsn370720-bib-0093" class="usa-link" aria-describedby="fsn370720-bib-0093">1993</a>). Forty Wistar male rats with 3MeDAB‐induced hepatoma, PB (4 mg/kg body weight), were found to dramatically inhibit tumor growth. PB was previously found to be cytotoxic to the hepatoma cell line HEPA‐3B (Kuo et al. <a href="#fsn370720-bib-0072" class="usa-link" aria-describedby="fsn370720-bib-0072">1997</a>).</p></section><section id="fsn370720-sec-0017"><h4 class="pmc_sec_title">3.1.9. Renal Cancer</h4>
<p>NAD(P)H oxidase Nox‐4 is found in the kidney and is predominantly expressed in brain tumor cells (LN229) and human embryonic kidney 293 (HEK293) cells. Ding et al. (<a href="#fsn370720-bib-0027" class="usa-link" aria-describedby="fsn370720-bib-0027">2005</a>) used lucigenin‐dependent chemiluminescence to investigate the effect of plumbagin (PB) on Nox‐4 activity in HEK293 cells. This study also used LN229 brain tumor cells. PB suppressed Nox‐4 activity in HEK293 and LN229 cells in a dose‐ and time‐dependent manner. The superoxide inhibitor diphenyleneiodonium, which inhibits NADPH oxidase, inhibited HEK293 cells. HEK293 cells required both NADPH and NADH to produce superoxide, demonstrating that NADPH oxidase in these cells produced superoxide, but not the lucigenin redox cycle. PB also inhibited Nox‐4's superoxide generation. The COS‐7 cells were then transfected. PB has shown that PB directly blocks Nox‐4 activity in several investigations.</p></section><section id="fsn370720-sec-0018"><h4 class="pmc_sec_title">3.1.10. Cervical Cancer</h4>
<p>To treat cervical carcinoma, Kuo et al. (<a href="#fsn370720-bib-0072" class="usa-link" aria-describedby="fsn370720-bib-0072">1997</a>) used the HeLa cell line to establish plumbagin's (PB) anticancer properties. Srinivas, Gopinath, et al. (<a href="#fsn370720-bib-0122" class="usa-link" aria-describedby="fsn370720-bib-0122">2004</a>) investigated the efficacy of PB treatment in human cervical cancer cells, ME 180. Their data indicate that the PB was effective suppressors of cell division. PB therapy induces apoptosis by activating caspase‐3 and caspase‐9, phosphatidylserine migration, nuclear condensation, and DNA fragmentation. A fluorescence test was performed to determine whether PB and its quinone derivatives were cytotoxic to HeLa cells (Montoya et al. <a href="#fsn370720-bib-0083" class="usa-link" aria-describedby="fsn370720-bib-0083">2004</a>). Apoptosis was identified by morphological changes caused by these chemicals, including blebbing and nuclear condensation. PB can be employed with C33A cells because it has been demonstrated to cause apoptosis in these cells and has been demonstrated to cause C33A (Nair et al. <a href="#fsn370720-bib-0085" class="usa-link" aria-describedby="fsn370720-bib-0085">2008</a>) cells to undergo apoptosis. When paired with modest radiation dosages, it efficiently inhibits cell proliferation without requiring high radiation dosages.</p></section><section id="fsn370720-sec-0019"><h4 class="pmc_sec_title">3.1.11. Inhibition of NF‐kB Activity</h4>
<p>Plumbagin significantly reduces NF‐kB activation caused by various stressors (Sandur et al. <a href="#fsn370720-bib-0107" class="usa-link" aria-describedby="fsn370720-bib-0107">2010</a>). PB inhibits constitutive NF‐kB in cancer cells, which inhibits downstream NF‐κB‐regulated gene products, as demonstrated in this study. These findings suggest that PB may have radiosensitizing, cell growth‐modifying, and anticarcinogenic effects. Our findings revealed dose‐dependent inhibition of endogenous NF‐kB when PB levels in BRCA cells were increased. This effect was observed in both ER‐negative MDA‐MB‐231 and ER‐positive MCF‐7 cells, suggesting a way to eliminate both cell types. PB inhibits the NF‐κB/Bcl‐2 pathway, which causes apoptosis in BRCA cells. Suppression of the NF‐kB/Bcl‐2 pathway by PB could be clinically significant for treating advanced and refractory BRCAs, as NF‐kB activity and Bcl‐2 expression are associated with chemotherapy resistance (Buchholz et al. <a href="#fsn370720-bib-0018" class="usa-link" aria-describedby="fsn370720-bib-0018">2005</a>). Table <a href="#fsn370720-tbl-0003" class="usa-link">3</a> shows the anticancer activities of the action of plumbagin.</p>
<section class="tw xbox font-sm" id="fsn370720-tbl-0003"><h5 class="obj_head">TABLE 3.</h5>
<div class="caption p"><p>Anticancer activities of plumbagin with mechanism of action.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">S. No</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Types of cancer</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Research models</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Pathways/mechanism affected by plumbagin</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="8" valign="top" colspan="1">1</td>
<td align="center" rowspan="8" valign="top" colspan="1">Leukemia</td>
<td align="center" valign="top" rowspan="1" colspan="1">APL cell line NB4</td>
<td align="center" valign="top" rowspan="1" colspan="1">Modulation of mitochondrial pathway</td>
<td align="center" valign="top" rowspan="1" colspan="1">Zhao and Lu (<a href="#fsn370720-bib-0150" class="usa-link" aria-describedby="fsn370720-bib-0150">2006</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">NOD/SCID mice with NB4 tumor xenograft</td>
<td align="center" valign="top" rowspan="1" colspan="1">Formation of ROS</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sun and McKallip (<a href="#fsn370720-bib-0126" class="usa-link" aria-describedby="fsn370720-bib-0126">2011</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">K562 human chronic myelogenous leukemia cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Formation of ROS and increased expression of TRAIL death receptor</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bae et al. (<a href="#fsn370720-bib-0009" class="usa-link" aria-describedby="fsn370720-bib-0009">2016</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">T‐cell acute lymphoblastic leukemia MOLT‐4 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Augmentation of caspase‐dependent apoptosis</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bae et al. (<a href="#fsn370720-bib-0009" class="usa-link" aria-describedby="fsn370720-bib-0009">2016</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">CLL cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Reduction of Bcl‐2 and increase in the level of Bax protein</td>
<td align="center" valign="top" rowspan="1" colspan="1">Uttarkar et al. (<a href="#fsn370720-bib-0137" class="usa-link" aria-describedby="fsn370720-bib-0137">2016</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">AML cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibition of c‐Myb binding to coactivator p300</td>
<td align="center" valign="top" rowspan="1" colspan="1">Uttarkar et al. (<a href="#fsn370720-bib-0137" class="usa-link" aria-describedby="fsn370720-bib-0137">2016</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">HL‐60 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Formation of ROS and selective inhibition of thioredoxin reductase</td>
<td align="center" valign="top" rowspan="1" colspan="1">Zhang et al. (<a href="#fsn370720-bib-0148" class="usa-link" aria-describedby="fsn370720-bib-0148">2017</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">HLK‐1 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Increased expression of TRAIL death receptor, activation of caspase‐8 and inhibition of cFLIP</td>
<td align="center" valign="top" rowspan="1" colspan="1">Kong et al. (<a href="#fsn370720-bib-0068" class="usa-link" aria-describedby="fsn370720-bib-0068">2017</a>)</td>
</tr>
<tr>
<td align="left" rowspan="5" valign="top" colspan="1">2</td>
<td align="center" rowspan="5" valign="top" colspan="1">Breast cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">MDA‐MB‐231 and MCF‐7 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibition of Akt/mammalian target of rapamycin pathway, inactivation of Bcl‐2 and NF‐κB and arrest of G2‐M cell cycle</td>
<td align="center" valign="top" rowspan="1" colspan="1">Kuo et al. (<a href="#fsn370720-bib-0071" class="usa-link" aria-describedby="fsn370720-bib-0071">2006</a>) and Ahmad et al. (<a href="#fsn370720-bib-0003" class="usa-link" aria-describedby="fsn370720-bib-0003">2008</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">MDA‐MB‐231 and BT474 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Decreased expression of chemokine receptor XCR4</td>
<td align="center" valign="top" rowspan="1" colspan="1">Kawiak et al. (<a href="#fsn370720-bib-0063" class="usa-link" aria-describedby="fsn370720-bib-0063">2012</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">SKBR3 and BT474 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Decreased levels of anti‐apoptotic Bcl‐2 and increased levels of pro‐apoptotic Bcl‐2 family of Proteins</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yan et al. (<a href="#fsn370720-bib-0142" class="usa-link" aria-describedby="fsn370720-bib-0142">2014</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">MDA‐MB‐231SA cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Reduced bone erosion area, number of TRAcP positive osteoclasts and prevented decrease in bone tissue volume</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sung et al. (<a href="#fsn370720-bib-0128" class="usa-link" aria-describedby="fsn370720-bib-0128">2012</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Mice with human breast cancer‐induced osteolytic bone metastasis</td>
<td align="center" valign="top" rowspan="1" colspan="1">Abrogated the RANKL triggered NF‐κB and MAPK signaling pathways by blocking association of RANK with TRAF6 in osteoclastogenesis</td>
<td align="center" valign="top" rowspan="1" colspan="1">Lee et al. (<a href="#fsn370720-bib-0074" class="usa-link" aria-describedby="fsn370720-bib-0074">2012</a>) and Zhang et al. (<a href="#fsn370720-bib-0155" class="usa-link" aria-describedby="fsn370720-bib-0155">2016</a>)</td>
</tr>
<tr>
<td align="left" rowspan="5" valign="top" colspan="1"></td>
<td align="center" rowspan="5" valign="top" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">MCF‐7 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Upregulation of p53 and p21 mediated arrest of G1 cell cycle, and inhibition of PI‐5 kinase to generate ROS</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yan et al. (<a href="#fsn370720-bib-0141" class="usa-link" aria-describedby="fsn370720-bib-0141">2013</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Human breast cancer MDA‐MB‐231SArfp cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibition of Stat3 signaling and downregulation of TGF‐β, IL‐1α, MMP‐2 and MMP‐9</td>
<td align="center" valign="top" rowspan="1" colspan="1">Somasundaram et al. (<a href="#fsn370720-bib-0118" class="usa-link" aria-describedby="fsn370720-bib-0118">2016</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">BRCA1‐defective breast cancer cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Formation of ROS to suppress plasticity of breast cancer stem cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Nair et al. (<a href="#fsn370720-bib-0084" class="usa-link" aria-describedby="fsn370720-bib-0084">2016</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Homologous recombination defective triple negative BRCA1 mutant cells, and cancer bearing mice</td>
<td align="center" valign="top" rowspan="1" colspan="1">Formation of ROS to trigger DNA double‐strand breaks</td>
<td align="center" valign="top" rowspan="1" colspan="1">Kawiak et al. (<a href="#fsn370720-bib-0062" class="usa-link" aria-describedby="fsn370720-bib-0062">2017</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">HER2‐overexpressing breast cancer cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibition of IKKα mediated activation of NF‐κB. MCF‐7 and T47D cells Inhibition of glucose regulated protein 78 and upregulation of Bik</td>
<td align="center" valign="top" rowspan="1" colspan="1">Powolny and Singh (<a href="#fsn370720-bib-0097" class="usa-link" aria-describedby="fsn370720-bib-0097">2008</a>)</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">3</td>
<td align="center" rowspan="4" valign="top" colspan="1">Prostate cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">PC‐3, LNCaP, and C4‐2 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Formation of ROS and depletion of intracellular GSH levels</td>
<td align="center" valign="top" rowspan="1" colspan="1">Lai et al. (<a href="#fsn370720-bib-0073" class="usa-link" aria-describedby="fsn370720-bib-0073">2012</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Prostate cancer xenograft mouse models</td>
<td align="center" valign="top" rowspan="1" colspan="1">Blockade of Ras/Rac/cofilin and Ras/MEK signaling pathways mediated by VEGFR2 in HUVECs</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hafeez et al. (<a href="#fsn370720-bib-0047" class="usa-link" aria-describedby="fsn370720-bib-0047">2012</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Excised prostate tumor tissues</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibition of the expression of PKCε, Stat3, proliferating cell nuclear antigen and neuroendocrine markers (synaptophysin and chromogranin‐A)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hafeez et al. (<a href="#fsn370720-bib-0046" class="usa-link" aria-describedby="fsn370720-bib-0046">2013</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PC‐3M‐luciferase cells in an orthotopic xenograft mouse model</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibition of the expression of PKCε, p Stat3Tyr705, and p Stat3Ser727, Stat3 downstream target genes survivin and Bcl(xL), proliferative markers Ki‐67 and PCNA, metastatic marker MMP9, MMP2, and uPA, and angiogenesis markers CD31 and VEGF</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hafeez et al. (<a href="#fsn370720-bib-0044" class="usa-link" aria-describedby="fsn370720-bib-0044">2015</a>)</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1"></td>
<td align="center" rowspan="4" valign="top" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Primary and CRPC in PTEN‐KO mice</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibition of PKCε, Stat3, AKT, and EMT markers (vimentin and slug)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Qiu et al. (<a href="#fsn370720-bib-0101" class="usa-link" aria-describedby="fsn370720-bib-0101">2015</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PC‐3 and DU145 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibition of epithelial‐to‐mesenchymal transition, and sirtuin1‐ and PI3K/Akt/mTOR‐mediated pathways</td>
<td align="center" valign="top" rowspan="1" colspan="1">Zhou et al. (<a href="#fsn370720-bib-0151" class="usa-link" aria-describedby="fsn370720-bib-0151">2015</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Hormone‐refractory prostate cancer cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Formation of ROS</td>
<td align="center" valign="top" rowspan="1" colspan="1">Huang et al. (<a href="#fsn370720-bib-0054" class="usa-link" aria-describedby="fsn370720-bib-0054">2018</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PTEN‐P2 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Modulation of gene expression through androgen receptor</td>
<td align="center" valign="top" rowspan="1" colspan="1">Son et al. (<a href="#fsn370720-bib-0119" class="usa-link" aria-describedby="fsn370720-bib-0119">2010</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Ovarian cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Suppress cell development in ER‐positive ovarian cancer cells depended on the BRCA1</td>
<td align="center" valign="top" rowspan="1" colspan="1">Helpful therapeutic intervention for cancers caused by BRCA1 mutations</td>
<td align="center" valign="top" rowspan="1" colspan="1">Thasni et al. (<a href="#fsn370720-bib-0132" class="usa-link" aria-describedby="fsn370720-bib-0132">2008</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Myeloma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Activating STAT‐3</td>
<td align="center" valign="top" rowspan="1" colspan="1">Slow down the development of cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sandur et al. (<a href="#fsn370720-bib-0107" class="usa-link" aria-describedby="fsn370720-bib-0107">2010</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Pancreatic cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Treated Panc‐1 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Significantly reduced Panc‐1 xenograft development</td>
<td align="center" valign="top" rowspan="1" colspan="1">Chen et al. (<a href="#fsn370720-bib-0022" class="usa-link" aria-describedby="fsn370720-bib-0022">2009</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Lung cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Reduced the proliferation of H460 cells when compared to A549 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ability to decrease MMP and urokinase‐type plasminogen activator (uPA) expression</td>
<td align="center" valign="top" rowspan="1" colspan="1">Shieh et al. (<a href="#fsn370720-bib-0112" class="usa-link" aria-describedby="fsn370720-bib-0112">2010</a>) and Gomathinayagam et al. (<a href="#fsn370720-bib-0040" class="usa-link" aria-describedby="fsn370720-bib-0040">2008</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Skin carcinoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cell growth in A375 by causing S‐G2/M cell cycle arrest and death S2 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibits proliferation and induces death in SKBR3 BRCA cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Prasad et al. (<a href="#fsn370720-bib-0099" class="usa-link" aria-describedby="fsn370720-bib-0099">1996</a>) and Mandala Rayabandla et al. (<a href="#fsn370720-bib-0082" class="usa-link" aria-describedby="fsn370720-bib-0082">2010</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Liver cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibit p300‐mediated p53 acetylation and histone acetyltransferase</td>
<td align="center" valign="top" rowspan="1" colspan="1">Reduce MMP‐2 and uPAlevels, preventing liver cancer cells from migrating and infiltrating HepG2 cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Jaiswal et al. (<a href="#fsn370720-bib-0057" class="usa-link" aria-describedby="fsn370720-bib-0057">2002</a>) and Shih et al. (<a href="#fsn370720-bib-0113" class="usa-link" aria-describedby="fsn370720-bib-0113">2009</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Renal cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">NADPH and NADH to produce superoxide</td>
<td align="center" valign="top" rowspan="1" colspan="1">Block Nox‐4 activity</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ding et al. (<a href="#fsn370720-bib-0027" class="usa-link" aria-describedby="fsn370720-bib-0027">2005</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">Cervical cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">HeLa cell line</td>
<td align="center" valign="top" rowspan="1" colspan="1">Inhibits cell proliferation</td>
<td align="center" valign="top" rowspan="1" colspan="1">Nair et al. (<a href="#fsn370720-bib-0085" class="usa-link" aria-describedby="fsn370720-bib-0085">2008</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/fsn370720-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="fsn370720-sec-0020"><h3 class="pmc_sec_title">3.2. Antibacterial Activity of Plumbagin</h3>
<p>Several studies have reported the antibacterial action of plumbagin. PB can effectively treat germs resistant to antibiotic therapy. The bacterium 
<em>Staphylococcus aureus</em>
 is a gram‐positive bacterium, and 
<em>Candida albicans</em>
 can co‐infect and cause sepsis, pneumonia, skin infections, urinary tract infections, and disorders linked to biofilms (Nair et al. <a href="#fsn370720-bib-0085" class="usa-link" aria-describedby="fsn370720-bib-0085">2008</a>). PB exhibits significant antimicrobial activity against 
<em>C. albicans</em>
 and 
<em>S. aureus</em>
 (Rondevaldova et al. <a href="#fsn370720-bib-0105" class="usa-link" aria-describedby="fsn370720-bib-0105">2015</a>). PB is effective in preventing Gram‐negative 
<em>Escherichia coli</em>
 and 
<em>S. aureus</em>
 from developing antibiotic resistance (Durga et al. <a href="#fsn370720-bib-0030" class="usa-link" aria-describedby="fsn370720-bib-0030">1990</a>). Additionally, it improved the antibacterial efficacy of tetracycline and oxacillin against 
<em>S. aureus</em>
 strains that were resistant to these drugs. PB boosted the antifungal efficacy of amphotericin B against 
<em>C. albicans</em>
. <em>Mycobacterium tuberculosis</em> (MTB) has been found to be resistant to both first‐ and second‐line anti‐tuberculosis medications. Plumbagin appeared to have good results. When it came to resistant 
<em>Helicobacter pylori</em>
 and Mycobacterium TB, PB showed encouraging results. By lowering polymerase activity and nucleoprotein production, 
<em>P. indica</em>
 extract suppresses the influenza A (H1N1) pdm09 virus (Hassan et al. <a href="#fsn370720-bib-0049" class="usa-link" aria-describedby="fsn370720-bib-0049">2016</a>). Additionally, PB may have anti‐measles and anti‐hepatitis C virus effects, and in some areas, leishmaniasis, a disease transmitted by infected sandflies, poses a serious threat to public health. PB suppresses <em>Leishmania donovani, L
</em>

<em>. mexicana</em>
, and <em>L. amazonensis</em>. Chagas disease is caused by the protozoan parasite <em>Trypanosoma cruzi,</em> which can cause major damage to digestive and cardiac systems. PB has been shown to have antitrypanosomal properties. PB has been found in vitro to be effective against both 3D7 chloroquine‐sensitive malaria parasites and K1 chloroquine‐resistant <em>Plasmodium falciparum</em> clones; when mice were infected with the <em>Plasmodium berghei</em> ANKA strain, PB showed antimalarial activity (Sumsakul et al. <a href="#fsn370720-bib-0124" class="usa-link" aria-describedby="fsn370720-bib-0124">2014</a>). There is evidence that PB deters mosquitoes as well (Pradeepa et al. <a href="#fsn370720-bib-0098" class="usa-link" aria-describedby="fsn370720-bib-0098">2016</a>) (Figure <a href="#fsn370720-fig-0003" class="usa-link">3</a>). The antibacterial and antiviral properties of plumbagin greatly enhance its therapeutic potential, particularly for drug‐resistant infections, chronic microbial illnesses, and new viral threats (Figure <a href="#fsn370720-fig-0003" class="usa-link">3</a>). Given its diverse modes of action and potential synergy with current medications, it is a promising candidate for further pharmacological development (Table <a href="#fsn370720-tbl-0004" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/34c12679275b/FSN3-13-e70720-g011.jpg" loading="lazy" id="jats-graphic-7" height="505" width="664" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Antibacterial activity of Plumbagin.</p></figcaption></figure><section class="tw xbox font-sm" id="fsn370720-tbl-0004"><h4 class="obj_head">TABLE 4.</h4>
<div class="caption p"><p>Plumbagin antimicrobial and antiviral activity.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">S. No</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Activity</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Mechanism of action</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">1</td>
<td align="center" rowspan="3" valign="top" colspan="1">Broad‐spectrum antibacterial and antifungal activity</td>
<td align="center" valign="top" rowspan="1" colspan="1">Plumbagin demonstrates significant activity against both Gram‐positive and Gram‐negative bacteria, as well as fungal species such as 
<em>C. albicans</em>

</td>
<td align="center" valign="top" rowspan="1" colspan="1">Chen, Yin, Wu, et al. (<a href="#fsn370720-bib-0021" class="usa-link" aria-describedby="fsn370720-bib-0021">2020</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>Disruption of bacterial membranes, Induction of reactive oxygen species (ROS) leading to oxidative stress</p>
<p>Inhibition of quorum sensing and biofilm formation, which is critical in chronic infections and antibiotic resistance</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Razavi et al. (<a href="#fsn370720-bib-0104" class="usa-link" aria-describedby="fsn370720-bib-0104">2023</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Synergistic effects with antibiotics</td>
<td align="center" valign="top" rowspan="1" colspan="1">Chen, Yin, Peng, et al. (<a href="#fsn370720-bib-0023" class="usa-link" aria-describedby="fsn370720-bib-0023">2020</a>)</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">2</td>
<td align="center" rowspan="2" valign="top" colspan="1">Antiviral</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>Inhibition of viral replication</p>
<p>Plumbagin has demonstrated inhibitory effects on replication of viruses such as herpes simplex virus (HSV) and has shown potential activity against HIV by interfering with viral enzymes and disrupting the redox balance necessary for viral survival</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Susithra et al. (<a href="#fsn370720-bib-0130" class="usa-link" aria-describedby="fsn370720-bib-0130">2016</a>)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>Immunomodulatory effects</p>
<p>Plumbagin modulates immune responses by influencing cytokine production and inflammatory signaling pathways, which may enhance host resistance to viral infections</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Aronsson et al. (<a href="#fsn370720-bib-0006" class="usa-link" aria-describedby="fsn370720-bib-0006">2016</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/fsn370720-tbl-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="fsn370720-sec-0021"><h3 class="pmc_sec_title">3.3. Antifungal Activity</h3>
<p>PB inhibits the growth of 12 filamentous fungi and yeast pathogens, including <em>Aspergillus flavus</em>, 
<em>A. niger</em>
, <em>Alternaria</em> sp., 
<em>C. albicans</em>
, 
<em>C. glabrata</em>
, and 
<em>C. krusei</em>
, as well as 
<em>Cryptococcus neoformans</em>
, 
<em>C. tropicalis</em>
, <em>Cladosporium</em>, <em>Geotrichum candidum</em>, <em>Fusarium</em>, and <em>Penicillium</em>. Comparing PB to the control medication ketoconazole, this study indicated PB to be a potential antifungal agent (Dzoyem et al. <a href="#fsn370720-bib-0031" class="usa-link" aria-describedby="fsn370720-bib-0031">2007</a>). Mahoney et al. (<a href="#fsn370720-bib-0080" class="usa-link" aria-describedby="fsn370720-bib-0080">2000</a>) investigated the effects of aflatoxigenesis and fungal vitality of walnuts on four naphthoquinones: juglone, menadione, PB, and 1,4‐naphthoquinone. At higher concentrations, quinones reduced 
<em>A. flavus</em>
 growth and delayed germination. Aflatoxigenesis and decreased fungal vitality have been associated with structural features including 2‐methyl and 5‐hydroxyl substituents. PB has been shown to inhibit <em>Pleurotus sajor‐caju</em>, a white‐rot basidiomycete, from growing on malt agar plates (Curreli et al. <a href="#fsn370720-bib-0025" class="usa-link" aria-describedby="fsn370720-bib-0025">2001</a>) (Figure <a href="#fsn370720-fig-0004" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/2c1f240af202/FSN3-13-e70720-g004.jpg" loading="lazy" id="jats-graphic-9" height="378" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Plumbagin mediated molecular mechanism of antifungal activity.</p></figcaption></figure></section><section id="fsn370720-sec-0022"><h3 class="pmc_sec_title">3.4. Anti‐Inflammatory and Antioxidant Properties</h3>
<p>Plumbagin has numerous pharmacological and therapeutic benefits. The anti‐inflammatory and antioxidant properties of PB help treat a wide range of ailments. PB has been found in various well‐researched in vitro and in vivo pharmacological studies to have positive antioxidant and anti‐inflammatory activities. Unbalanced levels of ROS and antioxidants promote oxidative stress, resulting in mitochondrial failure and increased astrocyte and microglia activation. These cells generate chemokines and inflammatory cytokines that encourage neuronal death and cellular apoptosis (Luo et al. <a href="#fsn370720-bib-0079" class="usa-link" aria-describedby="fsn370720-bib-0079">2024</a>). Numerous pathogenic mechanisms, including oxidative stress, inflammation, imbalanced neurotransmitters, mitochondrial dysfunction, apoptosis, and hereditary factors, can cause neuronal degeneration. Numerous studies have indicated the importance of inflammation is important (Sukkasem et al. <a href="#fsn370720-bib-0123" class="usa-link" aria-describedby="fsn370720-bib-0123">2016</a>). These include oxidative stress and neurodegenerative disease. PB has been shown in animal models of Alzheimer's disease to reduce neuroinflammation and oxidative stress by increasing GSH levels, inhibiting lipid peroxidation and ROS production, and lowering the levels of pro‐inflammatory cytokines (TNF‐α, IL‐6, IL‐1β, and IL‐1α), MDA, iNOS, NF‐κB, COX‐2, and NO. PB‐supported mice with behavioral and neurochemical deficiencies by lowering inflammation (IL‐1β) and oxidative stress (MDA, nitrite) (Poprac et al. <a href="#fsn370720-bib-0096" class="usa-link" aria-describedby="fsn370720-bib-0096">2017</a>). In neurodegenerative disorders, PB may possess antioxidant and anti‐inflammatory properties, and the production of free radicals might result in neuroinflammation and nitro‐oxidative stress. It is thought that the underlying cause of neurobehavioral problems is free radicals, which produce neuroinflammation and nitro‐oxidative stress (Kumar and Pandey <a href="#fsn370720-bib-0070" class="usa-link" aria-describedby="fsn370720-bib-0070">2015</a>) Plumbagin's anti‐inflammatory activity contributes to its potential therapeutic effects in managing chronic inflammatory conditions such as rheumatoid arthritis (RA). Plumbagin inhibits immune cell infiltration, reduces cytokine levels, and decreases joint inflammation in animal models of RA. Inflammatory Bowel Disease (IBD)‐ In experimental models of colitis, plumbagin decreases myeloperoxidase activity, inhibits inflammatory mediators, and enhances colon histology. In neurodegenerative diseases and neuroinflammation, plumbagin lowers the release of inflammatory cytokines and microglial activation, both of which are linked to neurodegenerative illnesses such as Parkinson's and Alzheimer's. Because plumbagin inhibits NF‐κB, reduces pro‐inflammatory mediators, and regulates oxidative stress, it has anti‐inflammatory properties that make it a potential therapeutic candidate for the treatment of chronic inflammatory illnesses. Nevertheless, additional clinical studies and formulation development (such as nanocarriers) are required to fully realize their therapeutic potential because of the possible cytotoxicity and bioavailability problems. Research has shown that PB has anti‐inflammatory and antioxidant properties in animal models of spinal cord injury, depression, cerebral ischemia, neuropathic pain, and chronic autoimmune diseases, including encephalomyelitis. For it to function, inflammatory mediators and ROS are inhibited (Verma and Goyal <a href="#fsn370720-bib-0138" class="usa-link" aria-describedby="fsn370720-bib-0138">2024</a>) (Figure <a href="#fsn370720-fig-0005" class="usa-link">5</a>).</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0005"><h4 class="obj_head">FIGURE 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/5fb69bae6bf1/FSN3-13-e70720-g002.jpg" loading="lazy" id="jats-graphic-11" height="488" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Molecular mechanism of antioxidant and anti‐inflammatory activity by plumbagin.</p></figcaption></figure></section><section id="fsn370720-sec-0023"><h3 class="pmc_sec_title">3.5. Anti‐Hypertension Activity</h3>
<p>This study used both in vitro and in vivo approaches to investigate the ability of plumbagin to reduce blood pressure in rats. The indicator of high blood pressure is that heart output and vascular resistance increase when vascular smooth muscle cells contract or relax, according to a study by Foëx and Sear (<a href="#fsn370720-bib-0036" class="usa-link" aria-describedby="fsn370720-bib-0036">2004</a>). The effectiveness of plumbagin in reducing blood pressure was examined in this study using an invasive blood pressure (IBP) instrument, which is the gold standard for measuring blood pressure (Parasuraman and Raveendran <a href="#fsn370720-bib-0092" class="usa-link" aria-describedby="fsn370720-bib-0092">2012</a>). The isolated rat thoracic aorta was used to evaluate vascular tension changes, whereas isolated right atrial strips were used to determine cardiac depressant effects based on the contraction force and rate. Plumbagin was administered intravenously to normally anesthetized patients, and the dose‐dependent effect of plumbagin was demonstrated by a notable reduction in mean arterial pressure (MAP) in rats administered the injection intravenously while under standard anesthesia. PB reduced the MAP by approximately 34% when administered at a dose of 10 mg/kg. The vascular pathways that PB uses to reduce blood pressure were studied in vitro on aortas that had been isolated from rats. PB was evaluated in restricted aortic rings with intact or injured endothelial cells to ascertain whether it operates through endothelium‐dependent or endothelium‐independent mechanisms. Phenylephrine and high Kþ vasoconstrictors caused plumbagin to respond in a distinct biphasic manner, inducing a brief rise in aortic tissue vasoconstriction followed by progressive relaxation. It has been demonstrated that plumbagin increases the contraction of the renal and mesenteric arteries in rats when phenylephrine is applied (Kim et al. <a href="#fsn370720-bib-0065" class="usa-link" aria-describedby="fsn370720-bib-0065">2017</a>). By binding to α1‐receptors in the smooth muscle, phenylephrine triggers G‐protein‐coupled processes that activate IP3 and DAG. Calcium is subsequently released from intracellular reserves and enters the extracellular calcium channels as a result. High Kþ levels stimulate calcium influx via voltage‐dependent L‐type Ca<sup>2+</sup> channels, causing vascular smooth muscles to contract (Qamar et al. <a href="#fsn370720-bib-0100" class="usa-link" aria-describedby="fsn370720-bib-0100">2018</a>). According to the findings, PB may act on voltage‐dependent calcium channels (VDCC) to limit calcium influx or restrict calcium release from intracellular reserves. It decreased the contractions caused by elevated Kþ and PE in aortic preparations. Calcium chloride (CaCl<sub>2</sub>) concentration response curves (CRCs) in an EDTA‐Krebs solution with and without 30 μM PB and without Ca<sup>2+</sup> were made in order to evaluate the compound's efficacy against voltage‐dependent calcium channels (VDCCs). These novel findings about the hypotensive qualities of PB may indicate its possible use in the management of hypertension. Previous studies have demonstrated the antioxidant, anti‐inflammatory, anti‐atherosclerotic, and cardioprotective properties of PB. PB exerts its antihypertensive effects and the mechanisms involved in its potential to regulate blood pressure. Recent research has shown that plumbagin, a naturally occurring naphthoquinone, exerts antihypertensive effects through several mechanisms. Plumbagin prevents calcium from entering vascular smooth muscle cells and causes vasodilation. In vitro tests using rat aortic rings demonstrated that plumbagin shifted the calcium concentration‐response curves to the right, which is comparable to the effect of the well‐known calcium channel blocker nifedipine. Accordingly, plumbagin lowers blood pressure by acting as a calcium antagonist and by lowering vascular resistance. Plumbagin decreased contraction power and heart rate in isolated rat atrial tissues. The fact that pretreatment with atropine or atenolol did not alter these effects suggests that plumbagin acts without the assistance of muscarinic and beta‐adrenergic receptors. One of the ways to lower blood pressure is by decreasing cardiac output. The vasorelaxant effects of plumbagin were apparent even after the vascular endothelium was removed and were not affected by the inhibition of guanylate cyclase (using methylene blue) or nitric oxide synthase (using L‐NAME). This suggests that its vasodilatory activity is independent of the NO pathway originating from the endothelium. Inhibition of Intracellular Calcium Release: Plumbagin clearly inhibited phenylephrine‐induced contractions in rat aortic rings in the absence of calcium, indicating that it obstructs intracellular calcium release, which adds to its vasodilatory effects (Ahmad et al. <a href="#fsn370720-bib-0004" class="usa-link" aria-describedby="fsn370720-bib-0004">2022</a>). Future studies on the effects of PB on hypertension and cardiovascular illnesses may be possible given its features, vasorelaxant action, and adverse chronotropic and inotropic effects (Ahmad et al. <a href="#fsn370720-bib-0004" class="usa-link" aria-describedby="fsn370720-bib-0004">2022</a>) (Figure <a href="#fsn370720-fig-0006" class="usa-link">6</a>).</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0006"><h4 class="obj_head">FIGURE 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/76ce717a9680/FSN3-13-e70720-g006.jpg" loading="lazy" id="jats-graphic-13" height="534" width="709" alt="FIGURE 6"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Plumbagin mediated mechanism of antihypertensive activity.</p></figcaption></figure></section><section id="fsn370720-sec-0024"><h3 class="pmc_sec_title">3.6. Anti‐Ulcer Activity</h3>
<p>This study focused on 
<em>P. zeylanica</em>
 antiulcer; the aqueous root extract of 
<em>P. zeylanica</em>
 offers similar protection against aspirin‐induced and indomethacin‐induced ulcers, in contrast to the well‐known antiulcer drug omeprazole. 
<em>Plumbago zeylanica</em>
 may protect against stomach lesions caused by aspirin and indomethacin by inhibiting 5‐lipoxygenase activity (Shaikh et al. <a href="#fsn370720-bib-0110" class="usa-link" aria-describedby="fsn370720-bib-0110">2015</a>). Furthermore, the protective action of the extract may be linked to the phytochemical compounds identified in many reports from previous studies (Shaikh et al. <a href="#fsn370720-bib-0110" class="usa-link" aria-describedby="fsn370720-bib-0110">2015</a>). 
<em>Plumbago zeylanica</em>
 roots contain astringent tannins, which could account for the antimicrobial effect and support an antiulcer effect. Lipids containing unsaturated fatty acids and many double bonds are particularly susceptible to the effects of free radicals among biological substances. Lipid peroxidation damages cellular membranes and causes significant structural and functional damage. Lipid peroxidation is being intensively investigated in relation to disease and its control by antioxidants in various contexts. This procedure generates numerous by‐products that affect locations other than those where they are produced; consequently, they behave as toxic secondary messengers. Oxidation leads to lipid degradation, often known as rancidity (Li et al. <a href="#fsn370720-bib-0077" class="usa-link" aria-describedby="fsn370720-bib-0077">2025</a>). Fission of cyclic endoperoxidases produces malondialdehyde (MDA). MDA and thiobarbituric acid were combined to make an addict. The selected plants exhibited antioxidant activity, supporting an anti‐free radical mechanism.</p>
<p>Therefore, extracts may serve as antioxidants to prevent the overproduction of reactive oxygen species (Sun et al. <a href="#fsn370720-bib-0125" class="usa-link" aria-describedby="fsn370720-bib-0125">2023</a>). Ulceration weakens antioxidant defenses, resulting in membrane damage and harmful effects. Research has indicated that plants with high antioxidant activity can decrease free radicals in biomolecules. This species, with its antioxidant activity, demonstrated a preventative intervention. The stomach's acidic interior is caused by “stomach acid” (0.1 M hydrochloric acid). Although stomach acid is required for digestion, too much can be uncomfortable. Neutralizing some of the excess acid in the stomach can help relieve stomach acidity; a weak base or “antacid” might be used to neutralize some of it. Acid‐neutralizing capacity (ANC) measures the ability to neutralize acidic inputs. This study attempted to compare the ANC of the extracts. All extracts, particularly 
<em>P. auriculata</em>
, exhibited good acid‐neutralizing activity. This study can be compared to other medicinal plants utilized in Ayurvedic therapy. The extract's purported antimicrobial activities could have been valuable in determining its effect on 
<em>Helicobacter pylori</em>
, a bacterium that causes peptic ulcers. Tannins have been shown to protect the stomach mucosa by suppressing secretion, which may contribute to the antiulcer properties of the extract. 
<em>P. zeylanica</em>
 roots also contain flavonoids. They have antioxidant effects and improve mucosal protection by increasing secretion of stomach mucus. Research suggests that boosting mucosal defense has antiulcer properties. This could explain the antiulcer properties of the extracts. Flavonoid extracts have been shown to have antioxidant activity, which is important because oxidative damage is linked to ulcer etiology in both experimental and clinical settings. Antioxidants can prevent lesion formation by ulcer‐related substances. 
<em>P. zeylanica</em>
 root extract, which is rich in flavonoids and antioxidants, may help to reduce gastrointestinal mucosal damage in animals, as observed in this study.</p>
<p>Ethanol‐induced ulcers are commonly used to evaluate gastroprotective efficacy. Ethanol generates free radicals by promoting the production of leukotrienes and mast cell secretory products. In reality, ulcers are most common in the glandular portion of the stomach. Free radicals play a role in scavenging mucosal ulcers and ultimately in healing them. In the current study, the test group experienced a much lower incidence of ulcers than the control group. The ability of the herbal extracts to prevent ulcers in both models suggests that they have cytoprotective properties. The gastric mucosa's production of prostaglandin may have acted as an antioxidant, scavenging free radicals. The study found that the plant extract has equivalent antiulcer activity to the control. The extract of 
<em>P. auriculata</em>
 without PB showed antiulcer action. This study assessed oxidative stress, acidity, NSAIDs, and ethanol levels in PB. Thus, this herb may have antiulcer properties. In vitro studies have indicated that 
<em>P. zeylanica</em>
 and 
<em>P. indica</em>
 have significant antiulcer properties. PB, which is known for its antioxidant and acid‐neutralizing properties, can effectively treat ulcers.</p>
<p>Phytochemical compounds such as tannins contribute to the antiulcer and antimicrobial effects of 
<em>P. zeylanica</em>
. The astringent tannins in 
<em>P. zeylanica</em>
 roots have the ability to shield the stomach mucosa. By covering the mucosal lining with a protective layer, irritation is reduced and healing is encouraged. Tannins have also been shown to reduce stomach secretions, which may help to prevent and treat ulcers. Flavonoids are another class of phytochemicals with antioxidant properties that contribute to the antiulcer effect by promoting the secretion of stomach mucus and strengthening the mucosal defense system (Han et al. <a href="#fsn370720-bib-0048" class="usa-link" aria-describedby="fsn370720-bib-0048">2025</a>). Tannins, flavonoids, alkaloids, and saponins are among several phytochemicals that give 
<em>P. zeylanica</em>
 its antibacterial properties against 
<em>P. zeylanica</em>
. These substances can break down microbial cell membranes and prevent certain infections from growing. Extracts from various plant parts, such as the roots and leaves, have been shown to have strong antibacterial activity against a variety of bacteria, including 
<em>Bacillus subtilis</em>
 and <em>Staphylococcus aureus</em>. Methanol and ethanol extracts exhibit significant outcomes, but their effectiveness varies depending on the extraction solvent used (Ahmad et al. <a href="#fsn370720-bib-0004" class="usa-link" aria-describedby="fsn370720-bib-0004">2022</a>). <em>Plumbago</em> species are being studied for their gastro‐protective benefits, particularly antiulcer activity (Falang et al. <a href="#fsn370720-bib-0033" class="usa-link" aria-describedby="fsn370720-bib-0033">2012</a>) (Figure <a href="#fsn370720-fig-0007" class="usa-link">7</a>).</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0007"><h4 class="obj_head">FIGURE 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/de07cfb39f26/FSN3-13-e70720-g001.jpg" loading="lazy" id="jats-graphic-15" height="454" width="709" alt="FIGURE 7"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Antiulcerative mechanism of Plumbagin activity.</p></figcaption></figure></section><section id="fsn370720-sec-0025"><h3 class="pmc_sec_title">3.7. Cognitive Function and Neuroprotection</h3>
<p>According to recent studies, PB may have neuroprotective properties. By activating the Nrf2/ARE pathway, it prevents brain ischemia, oxidative stress from spinal cord damage, and inflammation. By altering brain‐derived neurotrophic factor, plumbagin prevented isoflurane‐induced hippocampal neuronal loss. Signaling pathways (Son et al. <a href="#fsn370720-bib-0119" class="usa-link" aria-describedby="fsn370720-bib-0119">2010</a>; Zhang et al. <a href="#fsn370720-bib-0149" class="usa-link" aria-describedby="fsn370720-bib-0149"><sup>2015</sup></a>) including BDNF–TrkB–PI3/Akt and ERK/JNK (Yuan et al. <a href="#fsn370720-bib-0145" class="usa-link" aria-describedby="fsn370720-bib-0145">2017</a>) have been implicated in neuroprotection. PB boosted neuroprotective chemicals such as glutathione in stressed mouse brains (Trepanier and Milgram <a href="#fsn370720-bib-0135" class="usa-link" aria-describedby="fsn370720-bib-0135">2010</a>). Neuroinflammation causes neurodegeneration, leading to disorders such as Alzheimer's disease (AD). PB effectively reduces neuroinflammation in Alzheimer's disease by inhibiting COX‐2 (Trepanier and Milgram <a href="#fsn370720-bib-0135" class="usa-link" aria-describedby="fsn370720-bib-0135">2010</a>). PB inhibits NF‐κB activity, which lowers inflammation. In AD (Lukiw <a href="#fsn370720-bib-0078" class="usa-link" aria-describedby="fsn370720-bib-0078">2012</a>), pro‐inflammatory cytokine genes are activated by NF‐κB, leading to neuroinflammation. In BV‐2 microglial cells stimulated by lipopolysaccharide, PB reduces pro‐inflammatory cytokines. PB has recently been utilized in the treatment of neurological illnesses, such as Huntington's, Parkinson's, and Alzheimer's disease. PB showed neuroprotective effects and improved memory performance. Researchers have studied the potential to improve AD symptoms. This chronic neurological condition causes progressive deterioration of cognitive capacity, such as memory and thinking. In the Morris water maze, PB significantly improved memory and learning in mice with STZ‐induced AD. Trigonelline, an inhibitor of the Nrf2/ARE pathway, lessened PB effects (Figure <a href="#fsn370720-fig-0008" class="usa-link">8</a>).</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0008"><h4 class="obj_head">FIGURE 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/86f28ee7e6bc/FSN3-13-e70720-g012.jpg" loading="lazy" id="jats-graphic-17" height="446" width="665" alt="FIGURE 8"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Molecular mechanistic neuro‐protection activity by Plumbagin.</p></figcaption></figure></section></section><section id="fsn370720-sec-0026"><h2 class="pmc_sec_title">4. Plumbagin Derivatives</h2>
<p>They were created to enhance their pharmacokinetic properties and bioavailability (Figure <a href="#fsn370720-fig-0009" class="usa-link">9</a>). The N‐acetyl‐l‐amino acid side chain was substituted at position three, considerably increasing the antifeedant's (
<em>Spodoptera litura</em>
) activity. PB inhibits human DNA topoisomerase II. When a molecule has a quninone ring, electron transport may produce radicals that can be harmful. One possible explanation for the cytotoxicity of PB is its unusual structure, which includes a quinone ring. Tumor‐inhibitory action was not significantly improved by PLB's hydroquinone, nitro, cyano, or methyl ester derivatives. The reduction of naphthoquinone and amide derivatives from 1,4‐naphthoquinone carboxylic acid in PB inhibited trypanothione reductase (TR) from <em>Trypanosoma cruzi</em>, indicating trypanocidal action. The 3‐methyl derivatives of PB homologues (2‐alkyl‐1,4‐naphthoquinones) exhibited less potent inhibition of prostaglandin synthetase (PGS). The third‐position halogen substitution enhanced ichthyotoxicity (<em>Poeculia reticula</em>) in contrast to free PB. Thioglycosides and derivatives of alkylglucosides inhibit two enzymes involved in mycothiol synthesis in bacteria: N‐acetylglucosaminylinositol (GlcNAc‐Ins)‐deacetylase (MshB) and mycothiol‐S‐conjugate amidase. Phenyl‐2‐deoxy‐2‐amino‐1‐thio‐a‐D‐glucopyranoside, a potent MshB inhibitor, is formed via the formation of an amide bond and two to five methylene carbons at the C‐3 position. The inhibitory action of MshB on PB was demonstrated by significantly changing the carbon chain length. PB's hydroxyl group enables it to absorb electrons and generate reactive oxygen species, which increases its electrophilic properties and cytotoxicity (Rajalakshmi et al. <a href="#fsn370720-bib-0102" class="usa-link" aria-describedby="fsn370720-bib-0102">2018</a>).</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0009"><h3 class="obj_head">FIGURE 9.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/44c903320df0/FSN3-13-e70720-g007.jpg" loading="lazy" id="jats-graphic-19" height="478" width="709" alt="FIGURE 9"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0009/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Structural changes of plumbagin derivatives and their pharmaceutical activities.</p></figcaption></figure><section id="fsn370720-sec-0027"><h3 class="pmc_sec_title">4.1. Bioavailability of Plumbagin</h3>
<p>Plumbagin is a biological agent with high activity, and investigations have been conducted to determine its bioavailability. Hsieh et al. (<a href="#fsn370720-bib-0052" class="usa-link" aria-describedby="fsn370720-bib-0052">2006</a>) employed liquid chromatography–tandem mass spectrometry (LC–MS/MS) and automated blood sampling to determine the oral bioavailability of PB in rats. Following separation on a C18 column (150 mm × 4.6 mm I.D.; 5 mm), the rat plasma was eluted with a mobile phase consisting of water‐acetonitrile (40:60, v/v). PB analysis utilized multiple reaction monitoring to track the transition from the deprotonated molecule <em>m/z</em> 187 [MH](~) to the resulting ion <em>m/z</em> 159 [MHCO](~). Eighty (80%) recovered PB was detected in rat plasma, with detection values of 5 ng/mL and quantification limits of 10 ng/mL. According to pharmacokinetic studies, the oral bioavailability of PB in rats is 38.775%. The researchers employed LC–MS/MS to determine the excretion of PB and its metabolites in the urine and feces of rats administered oral therapy. In mice administered an oral dose of 100 mg/kg, 49% of the drug was removed through the feces. PB maximum serum concentration (<em>C</em>
<sub>max</sub>) was 0.35 mg/mL an hour later, but it quickly dropped after that. An AUC of 271.9 mg/kg was determined, with a <em>T</em>
<sub>max</sub> (min) of 150. PB metabolites with molecular weights of 202, 362, and 536 kDa were found in rat urine. These findings indicated that the PB metabolic pathway may include phase I aliphatic hydroxylation (MW 202) and phase II glucuronidation (MW 362, 536). Mandala Rayabandla et al. (<a href="#fsn370720-bib-0082" class="usa-link" aria-describedby="fsn370720-bib-0082">2010</a>) evaluated the antitumor efficacy and systemic toxicity of free PB in chitosan‐based microspheres. Pharmacokinetic studies showed that the PB elimination half‐life increased by 22 times, reducing tumor development and systemic toxicity. The authors proposed chitosan‐based plumbagin microspheres for systemic administration. Plumbagin can be found in the urine of rats four hours after injection, although it may not be present in blood for up to twenty‐four hours. Some drug residues persisted in the urine for up to 48 h, but the bulk was removed after 24 h. The authors suggested that the anticancer actions of this molecule may be due to a reaction initiated by the parent chemicals (Rajalakshmi et al. <a href="#fsn370720-bib-0102" class="usa-link" aria-describedby="fsn370720-bib-0102">2018</a>).</p></section><section id="fsn370720-sec-0028"><h3 class="pmc_sec_title">4.2. Drug Delivery of Plumbagin</h3>
<p>According to animal studies, PB has limited biopharmaceutical characteristics such as high lipophilicity, low melting point, short biological half‐life, and insolubility in water, leading to only 39% oral bioavailability (Bothiraja et al. <a href="#fsn370720-bib-0016" class="usa-link" aria-describedby="fsn370720-bib-0016">2013</a>). It is regarded as a very dangerous quinine moiety that functions as a spindle poison, exhibiting cytotoxic and radiomimetic effects at higher concentrations, and preventing cell mitosis at lower concentrations. Because of its competitive inhibition of vitamin K action, PLB administration over an extended period may cause bleeding. To increase the therapeutic efficacy in light of these limitations, researchers have developed a range of drug delivery strategies.</p>
<section id="fsn370720-sec-0029"><h4 class="pmc_sec_title">4.2.1. Liposomes</h4>
<p>Liposomes are natural phospholipids such as cholesterol, which are formed into small spherical vesicles. They improve pharmacokinetics, biodistribution patterns of active moieties, intracellular absorption of components, solubility, bioavailability, and stability in vitro and in vivo (Bardania et al. <a href="#fsn370720-bib-0011" class="usa-link" aria-describedby="fsn370720-bib-0011">2017</a>). Liposomes are preferred by the pharmaceutical and cosmetic sectors because of their unique properties, which include low toxicity, site specificity, biocompatibility, biodegradability, and the ability to entrap both hydrophobic and hydrophilic substances (Panahi et al. <a href="#fsn370720-bib-0091" class="usa-link" aria-describedby="fsn370720-bib-0091">2017</a>). Documentation in the literature indicates that a number of liposomal products are available, many of which are undergoing various stages of clinical testing. In addition to the previously mentioned factors, liposomal delivery techniques have been developed to resolve the problems related to PB's therapeutic potential. These factors included flexibility and compatibility. Tiwari et al. (<a href="#fsn370720-bib-0134" class="usa-link" aria-describedby="fsn370720-bib-0134">2002</a>) used a thin film hydration technique to create thermosensitive tiny unilamellar liposomes filled with DPPC and DSPC. At 42°C, liposomes were released, and at 37°C, less than 5% were released. Drug entrapment was made possible by the liquid crystalline fluid state of the liposome bilayer at high temperatures, and when used in conjunction with treatment for localized hyperthermia, the liposomes also enhanced the tumor response in mice (Tiwari et al. <a href="#fsn370720-bib-0134" class="usa-link" aria-describedby="fsn370720-bib-0134">2002</a>). Sunil Kumar et al. (<a href="#fsn370720-bib-0129" class="usa-link" aria-describedby="fsn370720-bib-0129">2011</a>) created PLB‐loaded extended circulating pegylated liposomes to improve plasma half‐life and anticancer potential utilizing B16F1 melanoma as a solid tumor model. The formulation exhibited improved zeta potential, cumulative drug release, efficiency, and particle size. It also reduced tumor volume significantly in B16F1 melanoma cells growing in vivo. By forming a hydrophilic covering, the pegylation process prevented opsonin from penetrating and adhering (Sunil Kumar et al. <a href="#fsn370720-bib-0129" class="usa-link" aria-describedby="fsn370720-bib-0129">2011</a>).</p></section><section id="fsn370720-sec-0030"><h4 class="pmc_sec_title">4.2.2. Niosomes</h4>
<p>Niosomes are vesicles composed of nonionic surfactants that form closed bilayer structures when they self‐assemble in an aqueous environment. Nonionic surfactants, such as polyoxyethylene alkyl ethers, sorbitan monoesters (Span 20, 40, 60, and 80), and polyoxyethylene sorbitan monoesters (Tween 20, 60, 61, and 80), have been used to create niosomes (Behnam et al. <a href="#fsn370720-bib-0012" class="usa-link" aria-describedby="fsn370720-bib-0012">2018</a>). The niosomal bilayer becomes more rigid and structured when cholesterol is added to the nonionic surfactant. Niosomes are more stable than liposomes and have many benefits over liposomes, such as better patient compliance and therapeutic efficacy when compared to traditional oily formulations. They can also entrap hydrophilic, lipophilic, and amphiphilic medications. Moreover, they can deliver specialized medications to particular organs and shield pharmaceuticals from biological enzymes (Behnam et al. <a href="#fsn370720-bib-0012" class="usa-link" aria-describedby="fsn370720-bib-0012">2018</a>). Oommen et al. (<a href="#fsn370720-bib-0090" class="usa-link" aria-describedby="fsn370720-bib-0090">1999</a>) used cholesterol, Span 60, and dicetyl phosphate to hydrate the lipid layer and load PLB‐β‐cyclodextrin (β‐CyD) into niosomes (D'Souza et al. <a href="#fsn370720-bib-0028" class="usa-link" aria-describedby="fsn370720-bib-0028"><sup>1998</sup></a>). With a diameter of 12 mm and an entrapment efficiency of 74%, the niosomes had an oval or spherical shape. Diffusion and lipid bilayer erosion caused the hydrophilic PLB‐β‐CyD complex to be released from the niosomes more quickly. When administered subcutaneously to C57BL/6J mice with melanoma B16F1, the niosomal PLB‐β‐CyD complex demonstrated stronger antitumor activity than free PB. Naresh et al. (<a href="#fsn370720-bib-0086" class="usa-link" aria-describedby="fsn370720-bib-0086">1996</a>) generated PLB‐loaded niosomes by wetting their lipid layer. The antitumor activity of niosomal PLB was higher in Ehrlich ascites and a solid tumor (sarcoma‐180). LD<sub>50</sub> survival tests and tumor volume doubling time revealed that niosomal PB was less toxic than free PB and had greater antitumor efficacy in a solid tumor (sarcoma‐180) and Ehrlich ascites model. To boost efficiency and reduce PB toxicity, Kini et al. (<a href="#fsn370720-bib-0066" class="usa-link" aria-describedby="fsn370720-bib-0066">1997</a>) developed albumin microspheres and regulated release PLB‐loaded niosomes. Compared to niosomes, albumin microspheres showed exceptional antitumor effectiveness against B16F1 melanoma produced in vivo at a dose of 5 mg/kg, as well as an antifertility effect. Additionally, data on animal survival indicated a slight increase in the survival rate and, consequently, antitumor efficacy. Additionally, histopathological investigations demonstrated that the antiovulatory action changed the antifertility activity.</p></section><section id="fsn370720-sec-0031"><h4 class="pmc_sec_title">4.2.3. Polymeric Nanoparticle</h4>
<p>Polymeric nanoparticles (NPs) are colloidal solid particles composed of biodegradable polymers and copolymers. Collagen and chitosan are two commonly used polymers, as are non‐biodegradable polymers, such as poly(lactic acid) (PLA) and poly(lactic co‐glycolic acid) (PLGA) (Sah et al. <a href="#fsn370720-bib-0106" class="usa-link" aria-describedby="fsn370720-bib-0106">2018</a>). Multifunctionalized polymeric materials produce dendrimers, micelles, nanocapsules, nanospheres, core shells, polymer matrices incorporating nanoparticles, and other structures. Because they can penetrate capillaries and be absorbed by cells, small particles (50–300 nm) can boost the medication concentration at the site of action (Afsharzadeh et al. <a href="#fsn370720-bib-0002" class="usa-link" aria-describedby="fsn370720-bib-0002">2018</a>). Indhumathi et al. (<a href="#fsn370720-bib-0056" class="usa-link" aria-describedby="fsn370720-bib-0056">2013</a>) created PLB‐loaded polymethylcyanoacrylate nanoparticles via emulsion polymerization in a continuous aqueous phase. Polymers such as Span 80, Tween 80, and PEG 4000 were added to the surface of the nanoparticles. The particle size was less than 100 nm, while the entrapment efficiency was 71.63%, indicating that continuous aqueous‐phase emulsion polymerization is the most effective method for producing nanoparticles.</p></section><section id="fsn370720-sec-0032"><h4 class="pmc_sec_title">4.2.4. Polymeric Micelle</h4>
<p>Bothiraja et al. (<a href="#fsn370720-bib-0016" class="usa-link" aria-describedby="fsn370720-bib-0016">2013</a>) used a self‐assembly technique to synthesize phospholipid and Tween 80 mixed micelles, which showed improved anticancer activity. These were investigated as viable injectable nanocarriers for PB. The combined micelles measured 46 nm and were spherical. Zeta potential was 5.04 mV, drug loading was 91.21, and encapsulation efficiency was 98.38%. PLB's in vitro antitumor activity against human breast cancer MCF‐7 cells was 2.1 times higher in micelles with sustained release than in the free form. PB was safe for intravenous administration because it remained stable at high pH, retaining micelle size and encapsulation effectiveness after dilution. Loading PB into D‐α‐tocopheryl polyethylene glycol 1000 succinate (vitamin E TPGS1k or TPGS)‐folic acid conjugate nanomicelles (also known as PTFM) reduces toxicity and allows for targeted distribution with synergistic anticancer efficacy. Loading PB into TPGS micelles without folic acid conjugates (also known as PTM) or PTFM reduced size and improved encapsulation efficiency. PTM and PTFM had longer circulation times, slower plasma clearance, no evidence of tissue or blood toxicity, and increased PB bioavailability by 3.8 and 4.8 times, respectively, when compared to free PB. In vitro, micelles had a greater anticancer effect on human breast cancer MCF‐7 cells with high folate levels. PTFM has a targeting effect. The medication concentration (GI50) needed to block 50% of cell growth at a specific time period (PB) is 13.15 ± 1.31 μg/mL, while it reduces by 40.68% with PTM. Additionally, PTFM has a GI50 value of 3.2 ± 0.4 μg/mL, which is 75.67% lower than free PB. TPGS and PB interact synergistically. The polymeric micellar drug delivery system is a revolutionary approach that reduces dosage and costs by utilizing a carrier with therapeutic properties (Pawar et al. <a href="#fsn370720-bib-0094" class="usa-link" aria-describedby="fsn370720-bib-0094">2016</a>).</p></section><section id="fsn370720-sec-0033"><h4 class="pmc_sec_title">4.2.5. Cyclodextrin Complexes</h4>
<p>A lipophilic core and hydrophilic outer shell characterize cyclic oligosaccharides, known as cyclodextrins (CDs). The three most common CD types are α‐, β‐, and γ‐CD. The solubility, bioavailability, tolerance, and elimination of unwanted side effects of pharmaceuticals are all improved by the bioadaptability and multifunctional qualities of CDs. Numerous lipophilic medications can be hosted by CD complexes (Gorjikhah et al. <a href="#fsn370720-bib-0041" class="usa-link" aria-describedby="fsn370720-bib-0041">2017</a>). CD complexes, which also offer a variety of platforms for cutting‐edge drug delivery techniques. Using the neutralization approach, Singh and Udupa (<a href="#fsn370720-bib-0117" class="usa-link" aria-describedby="fsn370720-bib-0117">1997</a>) produced a 1:1 M ratio inclusion combination of PB and betacyclodextrin. The complex and plain PLBs had respective LD50 values of 12.88 and 8.51 mg/kg body weight, respectively. The combination increased the antitumor effectiveness of PB while decreasing its toxicity, and the enhanced antitumor efficacy of complexation improved PB solubility at the same dosages as pure PB, enabling it to be absorbed more quickly in the bloodstream and have a greater antitumor effect.</p></section><section id="fsn370720-sec-0034"><h4 class="pmc_sec_title">4.2.6. Metal Nanoparticles</h4>
<p>Solid metal particles containing medicinal ingredients are known as metallic nanoparticles. They can be attached to a surface, enclosed in a shell, or dispersed in a polymer carrier matrix. They have become cutting‐edge tracking and contrast agents in many cancer treatments. The stability and bioavailability of medicinal substances are enhanced by the high surface area‐to‐volume ratios of metallic nanoparticles, which also make chemical modification easier and allow drugs to enter cellular compartments. They also protect pharmaceuticals from harmful biological environments. Plumbagin has been encapsulated in metallic nanoparticles. A pH‐responsive bone‐targeting drug delivery system is required for precise and sensitive diagnosis and treatment of bone metastases. MNP‐PL, or plumbagin‐loaded magnetic nanoparticles, have been developed in a novel manner, and plumbagin‐loaded magnetic nanoparticles (MNP‐PL) (Shahida Parveen et al. <a href="#fsn370720-bib-0109" class="usa-link" aria-describedby="fsn370720-bib-0109">2014</a>) have been developed and tested in a novel pancreatic cancer treatment formulation.</p>
<p>Although the toxicity and bioavailability of the MNP‐PL formulation were low, it offered a four‐fold dose advantage over regular plumbagin. The mechanical, thermal, and physical characteristics of collagen scaffolds were enhanced by caged plumbagin on silver nanoparticles (PCSN). By altering the redox signaling pathways of cancer cells, PB‐AgNPs (Hafeez et al. <a href="#fsn370720-bib-0045" class="usa-link" aria-describedby="fsn370720-bib-0045">2016</a>; Duraipandy et al. <a href="#fsn370720-bib-0029" class="usa-link" aria-describedby="fsn370720-bib-0029"><sup>2014</sup></a>) were engineered to specifically kill them. In order to reduce plumbagin's toxicity, cellular localization, and reactive oxygen species production, plumbagin‐conjugated gold nanoparticles (AuPB) were created (Bothiraja et al. <a href="#fsn370720-bib-0016" class="usa-link" aria-describedby="fsn370720-bib-0016">2013</a>).</p></section><section id="fsn370720-sec-0035"><h4 class="pmc_sec_title">4.2.7. Conjugation With Polymers</h4>
<p>Newton et al. (<a href="#fsn370720-bib-0089" class="usa-link" aria-describedby="fsn370720-bib-0089">2010</a>) reported that the 5‐hydroxy functionality was directly electro‐oxidized to produce a PB film on a carbon substrate. This film is employed as an entrapment matrix in biosensing applications. The film was anticipated to generate a polyphenylene oxide film that was primarily nonconductive, in line with standard phenolic electrooxidation. With the development of a phenol layer, cyclic voltammograms demonstrated that the phenol underwent irreversible oxidation at +0.95 V and declined with subsequent scans. One effect of scan number on the quinone component profile was the movement of the quinone reduction peak to higher negative potentials. The electrode surface retained the quinone component's activity. A gold‐patterned crystal was used to repeat the polymerization process in order to boost the monomer concentration and facilitate the deposition of a thicker, maybe more active coating. The stability of the film was evaluated by reacting it with typical biological agents such as glutathione.</p>
<p>Serum albumin and medication interactions are essential for creating novel treatments (Chrastina et al. <a href="#fsn370720-bib-0024" class="usa-link" aria-describedby="fsn370720-bib-0024">2020</a>). Because of its high reactivity with cysteine and nucleophiles containing cysteine, the spontaneous PB‐albumin adduct is expected to form a covalent connection between carbon C3 of PB and cysteine 34 of albumin. PB instability, high lipophilicity, and low solubility are resolved by this binding, which may restrict its therapeutic application. Conjugation of PB with albumin may improve its pharmacokinetic profile, eliminating the need for new formulations and delivery technologies, such as liposomes, niosomes, microspheres, nanoparticles, micelles, complexation, metal nanoparticles, and crystal modification.</p>
<p>In addition to Dandawate et al. (<a href="#fsn370720-bib-0026" class="usa-link" aria-describedby="fsn370720-bib-0026">2014</a>), this study synthesized and characterized a novel cyclodextrin inclusion complex of plumbagin‐isoniazid (PLIHZCD), which upon cyclodextrin complexation exhibits enhanced water solubility and potent antitubercular action. Under low‐iron conditions, which correspond to the isoniazid‐resistance scenario, the compound shows better action than isoniazid. According to the phase solubility investigation, PLIHZ's aqueous solubility increases linearly with cyclodextrin content. PLIHZ was discovered to have an aqueous solubility of 32.23 µg/mL, which significantly increased to 60.97 µg/mL upon complexation with β‐cyclodextrin.</p></section><section id="fsn370720-sec-0036"><h4 class="pmc_sec_title">4.2.8. Problems With Bioavailability</h4>
<p>Plumbagin has low water solubility and high lipophilicity, which results in restricted systemic bioavailability and poor gastrointestinal absorption. Its decreased effectiveness in animal models in comparison with in vitro results may be due to the fact that oral treatment only yields a bioavailability of roughly 39%, according to in vivo studies (Sumsakul et al. <a href="#fsn370720-bib-0124" class="usa-link" aria-describedby="fsn370720-bib-0124">2014</a>). Plumbagin has a short elimination half‐life of roughly five hours and delayed absorption according to pharmacokinetic studies conducted in rats (median time to peak plasma concentration of 9.63 h). These elements restrict the therapeutic window. Dose‐dependent toxicit—acute toxicity studies in rats have shown that a single oral dose of 150 mg/kg is the most tolerated dose; larger doses cause side effects such as agitation, salivation, and anxiety. In subacute experiments conducted over a 28‐day period, 25 mg/kg/day was found to be safe; higher doses caused toxicity and death. Hepatotoxicity, cardiotoxicity, and possible effects on blood coagulation processes have been documented in other studies, indicating that plumbagin toxicity may differ among species and organ systems (Sumsakul et al. <a href="#fsn370720-bib-0124" class="usa-link" aria-describedby="fsn370720-bib-0124">2014</a>).</p></section><section id="fsn370720-sec-0037"><h4 class="pmc_sec_title">4.2.9. Methods for Improving Therapeutic Potential</h4>
<p>In animal models, it has been demonstrated that protecting plumbagin in niosomes or nanoparticles improves anticancer effectiveness and decreases toxicity. These formulations lessen side effects and improve drug delivery. The production of molecules with enhanced stability and antiproliferative activity against specific cancer cell lines by the synthesis of plumbagin derivatives, such as nitric oxide‐releasing hybrids, suggests exciting potential for therapeutic development (Bao et al. <a href="#fsn370720-bib-0010" class="usa-link" aria-describedby="fsn370720-bib-0010">2017</a>).</p></section></section><section id="fsn370720-sec-0038"><h3 class="pmc_sec_title">4.3. Toxicity Study of Plumbagin</h3>
<p>PB plant extracts may be a chemopreventive agent that has long been utilized in traditional medicine. Nevertheless, allegations of vesicant and abortifacient qualities have sparked concerns about safety Shukla et al. (<a href="#fsn370720-bib-0156" class="usa-link" aria-describedby="fsn370720-bib-0156">2021</a>). In their work, NCI's Chemical Selectivity Group sufficiently addressed these problems, and the literature contained no accounts of PB exposure at work during processing or manufacturing (Singh and Udupa <a href="#fsn370720-bib-0117" class="usa-link" aria-describedby="fsn370720-bib-0117">1997</a>). No studies or case reports have linked human cancer risk to PB exposure. However, adverse side effects, such as diarrhea, skin rashes, and elevated white blood cell counts, have been reported. White blood cell and neutrophil counts, serum and acid phosphatase levels, and liver damage were increased (Singh and Udupa <a href="#fsn370720-bib-0117" class="usa-link" aria-describedby="fsn370720-bib-0117">1997</a>). PB mutagenicity, chromosomal abnormalities, and DNA damage have been investigated using standard methodologies. Farr et al. (<a href="#fsn370720-bib-0034" class="usa-link" aria-describedby="fsn370720-bib-0034">1985</a>) found that PB was highly mutagenic in exponential‐phase cells but not in stationary‐phase cells. 
<em>E. coli</em>
 AQ634 cells were used to determine the frequency of Trp‐ø Trp1 reversal. Santhakumari et al. (<a href="#fsn370720-bib-0108" class="usa-link" aria-describedby="fsn370720-bib-0108">1980</a>) investigated the effects of PB on fibroblasts in chick embryos. The number of metaphase cells increased as a result of slower cell development and proliferation and a lower mitotic index. The authors discovered that PB inhibited cells from undergoing mitosis by acting as a spindle toxin at lower concentrations. Nevertheless, it also exhibits radiomimetic cytotoxic and nucleotoxic effects at higher concentrations, and the metabolism, distribution, and excretion of PB have long remained unclear. Chandrasekaran and Nagarajan (<a href="#fsn370720-bib-0020" class="usa-link" aria-describedby="fsn370720-bib-0020">1981</a>) introduced a colorimetric technique to assess PB metabolism in rats. According to a recent study (Hsieh et al. <a href="#fsn370720-bib-0052" class="usa-link" aria-describedby="fsn370720-bib-0052">2006</a>), the oral bioavailability of plumbagin in conscious, free‐moving rats was 38.775%, as determined using liquid chromatography‐tandem mass spectroscopy (LC–MS/MS). PB demonstrated substantial antimutagenic efficacy against 1‐nitropyrene (1‐NP), 3‐nitrofluoranthene (3‐NFA), and 2‐nitrofluorene (2NF) in 
<em>Salmonella typhimurium</em>
 TA (Edenharder and Tang <a href="#fsn370720-bib-0032" class="usa-link" aria-describedby="fsn370720-bib-0032">1997</a>). Evidence suggests that this chemical targets cancer cells precisely and has minimal to no effect on healthy cells. PB effectively inhibits the growth of MDA‐MB‐231 and MCF‐7 BRCA cells and induces apoptosis, while it has no effect on MCF‐10A cells, which are nontumorigenic “normal” breast epithelial cells (Ahmad et al. <a href="#fsn370720-bib-0003" class="usa-link" aria-describedby="fsn370720-bib-0003">2008</a>).</p>
<p>Aziz et al. (<a href="#fsn370720-bib-0007" class="usa-link" aria-describedby="fsn370720-bib-0007">2008</a>) found that PB promoted apoptosis in prostate cancer cells (DU145, CWR22rv1, and LNCaP), but had no effect on nontumorigenic immortalized prostate epithelial RWPE‐1 cells. Despite these intriguing results, further preclinical animal studies are needed to improve the ability of PBs to fight cancer. Singh and Udupa (<a href="#fsn370720-bib-0117" class="usa-link" aria-describedby="fsn370720-bib-0117">1997</a>) created an injectable poly(lactic‐co‐glycolic) acid (PLGA) gel to improve the anticancer properties of PB while minimizing its toxicity. Through subcutaneous injection, the toxicity of a plumbagin‐containing gel was found to be lower in BALB/c mice than in native PB.</p>
<p>The efficacy of gel implants was demonstrated by their significantly higher volume doubling time (VDT). To reduce toxicity and increase the therapeutic efficiency of plumbagin, researchers have suggested an efficient drug delivery method (Singh et al. <a href="#fsn370720-bib-0116" class="usa-link" aria-describedby="fsn370720-bib-0116">1997</a>). The anti‐infertility and anticancer activities of plumbagin have been studied in controlled‐release formulations using different carriers to increase efficacy and decrease toxicity. Albumin microspheres and niosomes were used as carriers. Unlike niosome microspheres, albumin microspheres at an intraperitoneal dose of 5 mg/kg showed potential anticancer and antifertility effects.</p>
<p>Antitumoral activity and survival rate both somewhat improved, according to animal survival results. The results reported by Naresh et al. (<a href="#fsn370720-bib-0086" class="usa-link" aria-describedby="fsn370720-bib-0086">1996</a>) were marginally different. Hydrating the lipid layer allowed the researchers to manufacture plumbagin niosomes. Acute toxicity tests were performed when both free and niosomal PB were administered. Niosomal PB exhibits anticancer properties in Ehrlich ascites and sarcomas. Liposomal PB was found to be a more effective anticancer treatment in C57BL/6J mice with melanoma when paired with localized hyperthermia (431C for 30 min or 1 h) than animals given a similar dose of free PB, with or without hyperthermia. The study drew conclusions by investigating tumor development and VDT. A PB inclusion complex was produced using a neutralization approach and β‐cyclodextrin. More anticancer activity and reduced toxicity were demonstrated by this complex. All naphthoquinones exhibited antimutagenic activity. There was no change in antimutagenic potency when methyl or hydroxyl functional groups were added. Plumbagin performed better than any other drug in the antimutagenicity evaluation (Edenharder and Tang <a href="#fsn370720-bib-0032" class="usa-link" aria-describedby="fsn370720-bib-0032">1997</a>).</p>
<p>Inbaraj and Chignell (<a href="#fsn370720-bib-0055" class="usa-link" aria-describedby="fsn370720-bib-0055">2004</a>) studied the cytotoxicity of plumbagin and its demethylated analog, juglone, against HaCaT keratinocytes. Cell viability was considerably reduced upon exposure to juglone or PB (at concentrations ranging from 1 to 20 mM). Redox cycling and the glutathione (GSH) response are two ways in which quinones affect biology. GSH is oxidized to GSSG by the H<sub>2</sub>O<sub>2</sub> generated when keratinocytes are incubated with quinones. The increased formation of semiquinone radicals, H<sub>2</sub>O<sub>2</sub> generation, and cytotoxicity following GSH depletion illustrate the protective effect of buthionine sulfoximine. Both quinones reduced GSH levels in the cells. The stoichiometric conversion of GSH to GSSG by PB suggests that the primary metabolic mechanism is redox cycling. In particular, at higher concentrations (10 and 20 mM), juglone therapy dramatically decreased GSH, which did not appear as GSSG, suggesting that the cytotoxicity of quinone may be due to nucleophilic addition to GSH. This highlights the need for caution when applying topical treatments, including juglone and PB, because they may cause skin damage. Plumbagin, a bioactive naphthoquinone derived from <em>P. zeylanica</em>, has anti‐inflammatory, anticancer, and antibacterial properties, making it a promising therapeutic candidate. However, toxicity, bioavailability, and extraction efficiency restrict its clinical use. To increase its therapeutic utility, recent developments have focused on improving extraction techniques and creating plans to reduce toxicity (Tripathi et al. <a href="#fsn370720-bib-0136" class="usa-link" aria-describedby="fsn370720-bib-0136">2025</a>) (Figure <a href="#fsn370720-fig-0010" class="usa-link">10</a>). The differences in bioavailability and toxicity among various plumbagin analogs and their derivatives are shown in Table <a href="#fsn370720-tbl-0005" class="usa-link">5</a>.</p>
<figure class="fig xbox font-sm" id="fsn370720-fig-0010"><h4 class="obj_head">FIGURE 10.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf86/12365397/0add1628292c/FSN3-13-e70720-g003.jpg" loading="lazy" id="jats-graphic-21" height="336" width="626" alt="FIGURE 10"></p>
<div class="p text-right font-secondary"><a href="figure/fsn370720-fig-0010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Toxicity profile of plumbagin.</p></figcaption></figure><section class="tw xbox font-sm" id="fsn370720-tbl-0005"><h4 class="obj_head">TABLE 5.</h4>
<div class="caption p"><p>The differences in bioavailability and toxicity among various plumbagin analogues and their derivatives.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Derivative type</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Bio‐availability impact</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Toxicity impact</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Therapeutic potential</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Esterified analogues</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑ (moderate)</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ (better selectivity)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Ahmed et al. (<a href="#fsn370720-bib-0005" class="usa-link" aria-describedby="fsn370720-bib-0005">2014</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">NO‐hybrids</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑ (via NO‐release)</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ (targeted effect)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cancer, anti‐inflammatory</td>
<td align="center" valign="top" rowspan="1" colspan="1">Bao et al. (<a href="#fsn370720-bib-0010" class="usa-link" aria-describedby="fsn370720-bib-0010">2017</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Niosomal/nanoparticles</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑↑ (major increase)</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓↓ (lower systemic)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cancer</td>
<td align="center" valign="top" rowspan="1" colspan="1">Naresh et al. (<a href="#fsn370720-bib-0086" class="usa-link" aria-describedby="fsn370720-bib-0086">1996</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Hydroquinone analogues</td>
<td align="center" valign="top" rowspan="1" colspan="1">↔ (no significant change)</td>
<td align="center" valign="top" rowspan="1" colspan="1">↔ or ↓ (variable)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Less consistent</td>
<td align="center" valign="top" rowspan="1" colspan="1">Hazra et al. (<a href="#fsn370720-bib-0050" class="usa-link" aria-describedby="fsn370720-bib-0050">2002</a>)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Drug conjugates</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑ (targeted delivery)</td>
<td align="center" valign="top" rowspan="1" colspan="1">↓ (less résistance)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Antitubercular</td>
<td align="center" valign="top" rowspan="1" colspan="1">Nayak et al. (<a href="#fsn370720-bib-0087" class="usa-link" aria-describedby="fsn370720-bib-0087">2014</a>)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/fsn370720-tbl-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="fsn370720-sec-0039"><h3 class="pmc_sec_title">4.4. Strategies to Reduce Plumbagin's Toxicity</h3>
<section id="fsn370720-sec-0040"><h4 class="pmc_sec_title">4.4.1. Encapsulation of Niosomes</h4>
<p>Niosomes, which are vesicles based on non‐ionic surfactants, have been demonstrated to decrease plumbagin toxicity while increasing its anticancer effectiveness. By increasing drug stability and bio‐availability, this delivery method provides a safer therapeutic profile. Traditional Ayurvedic methods for detoxification (Shodhana) include utilizing lime water to purify 
<em>P. zeylanica</em>
 roots in order to lower the amount of plumbagin. By successfully reducing toxicity, this procedure makes the plant safer for medical use without sacrificing its therapeutic qualities. The cytotoxic effects of plumbagin have been discovered to be reduced when it is esterified with substances such as lipoic acid. While maintaining or possibly increasing the medicinal efficacy of the compound, these changes also improve its safety profile. While effectiveness studies examine an intervention's performance in real‐world situations, efficacy trials determine whether it is beneficial in ideal circumstances. Safety assessments are essential at every trial stage. Phase 3 trials are especially important for identifying less frequent side effects because they involve larger populations (Gartlehner et al. <a href="#fsn370720-bib-0039" class="usa-link" aria-describedby="fsn370720-bib-0039">2010</a>). Treatment recommendations were influenced by the RALES Trial, which showed that spironolactone decreased mortality in patients with severe heart failure by 30%. For Alzheimer's disease, lecanemab has received FDA approval after demonstrating a notable decrease in amyloid beta plaques and a slower rate of cognitive impairment. As demonstrated by the addition of spironolactone to the treatment of heart failure, encouraging trial outcomes may result in revisions to the clinical practice guidelines. To approve new medicines and ensure that they follow the safety and efficacy criteria, regulatory agencies rely on trial data. By being aware of the advantages and disadvantages of various therapies, medical professionals can make well‐informed judgments specific to each patient's needs.</p></section></section></section><section id="fsn370720-sec-0041"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>Plumbagin is a naturally occurring chemical found in the roots of the <em>Plumbago genus</em>, particularly 
<em>Plumbago zeylanica</em>
 and related species. Naphthoquinone has been the focus of numerous studies owing to its potential medical advantages. Current studies are being conducted to evaluate the safety and effectiveness of PB in clinical trials, optimize its formulation and distribution, and obtain a deeper understanding of the mechanisms underlying its activity. Although PB is a bioactive substance with several potential therapeutic applications, further research is necessary to fully comprehend its benefits and drawbacks in clinical settings. PB, which has antimalarial, anti‐obese, antidiabetic, antimicrobial, antiulcer, anti‐inflammatory, antioxidant, and anticancer properties, is found in the plant's roots, leaves, and stem. It has historically been used to treat a wide range of illnesses, such as arthritis, colds, coughs, rheumatic pain, leprosy, anemia, and dysmenorrhea. Owing to its weak solubility, metabolic instability, and transporter efflux, PB has low bioavailability. Despite its potential medicinal benefits, the toxicity of PB restricts its use in clinical settings. Oxidative stress, cytotoxicity, organ toxicity, and genotoxicity, and plumbagin and its derivatives have great therapeutic potential, especially in antibacterial and oncological applications. However, problems such as toxicity and bioavailability must be addressed. There are several intriguing ways to improve the therapeutic efficacy of PB and its derivatives, including combination therapies, chemical modifications, and advancements in drug delivery systems. Further research and clinical studies are required to fully understand the therapeutic potential and ensure human safety.</p></section><section id="fsn370720-sec-0047"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>
<strong>Souparnika Thekkumkara:</strong> data curation (equal), investigation (equal). <strong>Arenbenla Longchar:</strong> conceptualization (equal), project administration (equal), writing – original draft (equal). <strong>Baskar Venkidasamy:</strong> conceptualization (equal), project administration (equal), writing – original draft (equal). <strong>Benod Kumar Kondapavuluri:</strong> methodology (equal). <strong>Muthu Thiruvengadam:</strong> methodology (equal), writing – original draft (equal). <strong>Mansour Ghorbanpour:</strong> formal analysis (equal), writing – review and editing (equal). <strong>Sathianarayanan Sankaran:</strong> formal analysis (equal), writing – original draft (equal).</p></section><section id="fsn370720-sec-0042"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The authors have nothing to report.</p></section><section id="fsn370720-sec-0043"><h2 class="pmc_sec_title">Consent</h2>
<p>The authors have nothing to report.</p></section><section id="fsn370720-sec-0044"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="notes1"><p>


Thekkumkara, S.
, Longchar A., Venkidasamy B., et al. 2025. “Different Derivatives of Plumbagin Analogue: Bioavailability and Their Toxicity Studies.” Food Science &amp; Nutrition
13, no. 8: e70720. 10.1002/fsn3.70720.
</p></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Mansour Ghorbanpour, Email: m-ghorbanpour@araku.ac.ir.</p>
<p>Sathianarayanan Sankaran, Email: ssnvij@yahoo.co.in.</p></section><section id="fsn370720-sec-0046"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>No new data were generated or analyzed in this review. Data supporting the findings of this study are available in the referenced works.</p></section><section id="fsn370720-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="fsn370720-bibl-0001_sec2"><ol class="ref-list font-sm">
<li id="fsn370720-bib-0001">
<cite>

Acharya, B. R.
, Bhattacharyya B., and Chakrabarti G.. 2008. “The Natural Naphthoquinone Plumbagin Exhibits Antiproliferative Activity and Disrupts the Microtubule Network Through Tubulin Binding.” Biochemistry
47, no. 30: 7838–7845.
</cite> [<a href="https://doi.org/10.1021/bi800730q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18597479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=The%20Natural%20Naphthoquinone%20Plumbagin%20Exhibits%20Antiproliferative%20Activity%20and%20Disrupts%20the%20Microtubule%20Network%20Through%20Tubulin%20Binding&amp;author=B.%20R.%20Acharya&amp;author=B.%20Bhattacharyya&amp;author=G.%20Chakrabarti&amp;volume=47&amp;issue=30&amp;publication_year=2008&amp;pages=7838-7845&amp;pmid=18597479&amp;doi=10.1021/bi800730q&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0002">
<cite>

Afsharzadeh, M.
, Hashemi M., Mokhtarzadeh A., Abnous K., and Ramezani M.. 2018. “Recent Advances in Co‐Delivery Systems Based on Polymeric Nanoparticle for Cancer Treatment.” Artificial Cells, Nanomedicine, and Biotechnology
46, no. 6: 1095–1110.
</cite> [<a href="https://doi.org/10.1080/21691401.2017.1376675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28954547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Artificial%20Cells,%20Nanomedicine,%20and%20Biotechnology&amp;title=Recent%20Advances%20in%20Co%E2%80%90Delivery%20Systems%20Based%20on%20Polymeric%20Nanoparticle%20for%20Cancer%20Treatment&amp;author=M.%20Afsharzadeh&amp;author=M.%20Hashemi&amp;author=A.%20Mokhtarzadeh&amp;author=K.%20Abnous&amp;author=M.%20Ramezani&amp;volume=46&amp;issue=6&amp;publication_year=2018&amp;pages=1095-1110&amp;pmid=28954547&amp;doi=10.1080/21691401.2017.1376675&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0003">
<cite>

Ahmad, A.
, Banerjee S., Wang Z., Kong D., and Sarkar F. H.. 2008. “Plumbagin‐Induced Apoptosis of Human Breast Cancer Cells Is Mediated by Inactivation of NF‐κB and Bcl‐2.” Journal of Cellular Biochemistry
105, no. 6: 1461–1471.
</cite> [<a href="https://doi.org/10.1002/jcb.21966" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18980240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cellular%20Biochemistry&amp;title=Plumbagin%E2%80%90Induced%20Apoptosis%20of%20Human%20Breast%20Cancer%20Cells%20Is%20Mediated%20by%20Inactivation%20of%20NF%E2%80%90%CE%BAB%20and%20Bcl%E2%80%902&amp;author=A.%20Ahmad&amp;author=S.%20Banerjee&amp;author=Z.%20Wang&amp;author=D.%20Kong&amp;author=F.%20H.%20Sarkar&amp;volume=105&amp;issue=6&amp;publication_year=2008&amp;pages=1461-1471&amp;pmid=18980240&amp;doi=10.1002/jcb.21966&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0004">
<cite>

Ahmad, M.
, Ahmad T., Irfan H. M., and Noor N.. 2022. “Blood Pressure‐Lowering and Cardiovascular Effects of Plumbagin in Rats: An Insight Into the Underlying Mechanisms.” Current Research in Pharmacology and Drug Discovery
3: 100139.
</cite> [<a href="https://doi.org/10.1016/j.crphar.2022.100139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9780077/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36568266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Research%20in%20Pharmacology%20and%20Drug%20Discovery&amp;title=Blood%20Pressure%E2%80%90Lowering%20and%20Cardiovascular%20Effects%20of%20Plumbagin%20in%20Rats:%20An%20Insight%20Into%20the%20Underlying%20Mechanisms&amp;author=M.%20Ahmad&amp;author=T.%20Ahmad&amp;author=H.%20M.%20Irfan&amp;author=N.%20Noor&amp;volume=3&amp;publication_year=2022&amp;pages=100139&amp;pmid=36568266&amp;doi=10.1016/j.crphar.2022.100139&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0005">
<cite>

Ahmed, M. S.
, Kopel L. C., and Halaweish F. T.. 2014. “Structural Optimization and Biological Screening of a Steroidal Scaffold Possessing Cucurbitacin‐Like Functionalities as B‐Raf Inhibitors.” ChemMedChem
9, no. 7: 1361–1367.
</cite> [<a href="https://doi.org/10.1002/cmdc.201300523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24682977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ChemMedChem&amp;title=Structural%20Optimization%20and%20Biological%20Screening%20of%20a%20Steroidal%20Scaffold%20Possessing%20Cucurbitacin%E2%80%90Like%20Functionalities%20as%20B%E2%80%90Raf%20Inhibitors&amp;author=M.%20S.%20Ahmed&amp;author=L.%20C.%20Kopel&amp;author=F.%20T.%20Halaweish&amp;volume=9&amp;issue=7&amp;publication_year=2014&amp;pages=1361-1367&amp;pmid=24682977&amp;doi=10.1002/cmdc.201300523&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0006">
<cite>

Aronsson, P.
, Munissi J. J., Gruhonjic A., et al. 2016. “Phytoconstituents With Radical Scavenging and Cytotoxic Activities From Diospyros Shimbaensis.” Diseases
4, no. 1: 3.
</cite> [<a href="https://doi.org/10.3390/diseases4010003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5456303/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28933383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diseases&amp;title=Phytoconstituents%20With%20Radical%20Scavenging%20and%20Cytotoxic%20Activities%20From%20Diospyros%20Shimbaensis&amp;author=P.%20Aronsson&amp;author=J.%20J.%20Munissi&amp;author=A.%20Gruhonjic&amp;volume=4&amp;issue=1&amp;publication_year=2016&amp;pages=3&amp;pmid=28933383&amp;doi=10.3390/diseases4010003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0007">
<cite>

Aziz, M. H.
, Dreckschmidt N. E., and Verma A. K.. 2008. “Plumbagin, a Medicinal Plant–Derived Naphthoquinone, Is a Novel Inhibitor of the Growth and Invasion of Hormone‐Refractory Prostate Cancer.” Cancer Research
68, no. 21: 9024–9032.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-08-2494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2584362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18974148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Plumbagin,%20a%20Medicinal%20Plant%E2%80%93Derived%20Naphthoquinone,%20Is%20a%20Novel%20Inhibitor%20of%20the%20Growth%20and%20Invasion%20of%20Hormone%E2%80%90Refractory%20Prostate%20Cancer&amp;author=M.%20H.%20Aziz&amp;author=N.%20E.%20Dreckschmidt&amp;author=A.%20K.%20Verma&amp;volume=68&amp;issue=21&amp;publication_year=2008&amp;pages=9024-9032&amp;pmid=18974148&amp;doi=10.1158/0008-5472.CAN-08-2494&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0008">
<cite>

Badwaik, H. R.
, Kumari L., Nakhate K., Verma V. S., and Sakure K.. 2019. “Phytoconstituent Plumbagin: Chemical, Biotechnological and Pharmaceutical Aspects.” Studies in Natural Products Chemistry
63: 415–460.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Studies%20in%20Natural%20Products%20Chemistry&amp;title=Phytoconstituent%20Plumbagin:%20Chemical,%20Biotechnological%20and%20Pharmaceutical%20Aspects&amp;author=H.%20R.%20Badwaik&amp;author=L.%20Kumari&amp;author=K.%20Nakhate&amp;author=V.%20S.%20Verma&amp;author=K.%20Sakure&amp;volume=63&amp;publication_year=2019&amp;pages=415-460&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0009">
<cite>

Bae, K. J.
, Lee Y., Kim S. A., and Kim J.. 2016. “Plumbagin Exerts an Immunosuppressive Effect on Human T‐Cell Acute Lymphoblastic Leukemia MOLT‐4 Cells.” Biochemical and Biophysical Research Communications
473, no. 1: 272–277.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2016.03.092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27018383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=Plumbagin%20Exerts%20an%20Immunosuppressive%20Effect%20on%20Human%20T%E2%80%90Cell%20Acute%20Lymphoblastic%20Leukemia%20MOLT%E2%80%904%20Cells&amp;author=K.%20J.%20Bae&amp;author=Y.%20Lee&amp;author=S.%20A.%20Kim&amp;author=J.%20Kim&amp;volume=473&amp;issue=1&amp;publication_year=2016&amp;pages=272-277&amp;pmid=27018383&amp;doi=10.1016/j.bbrc.2016.03.092&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0010">
<cite>

Bao, N.
, Ou J., Xu M., et al. 2017. “Novel NO‐Releasing Plumbagin Derivatives: Design, Synthesis and Evaluation of Antiproliferative Activity.” European Journal of Medicinal Chemistry
137: 88–95.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2017.05.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28558333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Medicinal%20Chemistry&amp;title=Novel%20NO%E2%80%90Releasing%20Plumbagin%20Derivatives:%20Design,%20Synthesis%20and%20Evaluation%20of%20Antiproliferative%20Activity&amp;author=N.%20Bao&amp;author=J.%20Ou&amp;author=M.%20Xu&amp;volume=137&amp;publication_year=2017&amp;pages=88-95&amp;pmid=28558333&amp;doi=10.1016/j.ejmech.2017.05.046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0011">
<cite>

Bardania, H.
, Tarvirdipour S., and Dorkoosh F.. 2017. “Liposome‐Targeted Delivery for Highly Potent Drugs.” Artificial Cells, Nanomedicine, and Biotechnology
45, no. 8: 1478–1489.
</cite> [<a href="https://doi.org/10.1080/21691401.2017.1290647" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28278584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Artificial%20Cells,%20Nanomedicine,%20and%20Biotechnology&amp;title=Liposome%E2%80%90Targeted%20Delivery%20for%20Highly%20Potent%20Drugs&amp;author=H.%20Bardania&amp;author=S.%20Tarvirdipour&amp;author=F.%20Dorkoosh&amp;volume=45&amp;issue=8&amp;publication_year=2017&amp;pages=1478-1489&amp;pmid=28278584&amp;doi=10.1080/21691401.2017.1290647&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0012">
<cite>

Behnam, B.
, Rezazadehkermani M., Ahmadzadeh S., Mokhtarzadeh A., Nematollahi‐Mahani S. N., and Pardakhty A.. 2018. “Microniosomes for Concurrent Doxorubicin and Iron Oxide Nanoparticles Loading; Preparation, Characterization and Cytotoxicity Studies.” Artificial Cells, Nanomedicine, and Biotechnology
46, no. 1: 118–125.
</cite> [<a href="https://doi.org/10.1080/21691401.2017.1296850" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28375753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Artificial%20Cells,%20Nanomedicine,%20and%20Biotechnology&amp;title=Microniosomes%20for%20Concurrent%20Doxorubicin%20and%20Iron%20Oxide%20Nanoparticles%20Loading;%20Preparation,%20Characterization%20and%20Cytotoxicity%20Studies&amp;author=B.%20Behnam&amp;author=M.%20Rezazadehkermani&amp;author=S.%20Ahmadzadeh&amp;author=A.%20Mokhtarzadeh&amp;author=S.%20N.%20Nematollahi%E2%80%90Mahani&amp;volume=46&amp;issue=1&amp;publication_year=2018&amp;pages=118-125&amp;pmid=28375753&amp;doi=10.1080/21691401.2017.1296850&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0013">
<cite>

Bizuayehu, H. M.
, Ahmed K. Y., Kibret G. D., et al. 2024. “Global Disparities of Cancer and Its Projected Burden in 2050.” JAMA Network Open
7, no. 11: e2443198.
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2024.43198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11539015/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39499513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Network%20Open&amp;title=Global%20Disparities%20of%20Cancer%20and%20Its%20Projected%20Burden%20in%202050&amp;author=H.%20M.%20Bizuayehu&amp;author=K.%20Y.%20Ahmed&amp;author=G.%20D.%20Kibret&amp;volume=7&amp;issue=11&amp;publication_year=2024&amp;pages=e2443198&amp;pmid=39499513&amp;doi=10.1001/jamanetworkopen.2024.43198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0014">
<cite>

Bothiraja, C.
, Joshi P. P., Dama G. Y., and Pawar A. P.. 2011. “Rapid Method for Isolation of Plumbagin, an Alternative Medicine From Roots of 
<em>Plumbago zeylanica</em>

.” European Journal of Integrative Medicine
3, no. 1: 39–42.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Integrative%20Medicine&amp;title=Rapid%20Method%20for%20Isolation%20of%20Plumbagin,%20an%20Alternative%20Medicine%20From%20Roots%20of%20Plumbago%20zeylanica&amp;author=C.%20Bothiraja&amp;author=P.%20P.%20Joshi&amp;author=G.%20Y.%20Dama&amp;author=A.%20P.%20Pawar&amp;volume=3&amp;issue=1&amp;publication_year=2011&amp;pages=39-42&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0015">
<cite>

Bothiraja, C.
, Pawar A. P., Dama G. Y., Joshi P. P., and Shaikh K. S.. 2012. “Novel Solvent‐Free Gelucire Extract of 
<em>Plumbago zeylanica</em>
 Using Non‐Everted Rat Intestinal Sac Method for Improved Therapeutic Efficacy of Plumbagin.” Journal of Pharmacological and Toxicological Methods
66, no. 1: 35–42.
</cite> [<a href="https://doi.org/10.1016/j.vascn.2012.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22652081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacological%20and%20Toxicological%20Methods&amp;title=Novel%20Solvent%E2%80%90Free%20Gelucire%20Extract%20of%20Plumbago%20zeylanica%20Using%20Non%E2%80%90Everted%20Rat%20Intestinal%20Sac%20Method%20for%20Improved%20Therapeutic%20Efficacy%20of%20Plumbagin&amp;author=C.%20Bothiraja&amp;author=A.%20P.%20Pawar&amp;author=G.%20Y.%20Dama&amp;author=P.%20P.%20Joshi&amp;author=K.%20S.%20Shaikh&amp;volume=66&amp;issue=1&amp;publication_year=2012&amp;pages=35-42&amp;pmid=22652081&amp;doi=10.1016/j.vascn.2012.05.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0016">
<cite>

Bothiraja, C.
, Pawar A. P., Mali A. J., and Shaikh K. S.. 2013. “Improved Pharmaceutical Properties of Surface Modified Bioactive Plumbagin Crystals.” International Journal of Surface Science and Engineering
7, no. 2: 181–195.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Surface%20Science%20and%20Engineering&amp;title=Improved%20Pharmaceutical%20Properties%20of%20Surface%20Modified%20Bioactive%20Plumbagin%20Crystals&amp;author=C.%20Bothiraja&amp;author=A.%20P.%20Pawar&amp;author=A.%20J.%20Mali&amp;author=K.%20S.%20Shaikh&amp;volume=7&amp;issue=2&amp;publication_year=2013&amp;pages=181-195&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0017">
<cite>

Bringmann, G.
, Rüdenauer S., Irmer A., et al. 2008. “Antitumoral and Antileishmanial Dioncoquinones and Ancistroquinones From Cell Cultures of <em>Triphyophyllum peltatum</em> (Dioncophyllaceae) and <em>Ancistrocladus abbreviatus</em> (Ancistrocladaceae).” Phytochemistry
69, no. 13: 2501–2509.
</cite> [<a href="https://doi.org/10.1016/j.phytochem.2008.06.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18723197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytochemistry&amp;title=Antitumoral%20and%20Antileishmanial%20Dioncoquinones%20and%20Ancistroquinones%20From%20Cell%20Cultures%20of%20Triphyophyllum%20peltatum%20(Dioncophyllaceae)%20and%20Ancistrocladus%20abbreviatus%20(Ancistrocladaceae)&amp;author=G.%20Bringmann&amp;author=S.%20R%C3%BCdenauer&amp;author=A.%20Irmer&amp;volume=69&amp;issue=13&amp;publication_year=2008&amp;pages=2501-2509&amp;pmid=18723197&amp;doi=10.1016/j.phytochem.2008.06.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0018">
<cite>

Buchholz, T. A.
, Garg A. K., Chakravarti N., et al. 2005. “The Nuclear Transcription Factor κB/Bcl‐2 Pathway Correlates With Pathologic Complete Response to Doxorubicin‐Based Neoadjuvant Chemotherapy in Human Breast Cancer.” Clinical Cancer Research
11, no. 23: 8398–8402.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-05-0885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16322301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Cancer%20Research&amp;title=The%20Nuclear%20Transcription%20Factor%20%CE%BAB/Bcl%E2%80%902%20Pathway%20Correlates%20With%20Pathologic%20Complete%20Response%20to%20Doxorubicin%E2%80%90Based%20Neoadjuvant%20Chemotherapy%20in%20Human%20Breast%20Cancer&amp;author=T.%20A.%20Buchholz&amp;author=A.%20K.%20Garg&amp;author=N.%20Chakravarti&amp;volume=11&amp;issue=23&amp;publication_year=2005&amp;pages=8398-8402&amp;pmid=16322301&amp;doi=10.1158/1078-0432.CCR-05-0885&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0019">
<cite>

Cesari, I.
, Hoerlé M., Simoes‐Pires C., et al. 2013. “Anti‐Inflammatory, Antimicrobial and Antioxidant Activities of <em>Diospyros bipindensis</em> (Gürke) Extracts and Its Main Constituents.” Journal of Ethnopharmacology
146, no. 1: 264–270.
</cite> [<a href="https://doi.org/10.1016/j.jep.2012.12.041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23333745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Ethnopharmacology&amp;title=Anti%E2%80%90Inflammatory,%20Antimicrobial%20and%20Antioxidant%20Activities%20of%20Diospyros%20bipindensis%20(G%C3%BCrke)%20Extracts%20and%20Its%20Main%20Constituents&amp;author=I.%20Cesari&amp;author=M.%20Hoerl%C3%A9&amp;author=C.%20Simoes%E2%80%90Pires&amp;volume=146&amp;issue=1&amp;publication_year=2013&amp;pages=264-270&amp;pmid=23333745&amp;doi=10.1016/j.jep.2012.12.041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0020">
<cite>

Chandrasekaran, B.
, and Nagarajan B.. 1981. “Metabolism of Echitamine and Plumbagin in Rats.” Journal of Biosciences
3: 395–400.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biosciences&amp;title=Metabolism%20of%20Echitamine%20and%20Plumbagin%20in%20Rats&amp;author=B.%20Chandrasekaran&amp;author=B.%20Nagarajan&amp;volume=3&amp;publication_year=1981&amp;pages=395-400&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0022">
<cite>

Chen, C. A.
, Chang H. H., Kao C. Y., Tsai T. H., and Chen Y. J.. 2009. “Plumbagin, Isolated From 
<em>Plumbago zeylanica</em>
, Induces Cell Death Through Apoptosis in Human Pancreatic Cancer Cells.” Pancreatology
9, no. 6: 797–809.
</cite> [<a href="https://doi.org/10.1159/000210028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20110748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pancreatology&amp;title=Plumbagin,%20Isolated%20From%20Plumbago%20zeylanica%20,%20Induces%20Cell%20Death%20Through%20Apoptosis%20in%20Human%20Pancreatic%20Cancer%20Cells&amp;author=C.%20A.%20Chen&amp;author=H.%20H.%20Chang&amp;author=C.%20Y.%20Kao&amp;author=T.%20H.%20Tsai&amp;author=Y.%20J.%20Chen&amp;volume=9&amp;issue=6&amp;publication_year=2009&amp;pages=797-809&amp;pmid=20110748&amp;doi=10.1159/000210028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0021">
<cite>

Chen, C.
, Yin Q., Wu H., et al. 2020. “Different Effects of Premature Infant Formula and Breast Milk on Intestinal Microecological Development in Premature Infants.” Frontiers in Microbiology
10: 3020.
</cite> [<a href="https://doi.org/10.3389/fmicb.2019.03020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6978717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32010090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Microbiology&amp;title=Different%20Effects%20of%20Premature%20Infant%20Formula%20and%20Breast%20Milk%20on%20Intestinal%20Microecological%20Development%20in%20Premature%20Infants&amp;author=C.%20Chen&amp;author=Q.%20Yin&amp;author=H.%20Wu&amp;volume=10&amp;publication_year=2020&amp;pages=3020&amp;pmid=32010090&amp;doi=10.3389/fmicb.2019.03020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0023">
<cite>

Chen, X.
, Yin L., Peng L., Liang Y., Lv H., and Ma T.. 2020. “Synergistic Effect and Mechanism of Plumbagin With Gentamicin Against Carbapenem‐Resistant <em>Klebsiella pneumoniae</em>
.” Infection and Drug Resistance
13: 2751–2759.
</cite> [<a href="https://doi.org/10.2147/IDR.S265753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7432958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32884304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Infection%20and%20Drug%20Resistance&amp;title=Synergistic%20Effect%20and%20Mechanism%20of%20Plumbagin%20With%20Gentamicin%20Against%20Carbapenem%E2%80%90Resistant%20Klebsiella%20pneumoniae&amp;author=X.%20Chen&amp;author=L.%20Yin&amp;author=L.%20Peng&amp;author=Y.%20Liang&amp;author=H.%20Lv&amp;volume=13&amp;publication_year=2020&amp;pages=2751-2759&amp;pmid=32884304&amp;doi=10.2147/IDR.S265753&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0024">
<cite>

Chrastina, A.
, Welsh J., Rondeau G., Abedinpour P., Borgström P., and Baron V. T.. 2020. “Plumbagin‐Serum Albumin Interaction: Spectral, Electrochemical, Structure‐Binding Analysis, Antiproliferative and Cell Signaling Aspects With Implications for Anticancer Therapy.” ChemMedChem
15, no. 14: 1338–1347.
</cite> [<a href="https://doi.org/10.1002/cmdc.202000157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32410390/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ChemMedChem&amp;title=Plumbagin%E2%80%90Serum%20Albumin%20Interaction:%20Spectral,%20Electrochemical,%20Structure%E2%80%90Binding%20Analysis,%20Antiproliferative%20and%20Cell%20Signaling%20Aspects%20With%20Implications%20for%20Anticancer%20Therapy&amp;author=A.%20Chrastina&amp;author=J.%20Welsh&amp;author=G.%20Rondeau&amp;author=P.%20Abedinpour&amp;author=P.%20Borgstr%C3%B6m&amp;volume=15&amp;issue=14&amp;publication_year=2020&amp;pages=1338-1347&amp;pmid=32410390&amp;doi=10.1002/cmdc.202000157&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0025">
<cite>

Curreli, N.
, Sollai F., Massa L., et al. 2001. “Effects of Plant‐Derived Naphthoquinones on the Growth of Pleurotus Sajor‐Caju and Degradation of the Compounds by Fungal Cultures.” Journal of Basic Microbiology
41, no. 5: 253–259.
</cite> [<a href="https://doi.org/10.1002/1521-4028(200110)41:5&lt;253::AID-JOBM253&gt;3.0.CO;2-R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11688211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Basic%20Microbiology&amp;title=Effects%20of%20Plant%E2%80%90Derived%20Naphthoquinones%20on%20the%20Growth%20of%20Pleurotus%20Sajor%E2%80%90Caju%20and%20Degradation%20of%20the%20Compounds%20by%20Fungal%20Cultures&amp;author=N.%20Curreli&amp;author=F.%20Sollai&amp;author=L.%20Massa&amp;volume=41&amp;issue=5&amp;publication_year=2001&amp;pages=253-259&amp;pmid=11688211&amp;doi=10.1002/1521-4028(200110)41:5&lt;253::AID-JOBM253&gt;3.0.CO;2-R&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0026">
<cite>

Dandawate, P.
, Vemuri K., Swamy K. V., Khan E. M., Sritharan M., and Padhye S.. 2014. “Synthesis, Characterization, Molecular Docking and Anti‐Tubercular Activity of Plumbagin–Isoniazid Analog and Its β‐Cyclodextrin Conjugate.” Bioorganic &amp; Medicinal Chemistry Letters
24, no. 21: 5070–5075.
</cite> [<a href="https://doi.org/10.1016/j.bmcl.2014.09.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25264074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorganic%20&amp;%20Medicinal%20Chemistry%20Letters&amp;title=Synthesis,%20Characterization,%20Molecular%20Docking%20and%20Anti%E2%80%90Tubercular%20Activity%20of%20Plumbagin%E2%80%93Isoniazid%20Analog%20and%20Its%20%CE%B2%E2%80%90Cyclodextrin%20Conjugate&amp;author=P.%20Dandawate&amp;author=K.%20Vemuri&amp;author=K.%20V.%20Swamy&amp;author=E.%20M.%20Khan&amp;author=M.%20Sritharan&amp;volume=24&amp;issue=21&amp;publication_year=2014&amp;pages=5070-5075&amp;pmid=25264074&amp;doi=10.1016/j.bmcl.2014.09.032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0027">
<cite>

Ding, Y.
, Chen Z. J., Liu S., Che D., Vetter M., and Chang C. H.. 2005. “Inhibition of Nox‐4 Activity by Plumbagin, a Plant‐Derived Bioactive Naphthoquinone.” Journal of Pharmacy and Pharmacology
57, no. 1: 111–116.
</cite> [<a href="https://doi.org/10.1211/0022357055119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15638999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacy%20and%20Pharmacology&amp;title=Inhibition%20of%20Nox%E2%80%904%20Activity%20by%20Plumbagin,%20a%20Plant%E2%80%90Derived%20Bioactive%20Naphthoquinone&amp;author=Y.%20Ding&amp;author=Z.%20J.%20Chen&amp;author=S.%20Liu&amp;author=D.%20Che&amp;author=M.%20Vetter&amp;volume=57&amp;issue=1&amp;publication_year=2005&amp;pages=111-116&amp;pmid=15638999&amp;doi=10.1211/0022357055119&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0028"><cite>

D'Souza, R.
, Singh U. V., Aithal K. S., and Udupa M.. 1998. “Antifertility Activity of Niosomal HPβCD‐Plumbagin Complex.”
</cite></li>
<li id="fsn370720-bib-0029">
<cite>

Duraipandy, N.
, Lakra R., Kunnavakkam Vinjimur S., Samanta D., K P. S., and Kiran M. S.. 2014. “Caging of Plumbagin on Silver Nanoparticles Imparts Selectivity and Sensitivity to Plumbagin for Targeted Cancer Cell Apoptosis.” Metallomics
6, no. 11: 2025–2033.
</cite> [<a href="https://doi.org/10.1039/c4mt00165f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25188862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metallomics&amp;title=Caging%20of%20Plumbagin%20on%20Silver%20Nanoparticles%20Imparts%20Selectivity%20and%20Sensitivity%20to%20Plumbagin%20for%20Targeted%20Cancer%20Cell%20Apoptosis&amp;author=N.%20Duraipandy&amp;author=R.%20Lakra&amp;author=S.%20Kunnavakkam%20Vinjimur&amp;author=D.%20Samanta&amp;author=P.%20S.%20K&amp;volume=6&amp;issue=11&amp;publication_year=2014&amp;pages=2025-2033&amp;pmid=25188862&amp;doi=10.1039/c4mt00165f&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0030">
<cite>

Durga, R.
, Sridhar P., and Polasa H.. 1990. “Effects of Plumbagin on Antibiotic Resistance in Bacteria.” Indian Journal of Medical Research
91: 18–20.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2188907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Journal%20of%20Medical%20Research&amp;title=Effects%20of%20Plumbagin%20on%20Antibiotic%20Resistance%20in%20Bacteria&amp;author=R.%20Durga&amp;author=P.%20Sridhar&amp;author=H.%20Polasa&amp;volume=91&amp;publication_year=1990&amp;pages=18-20&amp;pmid=2188907&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0031">
<cite>

Dzoyem, J. P.
, Tangmouo J. G., Lontsi D., Etoa F. X., and Lohoue P. J.. 2007. “In Vitro Antifungal Activity of Extract and Plumbagin From the Stem Bark of <em>Diospyros crassiflora</em> Hiern (Ebenaceae).” Phytotherapy Research
21, no. 7: 671–674.
</cite> [<a href="https://doi.org/10.1002/ptr.2140" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17444575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytotherapy%20Research&amp;title=In%20Vitro%20Antifungal%20Activity%20of%20Extract%20and%20Plumbagin%20From%20the%20Stem%20Bark%20of%20Diospyros%20crassiflora%20Hiern%20(Ebenaceae)&amp;author=J.%20P.%20Dzoyem&amp;author=J.%20G.%20Tangmouo&amp;author=D.%20Lontsi&amp;author=F.%20X.%20Etoa&amp;author=P.%20J.%20Lohoue&amp;volume=21&amp;issue=7&amp;publication_year=2007&amp;pages=671-674&amp;pmid=17444575&amp;doi=10.1002/ptr.2140&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0032">
<cite>

Edenharder, R.
, and Tang X.. 1997. “Inhibition of the Mutagenicity of 2‐Nitrofluorene, 3‐Nitrofluoranthene and 1‐Nitropyrene by Flavonoids, Coumarins, Quinones and Other Phenolic Compounds.” Food and Chemical Toxicology
35, no. 3–4: 357–372.
</cite> [<a href="https://doi.org/10.1016/s0278-6915(97)00125-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9207898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Food%20and%20Chemical%20Toxicology&amp;title=Inhibition%20of%20the%20Mutagenicity%20of%202%E2%80%90Nitrofluorene,%203%E2%80%90Nitrofluoranthene%20and%201%E2%80%90Nitropyrene%20by%20Flavonoids,%20Coumarins,%20Quinones%20and%20Other%20Phenolic%20Compounds&amp;author=R.%20Edenharder&amp;author=X.%20Tang&amp;volume=35&amp;issue=3%E2%80%934&amp;publication_year=1997&amp;pages=357-372&amp;pmid=9207898&amp;doi=10.1016/s0278-6915(97)00125-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0033">
<cite>

Falang, K. D.
, Uguru M. O., Wannang N. N., Azi I. H., and Chiamaka N.. 2012. “Anti‐Ulcer Activity of <em>Plumbago zeylanica</em> Linn Root Extract.” Journal of Natural Products and Plant Resources
2, no. 5: 563–567.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Natural%20Products%20and%20Plant%20Resources&amp;title=Anti%E2%80%90Ulcer%20Activity%20of%20Plumbago%20zeylanica%20Linn%20Root%20Extract&amp;author=K.%20D.%20Falang&amp;author=M.%20O.%20Uguru&amp;author=N.%20N.%20Wannang&amp;author=I.%20H.%20Azi&amp;author=N.%20Chiamaka&amp;volume=2&amp;issue=5&amp;publication_year=2012&amp;pages=563-567&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0034">
<cite>

Farr, S. B.
, Natvig D. O., and Kogoma T.. 1985. “Toxicity and Mutagenicity of Plumbagin and the Induction of a Possible New DNA Repair Pathway in 
<em>Escherichia coli</em>

.” Journal of Bacteriology
164, no. 3: 1309–1316.
</cite> [<a href="https://doi.org/10.1128/jb.164.3.1309-1316.1985" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC219331/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2933393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Bacteriology&amp;title=Toxicity%20and%20Mutagenicity%20of%20Plumbagin%20and%20the%20Induction%20of%20a%20Possible%20New%20DNA%20Repair%20Pathway%20in%20Escherichia%20coli&amp;author=S.%20B.%20Farr&amp;author=D.%20O.%20Natvig&amp;author=T.%20Kogoma&amp;volume=164&amp;issue=3&amp;publication_year=1985&amp;pages=1309-1316&amp;pmid=2933393&amp;doi=10.1128/jb.164.3.1309-1316.1985&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0036">
<cite>

Foëx, P.
, and Sear J. W.. 2004. “Hypertension: Pathophysiology and Treatment.” Continuing Education in Anaesthesia Critical Care &amp; Pain
4, no. 3: 71–75.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Continuing%20Education%20in%20Anaesthesia%20Critical%20Care%20&amp;%20Pain&amp;title=Hypertension:%20Pathophysiology%20and%20Treatment&amp;author=P.%20Fo%C3%ABx&amp;author=J.%20W.%20Sear&amp;volume=4&amp;issue=3&amp;publication_year=2004&amp;pages=71-75&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0037">
<cite>

Galal, A. M.
, Raman V., Avula B., et al. 2013. “Comparative Study of Three Plumbago L. Species (Plumbaginaceae) by Microscopy, UPLC‐UV and HPTLC.” Journal of Natural Medicines
67: 554–561.
</cite> [<a href="https://doi.org/10.1007/s11418-012-0717-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23151906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Natural%20Medicines&amp;title=Comparative%20Study%20of%20Three%20Plumbago%20L.%20Species%20(Plumbaginaceae)%20by%20Microscopy,%20UPLC%E2%80%90UV%20and%20HPTLC&amp;author=A.%20M.%20Galal&amp;author=V.%20Raman&amp;author=B.%20Avula&amp;volume=67&amp;publication_year=2013&amp;pages=554-561&amp;pmid=23151906&amp;doi=10.1007/s11418-012-0717-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0038">
<cite>

Ganesan, K.
, and Gani S.. 2013. “Ethnomedical and Pharmacological Potentials of <em>Plumbago zeylanica</em> LA.” American Journal of Phytomedicine and Clinical Therapeutics
1, no. 3: 313–337.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Phytomedicine%20and%20Clinical%20Therapeutics&amp;title=Ethnomedical%20and%20Pharmacological%20Potentials%20of%20Plumbago%20zeylanica%20LA&amp;author=K.%20Ganesan&amp;author=S.%20Gani&amp;volume=1&amp;issue=3&amp;publication_year=2013&amp;pages=313-337&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0039">
<cite>

Gartlehner, G.
, Hansen R. A., Nissman D., Lohr K. N., and Carey T. S.. 2010. “Criteria for Distinguishing Effectiveness From Efficacy Trials in Systematic Reviews.” Agency for Healthcare Research and Quality (US).</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/20734508/" class="usa-link">PubMed</a>]</li>
<li id="fsn370720-bib-0040">
<cite>

Gomathinayagam, R.
, Sowmyalakshmi S., Mardhatillah F., Kumar R., Akbarsha M. A., and Damodaran C.. 2008. “Anticancer Mechanism of Plumbagin, a Natural Compound, on Non‐Small Cell Lung Cancer Cells.” Anticancer Research
28, no. 2A: 785–792.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/18507021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer%20Research&amp;title=Anticancer%20Mechanism%20of%20Plumbagin,%20a%20Natural%20Compound,%20on%20Non%E2%80%90Small%20Cell%20Lung%20Cancer%20Cells&amp;author=R.%20Gomathinayagam&amp;author=S.%20Sowmyalakshmi&amp;author=F.%20Mardhatillah&amp;author=R.%20Kumar&amp;author=M.%20A.%20Akbarsha&amp;volume=28&amp;issue=2A&amp;publication_year=2008&amp;pages=785-792&amp;pmid=18507021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0041">
<cite>

Gorjikhah, F.
, Azizi Jalalian F., Salehi R., et al. 2017. “Preparation and Characterization of PLGA‐β‐CD Polymeric Nanoparticles Containing Methotrexate and Evaluation of Their Effects on T47D Cell Line.” Artificial Cells, Nanomedicine, and Biotechnology
45, no. 3: 432–440.
</cite> [<a href="https://doi.org/10.3109/21691401.2016.1160915" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27002986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Artificial%20Cells,%20Nanomedicine,%20and%20Biotechnology&amp;title=Preparation%20and%20Characterization%20of%20PLGA%E2%80%90%CE%B2%E2%80%90CD%20Polymeric%20Nanoparticles%20Containing%20Methotrexate%20and%20Evaluation%20of%20Their%20Effects%20on%20T47D%20Cell%20Line&amp;author=F.%20Gorjikhah&amp;author=F.%20Azizi%20Jalalian&amp;author=R.%20Salehi&amp;volume=45&amp;issue=3&amp;publication_year=2017&amp;pages=432-440&amp;pmid=27002986&amp;doi=10.3109/21691401.2016.1160915&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0043">
<cite>

Grevenstuk, T.
, Gonçalves S., Nogueira J. M. F., Bernardo‐Gil M. G., and Romano A.. 2012. “Recovery of High Purity Plumbagin From 
<em>Drosera intermedia</em>

.” Industrial Crops and Products
35, no. 1: 257–260.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Industrial%20Crops%20and%20Products&amp;title=Recovery%20of%20High%20Purity%20Plumbagin%20From%20Drosera%20intermedia&amp;author=T.%20Grevenstuk&amp;author=S.%20Gon%C3%A7alves&amp;author=J.%20M.%20F.%20Nogueira&amp;author=M.%20G.%20Bernardo%E2%80%90Gil&amp;author=A.%20Romano&amp;volume=35&amp;issue=1&amp;publication_year=2012&amp;pages=257-260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0042">
<cite>

Grevenstuk, T.
, Gonçalves S., Nogueira J. M., and Romano A.. 2008. “Plumbagin Recovery From Field Specimens of <em>Drosophyllum lusitanicum</em> (L.) Link.” Phytochemical Analysis
19, no. 3: 229–235.
</cite> [<a href="https://doi.org/10.1002/pca.1034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17929241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytochemical%20Analysis&amp;title=Plumbagin%20Recovery%20From%20Field%20Specimens%20of%20Drosophyllum%20lusitanicum%20(L.)%20Link&amp;author=T.%20Grevenstuk&amp;author=S.%20Gon%C3%A7alves&amp;author=J.%20M.%20Nogueira&amp;author=A.%20Romano&amp;volume=19&amp;issue=3&amp;publication_year=2008&amp;pages=229-235&amp;pmid=17929241&amp;doi=10.1002/pca.1034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0044">
<cite>

Hafeez, B. B.
, Fischer J. W., Singh A., et al. 2015. “Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCϵ, Stat3, and Epithelial‐To‐Mesenchymal Transition Markers.” Cancer Prevention Research
8, no. 5: 375–386.
</cite> [<a href="https://doi.org/10.1158/1940-6207.CAPR-14-0231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4417441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25627799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Prevention%20Research&amp;title=Plumbagin%20Inhibits%20Prostate%20Carcinogenesis%20in%20Intact%20and%20Castrated%20PTEN%20Knockout%20Mice%20via%20Targeting%20PKC%CF%B5,%20Stat3,%20and%20Epithelial%E2%80%90To%E2%80%90Mesenchymal%20Transition%20Markers&amp;author=B.%20B.%20Hafeez&amp;author=J.%20W.%20Fischer&amp;author=A.%20Singh&amp;volume=8&amp;issue=5&amp;publication_year=2015&amp;pages=375-386&amp;pmid=25627799&amp;doi=10.1158/1940-6207.CAPR-14-0231&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0045">
<cite>

Hafeez, B. B.
, Kashyap V. K., Boya V. N., et al. 2016. “Novel Nanoparticle Formulation of Plumbagin for Pancreatic Cancer Treatment.” Cancer Research
76, no. 14 Suppl: 2208.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Novel%20Nanoparticle%20Formulation%20of%20Plumbagin%20for%20Pancreatic%20Cancer%20Treatment&amp;author=B.%20B.%20Hafeez&amp;author=V.%20K.%20Kashyap&amp;author=V.%20N.%20Boya&amp;volume=76&amp;issue=14%20Suppl&amp;publication_year=2016&amp;pages=2208&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0046">
<cite>

Hafeez, B. B.
, Zhong W., Fischer J. W., et al. 2013. “Plumbagin, a Medicinal Plant (<em>Plumbago zeylanica</em>)‐Derived 1,4‐Naphthoquinone, Inhibits Growth and Metastasis of Human Prostate Cancer PC‐3M‐Luciferase Cells in an Orthotopic Xenograft Mouse Model.” Molecular Oncology
7, no. 3: 428–439.
</cite> [<a href="https://doi.org/10.1016/j.molonc.2012.12.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3625495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23273564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Oncology&amp;title=Plumbagin,%20a%20Medicinal%20Plant%20(Plumbago%20zeylanica)%E2%80%90Derived%201,4%E2%80%90Naphthoquinone,%20Inhibits%20Growth%20and%20Metastasis%20of%20Human%20Prostate%20Cancer%20PC%E2%80%903M%E2%80%90Luciferase%20Cells%20in%20an%20Orthotopic%20Xenograft%20Mouse%20Model&amp;author=B.%20B.%20Hafeez&amp;author=W.%20Zhong&amp;author=J.%20W.%20Fischer&amp;volume=7&amp;issue=3&amp;publication_year=2013&amp;pages=428-439&amp;pmid=23273564&amp;doi=10.1016/j.molonc.2012.12.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0047">
<cite>

Hafeez, B. B.
, Zhong W., Mustafa A., Fischer J. W., Witkowsky O., and Verma A. K.. 2012. “Plumbagin Inhibits Prostate Cancer Development in TRAMP Mice via Targeting PKCε, Stat3 and Neuroendocrine Markers.” Carcinogenesis
33, no. 12: 2586–2592.
</cite> [<a href="https://doi.org/10.1093/carcin/bgs291" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3510739/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22976928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=Plumbagin%20Inhibits%20Prostate%20Cancer%20Development%20in%20TRAMP%20Mice%20via%20Targeting%20PKC%CE%B5,%20Stat3%20and%20Neuroendocrine%20Markers&amp;author=B.%20B.%20Hafeez&amp;author=W.%20Zhong&amp;author=A.%20Mustafa&amp;author=J.%20W.%20Fischer&amp;author=O.%20Witkowsky&amp;volume=33&amp;issue=12&amp;publication_year=2012&amp;pages=2586-2592&amp;pmid=22976928&amp;doi=10.1093/carcin/bgs291&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0048">
<cite>

Han, Z.
, Li C., and Liu G.. 2025. “Recent Advances in the Extraction, Purification and Analytical Techniques for Flavonoids From Plants: Taking Hawthorn as an Example.” Journal of Food Composition and Analysis
141: 107372.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Food%20Composition%20and%20Analysis&amp;title=Recent%20Advances%20in%20the%20Extraction,%20Purification%20and%20Analytical%20Techniques%20for%20Flavonoids%20From%20Plants:%20Taking%20Hawthorn%20as%20an%20Example&amp;author=Z.%20Han&amp;author=C.%20Li&amp;author=G.%20Liu&amp;volume=141&amp;publication_year=2025&amp;pages=107372&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0153">
<cite>

Hasan, M.
, Hwija I., and Mossa Y.. 2025. “Essential Oils from <em>Plumbago europaea</em> L. Aerial Parts (Leaves, Flowers): GC‐MS Analyses and Literature Biological Properties.” Natural Product Research
39, no. 2: 341–350. 10.1080/14786419.2023.2265537.
</cite> [<a href="https://doi.org/10.1080/14786419.2023.2265537" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37800169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Natural%20Product%20Research&amp;title=Essential%20Oils%20from%20Plumbago%20europaea%20L.%20Aerial%20Parts%20(Leaves,%20Flowers):%20GC%E2%80%90MS%20Analyses%20and%20Literature%20Biological%20Properties&amp;author=M.%20Hasan&amp;author=I.%20Hwija&amp;author=Y.%20Mossa&amp;volume=39&amp;issue=2&amp;publication_year=2025&amp;pages=341-350&amp;pmid=37800169&amp;doi=10.1080/14786419.2023.2265537&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0049">
<cite>

Hassan, S. T.
, Berchová‐Bímová K., and Petráš J.. 2016. “Plumbagin, a Plant‐Derived Compound, Exhibits Antifungal Combinatory Effect With Amphotericin B Against <em>Candida albicans</em> Clinical Isolates and Anti‐Hepatitis C Virus Activity.” Phytotherapy Research
30, no. 9: 1487–1492.
</cite> [<a href="https://doi.org/10.1002/ptr.5650" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27215409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytotherapy%20Research&amp;title=Plumbagin,%20a%20Plant%E2%80%90Derived%20Compound,%20Exhibits%20Antifungal%20Combinatory%20Effect%20With%20Amphotericin%20B%20Against%20Candida%20albicans%20Clinical%20Isolates%20and%20Anti%E2%80%90Hepatitis%20C%20Virus%20Activity&amp;author=S.%20T.%20Hassan&amp;author=K.%20Berchov%C3%A1%E2%80%90B%C3%ADmov%C3%A1&amp;author=J.%20Petr%C3%A1%C5%A1&amp;volume=30&amp;issue=9&amp;publication_year=2016&amp;pages=1487-1492&amp;pmid=27215409&amp;doi=10.1002/ptr.5650&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0050">
<cite>

Hazra, B.
, Sarkar R., Bhattacharyya S., Ghosh P. K., Chel G., and Dinda B.. 2002. “Synthesis of Plumbagin Derivatives and Their Inhibitory Activities Against Ehrlich Ascites Carcinoma In Vivo and <em>Leishmania donovani</em> Promastigotes In Vitro.” Phytotherapy Research
16, no. 2: 133–137.
</cite> [<a href="https://doi.org/10.1002/ptr.867" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11933114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytotherapy%20Research&amp;title=Synthesis%20of%20Plumbagin%20Derivatives%20and%20Their%20Inhibitory%20Activities%20Against%20Ehrlich%20Ascites%20Carcinoma%20In%C2%A0Vivo%20and%20Leishmania%20donovani%20Promastigotes%20In%C2%A0Vitro&amp;author=B.%20Hazra&amp;author=R.%20Sarkar&amp;author=S.%20Bhattacharyya&amp;author=P.%20K.%20Ghosh&amp;author=G.%20Chel&amp;volume=16&amp;issue=2&amp;publication_year=2002&amp;pages=133-137&amp;pmid=11933114&amp;doi=10.1002/ptr.867&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0051">
<cite>

Hazra, B.
, Sarma M. D., and Sanyal U.. 2004. “Separation Methods of Quinonoid Constituents of Plants Used in Oriental Traditional Medicines.” Journal of Chromatography B
812, no. 1–2: 259–275.</cite> [<a href="https://doi.org/10.1016/j.jchromb.2004.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15556503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Chromatography%20B&amp;title=Separation%20Methods%20of%20Quinonoid%20Constituents%20of%20Plants%20Used%20in%20Oriental%20Traditional%20Medicines&amp;author=B.%20Hazra&amp;author=M.%20D.%20Sarma&amp;author=U.%20Sanyal&amp;volume=812&amp;issue=1%E2%80%932&amp;publication_year=2004&amp;pages=259-275&amp;pmid=15556503&amp;doi=10.1016/j.jchromb.2004.08.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0052">
<cite>

Hsieh, Y. J.
, Lin L. C., and Tsai T. H.. 2006. “Measurement and Pharmacokinetic Study of Plumbagin in a Conscious Freely Moving Rat Using Liquid Chromatography/Tandem Mass Spectrometry.” Journal of Chromatography B
844, no. 1: 1–5.</cite> [<a href="https://doi.org/10.1016/j.jchromb.2006.06.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16837255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Chromatography%20B&amp;title=Measurement%20and%20Pharmacokinetic%20Study%20of%20Plumbagin%20in%20a%20Conscious%20Freely%20Moving%20Rat%20Using%20Liquid%20Chromatography/Tandem%20Mass%20Spectrometry&amp;author=Y.%20J.%20Hsieh&amp;author=L.%20C.%20Lin&amp;author=T.%20H.%20Tsai&amp;volume=844&amp;issue=1&amp;publication_year=2006&amp;pages=1-5&amp;pmid=16837255&amp;doi=10.1016/j.jchromb.2006.06.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0053">
<cite>

Hsu, Y. L.
, Cho C. Y., Kuo P. L., Huang Y. T., and Lin C. C.. 2006. “Plumbagin (5‐Hydroxy‐2‐Methyl‐1, 4‐Naphthoquinone) Induces Apoptosis and Cell Cycle Arrest in A549 Cells Through p53 Accumulation via c‐Jun NH2‐Terminal Kinase‐Mediated Phosphorylation at Serine 15 In Vitro and In Vivo.” Journal of Pharmacology and Experimental Therapeutics
318, no. 2: 484–494.
</cite> [<a href="https://doi.org/10.1124/jpet.105.098863" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16632641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Experimental%20Therapeutics&amp;title=Plumbagin%20(5%E2%80%90Hydroxy%E2%80%902%E2%80%90Methyl%E2%80%901,%204%E2%80%90Naphthoquinone)%20Induces%20Apoptosis%20and%20Cell%20Cycle%20Arrest%20in%20A549%20Cells%20Through%20p53%20Accumulation%20via%20c%E2%80%90Jun%20NH2%E2%80%90Terminal%20Kinase%E2%80%90Mediated%20Phosphorylation%20at%20Serine%2015%20In%C2%A0Vitro%20and%20In%C2%A0Vivo&amp;author=Y.%20L.%20Hsu&amp;author=C.%20Y.%20Cho&amp;author=P.%20L.%20Kuo&amp;author=Y.%20T.%20Huang&amp;author=C.%20C.%20Lin&amp;volume=318&amp;issue=2&amp;publication_year=2006&amp;pages=484-494&amp;pmid=16632641&amp;doi=10.1124/jpet.105.098863&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0054">
<cite>

Huang, H.
, Xie H., Pan Y., Zheng K., Xia Y., and Chen W.. 2018. “Plumbagin Triggers ER Stress‐Mediated Apoptosis in Prostate Cancer Cells via Induction of ROS.” Cellular Physiology and Biochemistry
45, no. 1: 267–280.
</cite> [<a href="https://doi.org/10.1159/000486773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29357323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20Physiology%20and%20Biochemistry&amp;title=Plumbagin%20Triggers%20ER%20Stress%E2%80%90Mediated%20Apoptosis%20in%20Prostate%20Cancer%20Cells%20via%20Induction%20of%20ROS&amp;author=H.%20Huang&amp;author=H.%20Xie&amp;author=Y.%20Pan&amp;author=K.%20Zheng&amp;author=Y.%20Xia&amp;volume=45&amp;issue=1&amp;publication_year=2018&amp;pages=267-280&amp;pmid=29357323&amp;doi=10.1159/000486773&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0055">
<cite>

Inbaraj, J. J.
, and Chignell C. F.. 2004. “Cytotoxic Action of Juglone and Plumbagin: A Mechanistic Study Using HaCaT Keratinocytes.” Chemical Research in Toxicology
17, no. 1: 55–62.
</cite> [<a href="https://doi.org/10.1021/tx034132s" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14727919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chemical%20Research%20in%20Toxicology&amp;title=Cytotoxic%20Action%20of%20Juglone%20and%20Plumbagin:%20A%20Mechanistic%20Study%20Using%20HaCaT%20Keratinocytes&amp;author=J.%20J.%20Inbaraj&amp;author=C.%20F.%20Chignell&amp;volume=17&amp;issue=1&amp;publication_year=2004&amp;pages=55-62&amp;pmid=14727919&amp;doi=10.1021/tx034132s&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0056">
<cite>

Indhumathi, D.
, Remya P. N., and Sangeetha S.. 2013. “Formulation Trails on Nanoparticular Preparation for Easy Scale Up Through Different Techniques.” Journal of Chemical and Pharmaceutical Sciences
6: 170–174.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Chemical%20and%20Pharmaceutical%20Sciences&amp;title=Formulation%20Trails%20on%20Nanoparticular%20Preparation%20for%20Easy%20Scale%20Up%20Through%20Different%20Techniques&amp;author=D.%20Indhumathi&amp;author=P.%20N.%20Remya&amp;author=S.%20Sangeetha&amp;volume=6&amp;publication_year=2013&amp;pages=170-174&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0057">
<cite>

Jaiswal, A. S.
, Bloom L. B., and Narayan S.. 2002. “Long‐Patch Base Excision Repair of Apurinic/Apyrimidinic Site DNA Is Decreased in Mouse Embryonic Fibroblast Cell Lines Treated With Plumbagin: Involvement of Cyclin‐Dependent Kinase Inhibitor p21Waf‐1/Cip‐1.” Oncogene
21, no. 38: 5912–5922.
</cite> [<a href="https://doi.org/10.1038/sj.onc.1205789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12185591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Long%E2%80%90Patch%20Base%20Excision%20Repair%20of%20Apurinic/Apyrimidinic%20Site%20DNA%20Is%20Decreased%20in%20Mouse%20Embryonic%20Fibroblast%20Cell%20Lines%20Treated%20With%20Plumbagin:%20Involvement%20of%20Cyclin%E2%80%90Dependent%20Kinase%20Inhibitor%20p21Waf%E2%80%901/Cip%E2%80%901&amp;author=A.%20S.%20Jaiswal&amp;author=L.%20B.%20Bloom&amp;author=S.%20Narayan&amp;volume=21&amp;issue=38&amp;publication_year=2002&amp;pages=5912-5922&amp;pmid=12185591&amp;doi=10.1038/sj.onc.1205789&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0058">
<cite>

Jiang, C.
, Sun T., Xiang D., Wei S., and Li W.. 2018. “Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (<em>Humulus lupulus</em> L.).” Frontiers in Pharmacology
9: 530.
</cite> [<a href="https://doi.org/10.3389/fphar.2018.00530" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5972274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29872398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Pharmacology&amp;title=Anticancer%20Activity%20and%20Mechanism%20of%20Xanthohumol:%20A%20Prenylated%20Flavonoid%20From%20Hops%20(Humulus%20lupulus%20L.)&amp;author=C.%20Jiang&amp;author=T.%20Sun&amp;author=D.%20Xiang&amp;author=S.%20Wei&amp;author=W.%20Li&amp;volume=9&amp;publication_year=2018&amp;pages=530&amp;pmid=29872398&amp;doi=10.3389/fphar.2018.00530&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0059">
<cite>

Juárez‐Méndez, M. T.
, Borges‐Argáez R., Ayora‐Talavera G., Escalante‐Rebolledo S. E., Escalante‐Erosa F., and Cáceres‐Farfán M.. 2022. “Diospyros Anisandra Phytochemical Analysis and Anti‐Hemagglutinin‐Neuraminidase Activity on Influenza AH1N1pdm09 Virus.” Natural Product Research
36, no. 10: 2666–2672.
</cite> [<a href="https://doi.org/10.1080/14786419.2021.1917568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34109896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Natural%20Product%20Research&amp;title=Diospyros%20Anisandra%20Phytochemical%20Analysis%20and%20Anti%E2%80%90Hemagglutinin%E2%80%90Neuraminidase%20Activity%20on%20Influenza%20AH1N1pdm09%20Virus&amp;author=M.%20T.%20Ju%C3%A1rez%E2%80%90M%C3%A9ndez&amp;author=R.%20Borges%E2%80%90Arg%C3%A1ez&amp;author=G.%20Ayora%E2%80%90Talavera&amp;author=S.%20E.%20Escalante%E2%80%90Rebolledo&amp;author=F.%20Escalante%E2%80%90Erosa&amp;volume=36&amp;issue=10&amp;publication_year=2022&amp;pages=2666-2672&amp;pmid=34109896&amp;doi=10.1080/14786419.2021.1917568&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0060">
<cite>

Kapadia, N. S.
, Isarani S. A., and Shah M. B.. 2005. “A Simple Method for Isolation of Plumbagin From Roots of <em>Plumbago rosea</em>
.” Pharmaceutical Biology
43, no. 6: 551–553.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutical%20Biology&amp;title=A%20Simple%20Method%20for%20Isolation%20of%20Plumbagin%20From%20Roots%20of%20Plumbago%20rosea&amp;author=N.%20S.%20Kapadia&amp;author=S.%20A.%20Isarani&amp;author=M.%20B.%20Shah&amp;volume=43&amp;issue=6&amp;publication_year=2005&amp;pages=551-553&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0061">
<cite>

Katoch, K.
, Nazir R., Khamparia A., Pandey B., Dey A., and Pandey D. K.. 2023. “Optimization of Microwave‐Assisted Extraction of Plumbagin From <em>Plumbago zeylanica</em> by Response Surface Methodology and Adaptive Neuro‐Fuzzy Inference System Modelling.” Industrial Crops and Products
203: 117107.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Industrial%20Crops%20and%20Products&amp;title=Optimization%20of%20Microwave%E2%80%90Assisted%20Extraction%20of%20Plumbagin%20From%20Plumbago%20zeylanica%20by%20Response%20Surface%20Methodology%20and%20Adaptive%20Neuro%E2%80%90Fuzzy%20Inference%20System%20Modelling&amp;author=K.%20Katoch&amp;author=R.%20Nazir&amp;author=A.%20Khamparia&amp;author=B.%20Pandey&amp;author=A.%20Dey&amp;volume=203&amp;publication_year=2023&amp;pages=117107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0062">
<cite>

Kawiak, A.
, Domachowska A., Jaworska A., and Lojkowska E.. 2017. “Plumbagin Sensitizes Breast Cancer Cells to Tamoxifen‐Induced Cell Death Through GRP78 Inhibition and Bik Upregulation.” Scientific Reports
7, no. 1: 43781.
</cite> [<a href="https://doi.org/10.1038/srep43781" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5347125/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28287102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Plumbagin%20Sensitizes%20Breast%20Cancer%20Cells%20to%20Tamoxifen%E2%80%90Induced%20Cell%20Death%20Through%20GRP78%20Inhibition%20and%20Bik%20Upregulation&amp;author=A.%20Kawiak&amp;author=A.%20Domachowska&amp;author=A.%20Jaworska&amp;author=E.%20Lojkowska&amp;volume=7&amp;issue=1&amp;publication_year=2017&amp;pages=43781&amp;pmid=28287102&amp;doi=10.1038/srep43781&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0063">
<cite>

Kawiak, A.
, Zawacka‐Pankau J., and Lojkowska E.. 2012. “Plumbagin Induces Apoptosis in Her2‐Overexpressing Breast Cancer Cells Through the Mitochondrial‐Mediated Pathway.” Journal of Natural Products
75, no. 4: 747–751.
</cite> [<a href="https://doi.org/10.1021/np3000409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22512718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Natural%20Products&amp;title=Plumbagin%20Induces%20Apoptosis%20in%20Her2%E2%80%90Overexpressing%20Breast%20Cancer%20Cells%20Through%20the%20Mitochondrial%E2%80%90Mediated%20Pathway&amp;author=A.%20Kawiak&amp;author=J.%20Zawacka%E2%80%90Pankau&amp;author=E.%20Lojkowska&amp;volume=75&amp;issue=4&amp;publication_year=2012&amp;pages=747-751&amp;pmid=22512718&amp;doi=10.1021/np3000409&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0064">
<cite>

Kilcar, A. Y.
, Tekin V., Biber Muftuler F. Z., and Medine E. I.. 2016. “99m Tc Labeled Plumbagin: Estrogen Receptor Dependent Examination Against Breast Cancer Cells and Comparison With PLGA Encapsulated Form.” Journal of Radioanalytical and Nuclear Chemistry
308: 13–22.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Radioanalytical%20and%20Nuclear%20Chemistry&amp;title=99m%20Tc%20Labeled%20Plumbagin:%20Estrogen%20Receptor%20Dependent%20Examination%20Against%20Breast%20Cancer%20Cells%20and%20Comparison%20With%20PLGA%20Encapsulated%20Form&amp;author=A.%20Y.%20Kilcar&amp;author=V.%20Tekin&amp;author=F.%20Z.%20Biber%20Muftuler&amp;author=E.%20I.%20Medine&amp;volume=308&amp;publication_year=2016&amp;pages=13-22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0065">
<cite>

Kim, H. J.
, Yoo H. Y., Zhang Y. H., Kim W. K., and Kim S. J.. 2017. “Biphasic Augmentation of Alpha‐Adrenergic Contraction by Plumbagin in Rat Systemic Arteries.” Korean Journal of Physiology &amp; Pharmacology
21, no. 6: 687–694.
</cite> [<a href="https://doi.org/10.4196/kjpp.2017.21.6.687" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5709486/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29200912/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Korean%20Journal%20of%20Physiology%20&amp;%20Pharmacology&amp;title=Biphasic%20Augmentation%20of%20Alpha%E2%80%90Adrenergic%20Contraction%20by%20Plumbagin%20in%20Rat%20Systemic%20Arteries&amp;author=H.%20J.%20Kim&amp;author=H.%20Y.%20Yoo&amp;author=Y.%20H.%20Zhang&amp;author=W.%20K.%20Kim&amp;author=S.%20J.%20Kim&amp;volume=21&amp;issue=6&amp;publication_year=2017&amp;pages=687-694&amp;pmid=29200912&amp;doi=10.4196/kjpp.2017.21.6.687&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0066">
<cite>

Kini, D. P.
, Pandey S., Shenoy B. D., et al. 1997. “Antitumor and Antifertility Activities of Plumbagin Controlled Release Formulations.” Indian Journal of Experimental Biology
35, no. 4: 374–379.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9315238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Journal%20of%20Experimental%20Biology&amp;title=Antitumor%20and%20Antifertility%20Activities%20of%20Plumbagin%20Controlled%20Release%20Formulations&amp;author=D.%20P.%20Kini&amp;author=S.%20Pandey&amp;author=B.%20D.%20Shenoy&amp;volume=35&amp;issue=4&amp;publication_year=1997&amp;pages=374-379&amp;pmid=9315238&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0067">
<cite>

Kishore, N.
, Mishra B. B., Tiwari V. K., and Tripathi V.. 2010. “Difuranonaphthoquinones From 
<em>Plumbago zeylanica</em>
 Roots.” Phytochemistry Letters
3, no. 2: 62–65.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Phytochemistry%20Letters&amp;title=Difuranonaphthoquinones%20From%20Plumbago%20zeylanica%20Roots&amp;author=N.%20Kishore&amp;author=B.%20B.%20Mishra&amp;author=V.%20K.%20Tiwari&amp;author=V.%20Tripathi&amp;volume=3&amp;issue=2&amp;publication_year=2010&amp;pages=62-65&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0068">
<cite>

Kong, X.
, Luo J., Xu T., et al. 2017. “Plumbagin Enhances TRAIL‐Induced Apoptosis of Human Leukemic Kasumi‐1 Cells Through Upregulation of TRAIL Death Receptor Expression, Activation of Caspase‐8 and Inhibition of cFLIP.” Oncology Reports
37, no. 6: 3423–3432.
</cite> [<a href="https://doi.org/10.3892/or.2017.5627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28498435/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncology%20Reports&amp;title=Plumbagin%20Enhances%20TRAIL%E2%80%90Induced%20Apoptosis%20of%20Human%20Leukemic%20Kasumi%E2%80%901%20Cells%20Through%20Upregulation%20of%20TRAIL%20Death%20Receptor%20Expression,%20Activation%20of%20Caspase%E2%80%908%20and%20Inhibition%20of%20cFLIP&amp;author=X.%20Kong&amp;author=J.%20Luo&amp;author=T.%20Xu&amp;volume=37&amp;issue=6&amp;publication_year=2017&amp;pages=3423-3432&amp;pmid=28498435&amp;doi=10.3892/or.2017.5627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0069">
<cite>

Kreher, B.
, Neszmélyi A., and Wagner H.. 1990. “Naphthoquinones From 
<em>Dionaea muscipula</em>

.” Phytochemistry
29, no. 2: 605–606.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Phytochemistry&amp;title=Naphthoquinones%20From%20Dionaea%20muscipula&amp;author=B.%20Kreher&amp;author=A.%20Neszm%C3%A9lyi&amp;author=H.%20Wagner&amp;volume=29&amp;issue=2&amp;publication_year=1990&amp;pages=605-606&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0070">
<cite>

Kumar, S.
, and Pandey A. K.. 2015. “Free Radicals: Health Implications and Their Mitigation by Herbals.” British Journal of Medicine and Medical Research
7, no. 6: 438–457.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Medicine%20and%20Medical%20Research&amp;title=Free%20Radicals:%20Health%20Implications%20and%20Their%20Mitigation%20by%20Herbals&amp;author=S.%20Kumar&amp;author=A.%20K.%20Pandey&amp;volume=7&amp;issue=6&amp;publication_year=2015&amp;pages=438-457&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0071">
<cite>

Kuo, P. L.
, Hsu Y. L., and Cho C. Y.. 2006. “Plumbagin Induces G2‐M Arrest and Autophagy by Inhibiting the AKT/Mammalian Target of Rapamycin Pathway in Breast Cancer Cells.” Molecular Cancer Therapeutics
5, no. 12: 3209–3221.
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-06-0478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17172425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Cancer%20Therapeutics&amp;title=Plumbagin%20Induces%20G2%E2%80%90M%20Arrest%20and%20Autophagy%20by%20Inhibiting%20the%20AKT/Mammalian%20Target%20of%20Rapamycin%20Pathway%20in%20Breast%20Cancer%20Cells&amp;author=P.%20L.%20Kuo&amp;author=Y.%20L.%20Hsu&amp;author=C.%20Y.%20Cho&amp;volume=5&amp;issue=12&amp;publication_year=2006&amp;pages=3209-3221&amp;pmid=17172425&amp;doi=10.1158/1535-7163.MCT-06-0478&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0072">
<cite>

Kuo, Y. H.
, Chang C. I., Li S. Y., et al. 1997. “Cytotoxic Constituents From the Stems of <em>Diospyros maritima</em>
.” Planta Medica
63, no. 04: 363–365.
</cite> [<a href="https://doi.org/10.1055/s-2006-957703" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9270382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Planta%20Medica&amp;title=Cytotoxic%20Constituents%20From%20the%20Stems%20of%20Diospyros%20maritima&amp;author=Y.%20H.%20Kuo&amp;author=C.%20I.%20Chang&amp;author=S.%20Y.%20Li&amp;volume=63&amp;issue=04&amp;publication_year=1997&amp;pages=363-365&amp;pmid=9270382&amp;doi=10.1055/s-2006-957703&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0073">
<cite>

Lai, L.
, Liu J., Zhai D., et al. 2012. “Plumbagin Inhibits Tumour Angiogenesis and Tumour Growth Through the Ras Signalling Pathway Following Activation of the VEGF Receptor‐2.” British Journal of Pharmacology
165, no. 4b: 1084–1096.
</cite> [<a href="https://doi.org/10.1111/j.1476-5381.2011.01532.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3346245/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21658027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Pharmacology&amp;title=Plumbagin%20Inhibits%20Tumour%20Angiogenesis%20and%20Tumour%20Growth%20Through%20the%20Ras%20Signalling%20Pathway%20Following%20Activation%20of%20the%20VEGF%20Receptor%E2%80%902&amp;author=L.%20Lai&amp;author=J.%20Liu&amp;author=D.%20Zhai&amp;volume=165&amp;issue=4b&amp;publication_year=2012&amp;pages=1084-1096&amp;pmid=21658027&amp;doi=10.1111/j.1476-5381.2011.01532.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0074">
<cite>

Lee, J. H.
, Yeon J. H., Kim H., et al. 2012. “The Natural Anticancer Agent Plumbagin Induces Potent Cytotoxicity in MCF‐7 Human Breast Cancer Cells by Inhibiting a PI‐5 Kinase for ROS Generation.”
</cite> [<a href="https://doi.org/10.1371/journal.pone.0045023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3441601/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23028742/" class="usa-link">PubMed</a>]</li>
<li id="fsn370720-bib-0154">
<cite>

Lee, Y. K.
, and Park O. J.. 2011. “Involvement of AMPK/mTOR/HIF‐1α in Anticancer Control of Quercetin in Hypoxic MCF‐7 Cells.” Food Science and Biotechnology
20: 371–375. 10.1007/s10068-011-0052-3.</cite> [<a href="https://doi.org/10.1007/s10068-011-0052-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Food%20Science%20and%20Biotechnology&amp;title=Involvement%20of%20AMPK/mTOR/HIF%E2%80%901%CE%B1%20in%20Anticancer%20Control%20of%20Quercetin%20in%20Hypoxic%20MCF%E2%80%907%20Cells&amp;author=Y.%20K.%20Lee&amp;author=O.%20J.%20Park&amp;volume=20&amp;publication_year=2011&amp;pages=371-375&amp;doi=10.1007/s10068-011-0052-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0076">
<cite>

Li, G.
, Shan C., Liu L., et al. 2015. “Tanshinone IIA Inhibits HIF‐1α and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E‐BP1 Signaling Pathway.” PLoS One
10, no. 2: e0117440.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0117440" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4320086/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25659153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Tanshinone%20IIA%20Inhibits%20HIF%E2%80%901%CE%B1%20and%20VEGF%20Expression%20in%20Breast%20Cancer%20Cells%20via%20mTOR/p70S6K/RPS6/4E%E2%80%90BP1%20Signaling%20Pathway&amp;author=G.%20Li&amp;author=C.%20Shan&amp;author=L.%20Liu&amp;volume=10&amp;issue=2&amp;publication_year=2015&amp;pages=e0117440&amp;pmid=25659153&amp;doi=10.1371/journal.pone.0117440&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="/articles/PMC11928062/" class="text-red">Retracted</a>]</li>
<li id="fsn370720-bib-0077">
<cite>

Li, T.
, Liang M., Li Z., Gu F., Guo Q., and Wang Q.. 2025. “Synthesis of Novel Resveratrol Nervonic Acid Ester Using a Solvent‐Free Mechanochemical Method: Improved Lipophilicity, Thermostability, and Oxidation Stability.” Food Chemistry
480: 143958.
</cite> [<a href="https://doi.org/10.1016/j.foodchem.2025.143958" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40138825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Food%20Chemistry&amp;title=Synthesis%20of%20Novel%20Resveratrol%20Nervonic%20Acid%20Ester%20Using%20a%20Solvent%E2%80%90Free%20Mechanochemical%20Method:%20Improved%20Lipophilicity,%20Thermostability,%20and%20Oxidation%20Stability&amp;author=T.%20Li&amp;author=M.%20Liang&amp;author=Z.%20Li&amp;author=F.%20Gu&amp;author=Q.%20Guo&amp;volume=480&amp;publication_year=2025&amp;pages=143958&amp;pmid=40138825&amp;doi=10.1016/j.foodchem.2025.143958&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0078">
<cite>

Lukiw, W. J.

2012. “NF‐κB‐Regulated, Proinflammatory miRNAs in Alzheimer's Disease.” Alzheimer's Research &amp; Therapy
4: 1–11.</cite> [<a href="https://doi.org/10.1186/alzrt150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3580456/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23217212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimer's%20Research%20&amp;%20Therapy&amp;title=NF%E2%80%90%CE%BAB%E2%80%90Regulated,%20Proinflammatory%20miRNAs%20in%20Alzheimer's%20Disease&amp;author=W.%20J.%20Lukiw&amp;volume=4&amp;publication_year=2012&amp;pages=1-11&amp;pmid=23217212&amp;doi=10.1186/alzrt150&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0079">
<cite>

Luo, P.
, Feng X., Liu S., and Jiang Y.. 2024. “Traditional Uses, Phytochemistry, Pharmacology and Toxicology of <em>Ruta graveolens</em> L.: A Critical Review and Future Perspectives.” Drug Design, Development and Therapy
18: 6459–6485.
</cite> [<a href="https://doi.org/10.2147/DDDT.S494417" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11697671/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39758226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Design,%20Development%20and%20Therapy&amp;title=Traditional%20Uses,%20Phytochemistry,%20Pharmacology%20and%20Toxicology%20of%20Ruta%20graveolens%20L.:%20A%20Critical%20Review%20and%20Future%20Perspectives&amp;author=P.%20Luo&amp;author=X.%20Feng&amp;author=S.%20Liu&amp;author=Y.%20Jiang&amp;volume=18&amp;publication_year=2024&amp;pages=6459-6485&amp;pmid=39758226&amp;doi=10.2147/DDDT.S494417&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0152">
<cite>

Madinaveitia, A.
, and Gallego M.. 1928. “Estudio de la plumbagina.” Anales Sociedad Espanola de Fisica y Quimica (SEFQ)
26: 263–270.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Anales%20Sociedad%20Espanola%20de%20Fisica%20y%20Quimica%20(SEFQ)&amp;title=Estudio%20de%20la%20plumbagina&amp;author=A.%20Madinaveitia&amp;author=M.%20Gallego&amp;volume=26&amp;publication_year=1928&amp;pages=263-270&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0080">
<cite>

Mahoney, N.
, Molyneux R. J., and Campbell B. C.. 2000. “Regulation of Aflatoxin Production by Naphthoquinones of Walnut (<em>Juglans regia</em>).” Journal of Agricultural and Food Chemistry
48, no. 9: 4418–4421.
</cite> [<a href="https://doi.org/10.1021/jf0003449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10995372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Agricultural%20and%20Food%20Chemistry&amp;title=Regulation%20of%20Aflatoxin%20Production%20by%20Naphthoquinones%20of%20Walnut%20(Juglans%20regia)&amp;author=N.%20Mahoney&amp;author=R.%20J.%20Molyneux&amp;author=B.%20C.%20Campbell&amp;volume=48&amp;issue=9&amp;publication_year=2000&amp;pages=4418-4421&amp;pmid=10995372&amp;doi=10.1021/jf0003449&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0081">
<cite>

Makchuchit, S.
, Rattarom R., and Itharat A.. 2017. “The Anti‐Allergic and Anti‐Inflammatory Effects of Benjakul Extract (a Thai Traditional Medicine), Its Constituent Plants and Its Some Pure Constituents Using In Vitro Experiments.” Biomedicine &amp; Pharmacotherapy
89: 1018–1026.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2017.02.066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28292010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine%20&amp;%20Pharmacotherapy&amp;title=The%20Anti%E2%80%90Allergic%20and%20Anti%E2%80%90Inflammatory%20Effects%20of%20Benjakul%20Extract%20(a%20Thai%20Traditional%20Medicine),%20Its%20Constituent%20Plants%20and%20Its%20Some%20Pure%20Constituents%20Using%20In%C2%A0Vitro%20Experiments&amp;author=S.%20Makchuchit&amp;author=R.%20Rattarom&amp;author=A.%20Itharat&amp;volume=89&amp;publication_year=2017&amp;pages=1018-1026&amp;pmid=28292010&amp;doi=10.1016/j.biopha.2017.02.066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0082">
<cite>

Mandala Rayabandla, S. K.
, Aithal K., Anandam A., et al. 2010. “Preparation, In Vitro Characterization, Pharmacokinetic, and Pharmacodynamic Evaluation of Chitosan‐Based Plumbagin Microspheres in Mice Bearing B16F1 Melanoma.” Drug Delivery
17, no. 3: 103–113.
</cite> [<a href="https://doi.org/10.3109/10717540903548447" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20100068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Delivery&amp;title=Preparation,%20In%C2%A0Vitro%20Characterization,%20Pharmacokinetic,%20and%20Pharmacodynamic%20Evaluation%20of%20Chitosan%E2%80%90Based%20Plumbagin%20Microspheres%20in%20Mice%20Bearing%20B16F1%20Melanoma&amp;author=S.%20K.%20Mandala%20Rayabandla&amp;author=K.%20Aithal&amp;author=A.%20Anandam&amp;volume=17&amp;issue=3&amp;publication_year=2010&amp;pages=103-113&amp;pmid=20100068&amp;doi=10.3109/10717540903548447&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0083">
<cite>

Montoya, J.
, Varela‐Ramirez A., Estrada A., Martinez L. E., Garza K., and Aguilera R. J.. 2004. “A Fluorescence‐Based Rapid Screening Assay for Cytotoxic Compounds.” Biochemical and Biophysical Research Communications
325, no. 4: 1517–1523.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2004.10.196" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15555600/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=A%20Fluorescence%E2%80%90Based%20Rapid%20Screening%20Assay%20for%20Cytotoxic%20Compounds&amp;author=J.%20Montoya&amp;author=A.%20Varela%E2%80%90Ramirez&amp;author=A.%20Estrada&amp;author=L.%20E.%20Martinez&amp;author=K.%20Garza&amp;volume=325&amp;issue=4&amp;publication_year=2004&amp;pages=1517-1523&amp;pmid=15555600&amp;doi=10.1016/j.bbrc.2004.10.196&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0084">
<cite>

Nair, R. S.
, Kumar J. M., Jose J., et al. 2016. “Increased Sensitivity of BRCA Defective Triple Negative Breast Tumors to Plumbagin Through Induction of DNA Double Strand Breaks (DSB).” Scientific Reports
6, no. 1: 26631.
</cite> [<a href="https://doi.org/10.1038/srep26631" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4879579/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27220670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Increased%20Sensitivity%20of%20BRCA%20Defective%20Triple%20Negative%20Breast%20Tumors%20to%20Plumbagin%20Through%20Induction%20of%20DNA%20Double%20Strand%20Breaks%20(DSB)&amp;author=R.%20S.%20Nair&amp;author=J.%20M.%20Kumar&amp;author=J.%20Jose&amp;volume=6&amp;issue=1&amp;publication_year=2016&amp;pages=26631&amp;pmid=27220670&amp;doi=10.1038/srep26631&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0085">
<cite>

Nair, S.
, Nair R. R. K., Srinivas P., Srinivas G., and Pillai M. R.. 2008. “Radiosensitizing Effects of Plumbagin in Cervical Cancer Cells Is Through Modulation of Apoptotic Pathway.” Molecular Carcinogenesis
47, no. 1: 22–33.
</cite> [<a href="https://doi.org/10.1002/mc.20359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17562542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Carcinogenesis&amp;title=Radiosensitizing%20Effects%20of%20Plumbagin%20in%20Cervical%20Cancer%20Cells%20Is%20Through%20Modulation%20of%20Apoptotic%20Pathway&amp;author=S.%20Nair&amp;author=R.%20R.%20K.%20Nair&amp;author=P.%20Srinivas&amp;author=G.%20Srinivas&amp;author=M.%20R.%20Pillai&amp;volume=47&amp;issue=1&amp;publication_year=2008&amp;pages=22-33&amp;pmid=17562542&amp;doi=10.1002/mc.20359&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0086">
<cite>

Naresh, R. A.
, Udupa N., and Devi P. U.. 1996. “Niosomal Plumbagin With Reduced Toxicity and Improved Anticancer Activity in BALB/C Mice.” Journal of Pharmacy and Pharmacology
48, no. 11: 1128–1132.
</cite> [<a href="https://doi.org/10.1111/j.2042-7158.1996.tb03907.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8961159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacy%20and%20Pharmacology&amp;title=Niosomal%20Plumbagin%20With%20Reduced%20Toxicity%20and%20Improved%20Anticancer%20Activity%20in%20BALB/C%20Mice&amp;author=R.%20A.%20Naresh&amp;author=N.%20Udupa&amp;author=P.%20U.%20Devi&amp;volume=48&amp;issue=11&amp;publication_year=1996&amp;pages=1128-1132&amp;pmid=8961159&amp;doi=10.1111/j.2042-7158.1996.tb03907.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0087">
<cite>

Nayak, N.
, Bajpai M., and Razdan B.. 2014. “Plumbagin Analogs‐Synthesis, Characterization, and Antitubercular Activity.” Journal of Advanced Pharmaceutical Technology &amp; Research
5, no. 1: 28–32.
</cite> [<a href="https://doi.org/10.4103/2231-4040.126984" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3960791/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24696815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Advanced%20Pharmaceutical%20Technology%20&amp;%20Research&amp;title=Plumbagin%20Analogs%E2%80%90Synthesis,%20Characterization,%20and%20Antitubercular%20Activity&amp;author=N.%20Nayak&amp;author=M.%20Bajpai&amp;author=B.%20Razdan&amp;volume=5&amp;issue=1&amp;publication_year=2014&amp;pages=28-32&amp;pmid=24696815&amp;doi=10.4103/2231-4040.126984&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0088">
<cite>

Nazeem, S.
, Azmi A. S., Hanif S., et al. 2009. “Plumbagin Induces Cell Death Through a Copper‐Redox Cycle Mechanism in Human Cancer Cells.” Mutagenesis
24, no. 5: 413–418.
</cite> [<a href="https://doi.org/10.1093/mutage/gep023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19505895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mutagenesis&amp;title=Plumbagin%20Induces%20Cell%20Death%20Through%20a%20Copper%E2%80%90Redox%20Cycle%20Mechanism%20in%20Human%20Cancer%20Cells&amp;author=S.%20Nazeem&amp;author=A.%20S.%20Azmi&amp;author=S.%20Hanif&amp;volume=24&amp;issue=5&amp;publication_year=2009&amp;pages=413-418&amp;pmid=19505895&amp;doi=10.1093/mutage/gep023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0089">
<cite>

Newton, L. A.
, Cowham E., Sharp D., Leslie R., and Davis J.. 2010. “Plumbagin: A Natural Product for Smart Materials?” New Journal of Chemistry
34, no. 3: 395–397.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=New%20Journal%20of%20Chemistry&amp;title=Plumbagin:%20A%20Natural%20Product%20for%20Smart%20Materials?&amp;author=L.%20A.%20Newton&amp;author=E.%20Cowham&amp;author=D.%20Sharp&amp;author=R.%20Leslie&amp;author=J.%20Davis&amp;volume=34&amp;issue=3&amp;publication_year=2010&amp;pages=395-397&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0090">
<cite>

Oommen, E.
, Shenoy B. D., Udupa N., Kamath R., and Devi P. U.. 1999. “Antitumour Efficacy of Cyclodextrin‐Complexed and Niosome‐Encapsulated Plumbagin in Mice Bearing Melanoma B16F1.” Pharmacy and Pharmacology Communications
5, no. 4: 281–285.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacy%20and%20Pharmacology%20Communications&amp;title=Antitumour%20Efficacy%20of%20Cyclodextrin%E2%80%90Complexed%20and%20Niosome%E2%80%90Encapsulated%20Plumbagin%20in%20Mice%20Bearing%20Melanoma%20B16F1&amp;author=E.%20Oommen&amp;author=B.%20D.%20Shenoy&amp;author=N.%20Udupa&amp;author=R.%20Kamath&amp;author=P.%20U.%20Devi&amp;volume=5&amp;issue=4&amp;publication_year=1999&amp;pages=281-285&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0091">
<cite>

Panahi, Y.
, Farshbaf M., Mohammadhosseini M., et al. 2017. “Recent Advances on Liposomal Nanoparticles: Synthesis, Characterization and Biomedical Applications.” Artificial Cells, Nanomedicine, and Biotechnology
45, no. 4: 788–799.
</cite> [<a href="https://doi.org/10.1080/21691401.2017.1282496" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28278586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Artificial%20Cells,%20Nanomedicine,%20and%20Biotechnology&amp;title=Recent%20Advances%20on%20Liposomal%20Nanoparticles:%20Synthesis,%20Characterization%20and%20Biomedical%20Applications&amp;author=Y.%20Panahi&amp;author=M.%20Farshbaf&amp;author=M.%20Mohammadhosseini&amp;volume=45&amp;issue=4&amp;publication_year=2017&amp;pages=788-799&amp;pmid=28278586&amp;doi=10.1080/21691401.2017.1282496&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0092">
<cite>

Parasuraman, S.
, and Raveendran R.. 2012. “Measurement of Invasive Blood Pressure in Rats.” Journal of Pharmacology and Pharmacotherapeutics
3, no. 2: 172–177.
</cite> [<a href="https://doi.org/10.4103/0976-500X.95521" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3356959/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22629093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacology%20and%20Pharmacotherapeutics&amp;title=Measurement%20of%20Invasive%20Blood%20Pressure%20in%20Rats&amp;author=S.%20Parasuraman&amp;author=R.%20Raveendran&amp;volume=3&amp;issue=2&amp;publication_year=2012&amp;pages=172-177&amp;pmid=22629093&amp;doi=10.4103/0976-500X.95521&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0093">
<cite>

Parimala, R.
, and Sachdanandam P.. 1993. “Effect of Plumbagin on Some Glucose Metabolising Enzymes Studied in Rats in Experimental Hepatoma.” Molecular and Cellular Biochemistry
125: 59–63.
</cite> [<a href="https://doi.org/10.1007/BF00926835" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8264573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Biochemistry&amp;title=Effect%20of%20Plumbagin%20on%20Some%20Glucose%20Metabolising%20Enzymes%20Studied%20in%20Rats%20in%20Experimental%20Hepatoma&amp;author=R.%20Parimala&amp;author=P.%20Sachdanandam&amp;volume=125&amp;publication_year=1993&amp;pages=59-63&amp;pmid=8264573&amp;doi=10.1007/BF00926835&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0094">
<cite>

Pawar, A.
, Patel R., Arulmozhi S., and Bothiraja C.. 2016. “D‐α‐Tocopheryl Polyethylene Glycol 1000 Succinate Conjugated Folic Acid Nanomicelles: Towards Enhanced Bioavailability, Stability, Safety, Prolonged Drug Release and Synergized Anticancer Effect of Plumbagin.” RSC Advances
6, no. 81: 78106–78121.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=RSC%20Advances&amp;title=D%E2%80%90%CE%B1%E2%80%90Tocopheryl%20Polyethylene%20Glycol%201000%20Succinate%20Conjugated%20Folic%20Acid%20Nanomicelles:%20Towards%20Enhanced%20Bioavailability,%20Stability,%20Safety,%20Prolonged%20Drug%20Release%20and%20Synergized%20Anticancer%20Effect%20of%20Plumbagin&amp;author=A.%20Pawar&amp;author=R.%20Patel&amp;author=S.%20Arulmozhi&amp;author=C.%20Bothiraja&amp;volume=6&amp;issue=81&amp;publication_year=2016&amp;pages=78106-78121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0095">
<cite>

Petrocelli, G.
, Marrazzo P., Bonsi L., Facchin F., Alviano F., and Canaider S.. 2023. “Plumbagin, a Natural Compound With Several Biological Effects and Anti‐Inflammatory Properties.” Life
13, no. 6: 1303.
</cite> [<a href="https://doi.org/10.3390/life13061303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10301567/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37374085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life&amp;title=Plumbagin,%20a%20Natural%20Compound%20With%20Several%20Biological%20Effects%20and%20Anti%E2%80%90Inflammatory%20Properties&amp;author=G.%20Petrocelli&amp;author=P.%20Marrazzo&amp;author=L.%20Bonsi&amp;author=F.%20Facchin&amp;author=F.%20Alviano&amp;volume=13&amp;issue=6&amp;publication_year=2023&amp;pages=1303&amp;pmid=37374085&amp;doi=10.3390/life13061303&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0096">
<cite>

Poprac, P.
, Jomova K., Simunkova M., Kollar V., Rhodes C. J., and Valko M.. 2017. “Targeting Free Radicals in Oxidative Stress‐Related Human Diseases.” Trends in Pharmacological Sciences
38, no. 7: 592–607.
</cite> [<a href="https://doi.org/10.1016/j.tips.2017.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28551354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Pharmacological%20Sciences&amp;title=Targeting%20Free%20Radicals%20in%20Oxidative%20Stress%E2%80%90Related%20Human%20Diseases&amp;author=P.%20Poprac&amp;author=K.%20Jomova&amp;author=M.%20Simunkova&amp;author=V.%20Kollar&amp;author=C.%20J.%20Rhodes&amp;volume=38&amp;issue=7&amp;publication_year=2017&amp;pages=592-607&amp;pmid=28551354&amp;doi=10.1016/j.tips.2017.04.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0097">
<cite>

Powolny, A. A.
, and Singh S. V.. 2008. “Plumbagin‐Induced Apoptosis in Human Prostate Cancer Cells Is Associated With Modulation of Cellular Redox Status and Generation of Reactive Oxygen Species.” Pharmaceutical Research
25: 2171–2180.
</cite> [<a href="https://doi.org/10.1007/s11095-008-9533-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18213451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutical%20Research&amp;title=Plumbagin%E2%80%90Induced%20Apoptosis%20in%20Human%20Prostate%20Cancer%20Cells%20Is%20Associated%20With%20Modulation%20of%20Cellular%20Redox%20Status%20and%20Generation%20of%20Reactive%20Oxygen%20Species&amp;author=A.%20A.%20Powolny&amp;author=S.%20V.%20Singh&amp;volume=25&amp;publication_year=2008&amp;pages=2171-2180&amp;pmid=18213451&amp;doi=10.1007/s11095-008-9533-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0098">
<cite>

Pradeepa, V.
, Senthil‐Nathan S., Sathish‐Narayanan S., et al. 2016. “Potential Mode of Action of a Novel Plumbagin as a Mosquito Repellent Against the Malarial Vector Anopheles Stephensi, (Culicidae: Diptera).” Pesticide Biochemistry and Physiology
134: 84–93.
</cite> [<a href="https://doi.org/10.1016/j.pestbp.2016.04.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27914545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pesticide%20Biochemistry%20and%20Physiology&amp;title=Potential%20Mode%20of%20Action%20of%20a%20Novel%20Plumbagin%20as%20a%20Mosquito%20Repellent%20Against%20the%20Malarial%20Vector%20Anopheles%20Stephensi,%20(Culicidae:%20Diptera)&amp;author=V.%20Pradeepa&amp;author=S.%20Senthil%E2%80%90Nathan&amp;author=S.%20Sathish%E2%80%90Narayanan&amp;volume=134&amp;publication_year=2016&amp;pages=84-93&amp;pmid=27914545&amp;doi=10.1016/j.pestbp.2016.04.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0099">
<cite>

Prasad, V. S.
, Devi P. U., Rao B. S., and Kamath R.. 1996. “Radiosensitizing Effect of Plumbagin on Mouse Melanoma Cells Grown In Vitro.” Indian Journal of Experimental Biology
34, no. 9: 857–858.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9014520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Journal%20of%20Experimental%20Biology&amp;title=Radiosensitizing%20Effect%20of%20Plumbagin%20on%20Mouse%20Melanoma%20Cells%20Grown%20In%C2%A0Vitro&amp;author=V.%20S.%20Prasad&amp;author=P.%20U.%20Devi&amp;author=B.%20S.%20Rao&amp;author=R.%20Kamath&amp;volume=34&amp;issue=9&amp;publication_year=1996&amp;pages=857-858&amp;pmid=9014520&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0100">
<cite>

Qamar, H. M. U. D.
, Qayyum R., Salma U., Khan S., Khan T., and Shah A. J.. 2018. “Vascular Mechanisms Underlying the Hypotensive Effect of <em>Rumex acetosa</em>
.” Pharmaceutical Biology
56, no. 1: 225–234.
</cite> [<a href="https://doi.org/10.1080/13880209.2018.1446031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6130607/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29560776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutical%20Biology&amp;title=Vascular%20Mechanisms%20Underlying%20the%20Hypotensive%20Effect%20of%20Rumex%20acetosa&amp;author=H.%20M.%20U.%20D.%20Qamar&amp;author=R.%20Qayyum&amp;author=U.%20Salma&amp;author=S.%20Khan&amp;author=T.%20Khan&amp;volume=56&amp;issue=1&amp;publication_year=2018&amp;pages=225-234&amp;pmid=29560776&amp;doi=10.1080/13880209.2018.1446031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0101">
<cite>

Qiu, J. X.
, Zhou Z. W., He Z. X., et al. 2015. “Plumbagin Elicits Differential Proteomic Responses Mainly Involving Cell Cycle, Apoptosis, Autophagy, and Epithelial‐To‐Mesenchymal Transition Pathways in Human Prostate Cancer PC‐3 and DU145 Cells.” Drug Design, Development and Therapy
9: 349–417.
</cite> [<a href="https://doi.org/10.2147/DDDT.S71677" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4294653/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25609920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Design,%20Development%20and%20Therapy&amp;title=Plumbagin%20Elicits%20Differential%20Proteomic%20Responses%20Mainly%20Involving%20Cell%20Cycle,%20Apoptosis,%20Autophagy,%20and%20Epithelial%E2%80%90To%E2%80%90Mesenchymal%20Transition%20Pathways%20in%20Human%20Prostate%20Cancer%20PC%E2%80%903%20and%20DU145%20Cells&amp;author=J.%20X.%20Qiu&amp;author=Z.%20W.%20Zhou&amp;author=Z.%20X.%20He&amp;volume=9&amp;publication_year=2015&amp;pages=349-417&amp;pmid=25609920&amp;doi=10.2147/DDDT.S71677&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0102">
<cite>

Rajalakshmi, S.
, Vyawahare N., Pawar A., Mahaparale P., and Chellampillai B.. 2018. “Current Development in Novel Drug Delivery Systems of Bioactive Molecule Plumbagin.” Artificial Cells, Nanomedicine, and Biotechnology
46, no. sup1: 209–218.
</cite> [<a href="https://doi.org/10.1080/21691401.2017.1417865" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29298523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Artificial%20Cells,%20Nanomedicine,%20and%20Biotechnology&amp;title=Current%20Development%20in%20Novel%20Drug%20Delivery%20Systems%20of%20Bioactive%20Molecule%20Plumbagin&amp;author=S.%20Rajalakshmi&amp;author=N.%20Vyawahare&amp;author=A.%20Pawar&amp;author=P.%20Mahaparale&amp;author=B.%20Chellampillai&amp;volume=46&amp;issue=sup1&amp;publication_year=2018&amp;pages=209-218&amp;pmid=29298523&amp;doi=10.1080/21691401.2017.1417865&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0103">
<cite>

Ravindra, K. C.
, Selvi B. R., Arif M., et al. 2009. “Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin.” Journal of Biological Chemistry
284, no. 36: 24453–24464.
</cite> [<a href="https://doi.org/10.1074/jbc.M109.023861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2782038/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19570987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&amp;title=Inhibition%20of%20Lysine%20Acetyltransferase%20KAT3B/p300%20Activity%20by%20a%20Naturally%20Occurring%20Hydroxynaphthoquinone,%20Plumbagin&amp;author=K.%20C.%20Ravindra&amp;author=B.%20R.%20Selvi&amp;author=M.%20Arif&amp;volume=284&amp;issue=36&amp;publication_year=2009&amp;pages=24453-24464&amp;pmid=19570987&amp;doi=10.1074/jbc.M109.023861&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0104">
<cite>

Razavi, R.
, Amiri M., Divsalar K., and Foroumadi A.. 2023. “CuONPs/MWCNTs/Carbon Paste Modified Electrode for Determination of Tramadol: Theoretical and Experimental Investigation.” Scientific Reports
13, no. 1: 7999.
</cite> [<a href="https://doi.org/10.1038/s41598-023-34569-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10192210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37198239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=CuONPs/MWCNTs/Carbon%20Paste%20Modified%20Electrode%20for%20Determination%20of%20Tramadol:%20Theoretical%20and%20Experimental%20Investigation&amp;author=R.%20Razavi&amp;author=M.%20Amiri&amp;author=K.%20Divsalar&amp;author=A.%20Foroumadi&amp;volume=13&amp;issue=1&amp;publication_year=2023&amp;pages=7999&amp;pmid=37198239&amp;doi=10.1038/s41598-023-34569-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0105">
<cite>

Rondevaldova, J.
, Novy P., and Kokoska L.. 2015. “In Vitro Combinatory Antimicrobial Effect of Plumbagin With Oxacillin and Tetracycline Against <em>Staphylococcus aureus</em>
.” Phytotherapy Research
29, no. 1: 144–147.
</cite> [<a href="https://doi.org/10.1002/ptr.5237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25266704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phytotherapy%20Research&amp;title=In%20Vitro%20Combinatory%20Antimicrobial%20Effect%20of%20Plumbagin%20With%20Oxacillin%20and%20Tetracycline%20Against%20Staphylococcus%20aureus&amp;author=J.%20Rondevaldova&amp;author=P.%20Novy&amp;author=L.%20Kokoska&amp;volume=29&amp;issue=1&amp;publication_year=2015&amp;pages=144-147&amp;pmid=25266704&amp;doi=10.1002/ptr.5237&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0106">
<cite>

Sah, A. K.
, Vyas A., Suresh P. K., and Gidwani B.. 2018. “Application of Nanocarrier‐Based Drug Delivery System in Treatment of Oral Cancer.” Artificial Cells, Nanomedicine, and Biotechnology
46, no. 4: 650–657.
</cite> [<a href="https://doi.org/10.1080/21691401.2017.1373284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28880679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Artificial%20Cells,%20Nanomedicine,%20and%20Biotechnology&amp;title=Application%20of%20Nanocarrier%E2%80%90Based%20Drug%20Delivery%20System%20in%20Treatment%20of%20Oral%20Cancer&amp;author=A.%20K.%20Sah&amp;author=A.%20Vyas&amp;author=P.%20K.%20Suresh&amp;author=B.%20Gidwani&amp;volume=46&amp;issue=4&amp;publication_year=2018&amp;pages=650-657&amp;pmid=28880679&amp;doi=10.1080/21691401.2017.1373284&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0107">
<cite>

Sandur, S. K.
, Pandey M. K., Sung B., and Aggarwal B. B.. 2010. “5‐Hydroxy‐2‐Methyl‐1, 4‐Naphthoquinone, a Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway Through Induction of Protein Tyrosine Phosphatase, SHP‐1: Potential Role in Chemosensitization.” Molecular Cancer Research
8, no. 1: 107–118.
</cite> [<a href="https://doi.org/10.1158/1541-7786.MCR-09-0257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2808447/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20068065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Cancer%20Research&amp;title=5%E2%80%90Hydroxy%E2%80%902%E2%80%90Methyl%E2%80%901,%204%E2%80%90Naphthoquinone,%20a%20Vitamin%20K3%20Analogue,%20Suppresses%20STAT3%20Activation%20Pathway%20Through%20Induction%20of%20Protein%20Tyrosine%20Phosphatase,%20SHP%E2%80%901:%20Potential%20Role%20in%20Chemosensitization&amp;author=S.%20K.%20Sandur&amp;author=M.%20K.%20Pandey&amp;author=B.%20Sung&amp;author=B.%20B.%20Aggarwal&amp;volume=8&amp;issue=1&amp;publication_year=2010&amp;pages=107-118&amp;pmid=20068065&amp;doi=10.1158/1541-7786.MCR-09-0257&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0108">
<cite>

Santhakumari, G.
, Saralamma P. G., and Radhakrishnan N.. 1980. “Effect of Plumbagin on Cell Growth &amp; Mitosis.” Indian Journal of Experimental Biology
18: 215–218.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7390548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Journal%20of%20Experimental%20Biology&amp;title=Effect%20of%20Plumbagin%20on%20Cell%20Growth%20&amp;%20Mitosis&amp;author=G.%20Santhakumari&amp;author=P.%20G.%20Saralamma&amp;author=N.%20Radhakrishnan&amp;volume=18&amp;publication_year=1980&amp;pages=215-218&amp;pmid=7390548&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0109">
<cite>

Shahida Parveen, S. D.
, Affrose A., Suresh Kumar B., Annaraj J., and Pitchumani K.. 2014. “Synthesis, Characterization, and DNA Binding Studies of Nanoplumbagin.” Journal of Nanomaterials
2014, no. 1: 179149.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Nanomaterials&amp;title=Synthesis,%20Characterization,%20and%20DNA%20Binding%20Studies%20of%20Nanoplumbagin&amp;author=S.%20D.%20Shahida%20Parveen&amp;author=A.%20Affrose&amp;author=B.%20Suresh%20Kumar&amp;author=J.%20Annaraj&amp;author=K.%20Pitchumani&amp;volume=2014&amp;issue=1&amp;publication_year=2014&amp;pages=179149&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0110">
<cite>

Shaikh, R. U.
, Pund M. M., and Gacche R. N.. 2015. “Evaluation of Anti‐Inflammatory Activity of Selected Medicinal Plants Used in Indian Traditional Medication System In Vitro as Well as In Vivo.” Journal of Traditional and Complementary Medicine
6, no. 4: 355–361.
</cite> [<a href="https://doi.org/10.1016/j.jtcme.2015.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5067865/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27774419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Traditional%20and%20Complementary%20Medicine&amp;title=Evaluation%20of%20Anti%E2%80%90Inflammatory%20Activity%20of%20Selected%20Medicinal%20Plants%20Used%20in%20Indian%20Traditional%20Medication%20System%20In%C2%A0Vitro%20as%20Well%20as%20In%C2%A0Vivo&amp;author=R.%20U.%20Shaikh&amp;author=M.%20M.%20Pund&amp;author=R.%20N.%20Gacche&amp;volume=6&amp;issue=4&amp;publication_year=2015&amp;pages=355-361&amp;pmid=27774419&amp;doi=10.1016/j.jtcme.2015.07.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0111">
<cite>

Shi, Y.
, Chang M., Wang F., Ouyang X., Jia Y., and Du H.. 2010. “Role and Mechanism of Hypoxia‐Inducible Factor‐1 in Cell Growth and Apoptosis of Breast Cancer Cell Line MDA‐MB‐231.” Oncology Letters
1, no. 4: 657–662.
</cite> [<a href="https://doi.org/10.3892/ol_00000115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3436333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22966359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncology%20Letters&amp;title=Role%20and%20Mechanism%20of%20Hypoxia%E2%80%90Inducible%20Factor%E2%80%901%20in%20Cell%20Growth%20and%20Apoptosis%20of%20Breast%20Cancer%20Cell%20Line%20MDA%E2%80%90MB%E2%80%90231&amp;author=Y.%20Shi&amp;author=M.%20Chang&amp;author=F.%20Wang&amp;author=X.%20Ouyang&amp;author=Y.%20Jia&amp;volume=1&amp;issue=4&amp;publication_year=2010&amp;pages=657-662&amp;pmid=22966359&amp;doi=10.3892/ol_00000115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0112">
<cite>

Shieh, J. M.
, Chiang T. A., Chang W. T., et al. 2010. “Plumbagin Inhibits TPA‐Induced MMP‐2 and u‐PA Expressions by Reducing Binding Activities of NF‐kappaB and AP‐1 via ERK Signaling Pathway in A549 Human Lung Cancer Cells.” Molecular and Cellular Biochemistry
335, no. 1–2: 181–193.
</cite> [<a href="https://doi.org/10.1007/s11010-009-0254-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19768635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Biochemistry&amp;title=Plumbagin%20Inhibits%20TPA%E2%80%90Induced%20MMP%E2%80%902%20and%20u%E2%80%90PA%20Expressions%20by%20Reducing%20Binding%20Activities%20of%20NF%E2%80%90kappaB%20and%20AP%E2%80%901%20via%20ERK%20Signaling%20Pathway%20in%20A549%20Human%20Lung%20Cancer%20Cells&amp;author=J.%20M.%20Shieh&amp;author=T.%20A.%20Chiang&amp;author=W.%20T.%20Chang&amp;volume=335&amp;issue=1%E2%80%932&amp;publication_year=2010&amp;pages=181-193&amp;pmid=19768635&amp;doi=10.1007/s11010-009-0254-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0113">
<cite>

Shih, Y. W.
, Lee Y. C., Wu P. F., Lee Y. B., and Chiang T. A.. 2009. “Plumbagin Inhibits Invasion and Migration of Liver Cancer HepG2 Cells by Decreasing Productions of Matrix Metalloproteinase‐2 and Urokinase‐Plasminogen Activator.” Hepatology Research
39, no. 10: 998–1009.
</cite> [<a href="https://doi.org/10.1111/j.1872-034X.2009.00540.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19624766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology%20Research&amp;title=Plumbagin%20Inhibits%20Invasion%20and%20Migration%20of%20Liver%20Cancer%20HepG2%20Cells%20by%20Decreasing%20Productions%20of%20Matrix%20Metalloproteinase%E2%80%902%20and%20Urokinase%E2%80%90Plasminogen%20Activator&amp;author=Y.%20W.%20Shih&amp;author=Y.%20C.%20Lee&amp;author=P.%20F.%20Wu&amp;author=Y.%20B.%20Lee&amp;author=T.%20A.%20Chiang&amp;volume=39&amp;issue=10&amp;publication_year=2009&amp;pages=998-1009&amp;pmid=19624766&amp;doi=10.1111/j.1872-034X.2009.00540.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0156">
<cite>

Shukla, B.
, Saxena S., Usmani S., et al. 2021. “Phytochemistry and Pharmacological Studies of <em>Plumbago zeylanica</em> L.: A Medicinal Plant Review.” Clinical Phytoscience
7: 34.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Phytoscience&amp;title=Phytochemistry%20and%20Pharmacological%20Studies%20of%20Plumbago%20zeylanica%20L.:%20A%20Medicinal%20Plant%20Review&amp;author=B.%20Shukla&amp;author=S.%20Saxena&amp;author=S.%20Usmani&amp;volume=7&amp;publication_year=2021&amp;pages=34&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0114">
<cite>

Silja, P. K.
, Dhanya B., and Satheeshkumar K.. 2016. “Plumbagin Enhancement by Inducing Roots in Cell Suspension of <em>Plumbago rosea</em> L.” Journal of Herbs, Spices &amp; Medicinal Plants
22, no. 2: 148–156.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Herbs,%20Spices%20&amp;%20Medicinal%20Plants&amp;title=Plumbagin%20Enhancement%20by%20Inducing%20Roots%20in%20Cell%20Suspension%20of%20Plumbago%20rosea%20L&amp;author=P.%20K.%20Silja&amp;author=B.%20Dhanya&amp;author=K.%20Satheeshkumar&amp;volume=22&amp;issue=2&amp;publication_year=2016&amp;pages=148-156&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0115">
<cite>

Singh, M.
, Kumar J., Singh S., Singh V. P., Prasad S. M., and Singh M. P. V. V. B.. 2015. “Adaptation Strategies of Plants Against Heavy Metal Toxicity: A Short Review.” Biochemical Pharmacology
4: 161.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20Pharmacology&amp;title=Adaptation%20Strategies%20of%20Plants%20Against%20Heavy%20Metal%20Toxicity:%20A%20Short%20Review&amp;author=M.%20Singh&amp;author=J.%20Kumar&amp;author=S.%20Singh&amp;author=V.%20P.%20Singh&amp;author=S.%20M.%20Prasad&amp;volume=4&amp;publication_year=2015&amp;pages=161&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0116">
<cite>

Singh, U. V.
, Bisht K. S., Rao S., Devi P. U., and Udupa N.. 1997. “Reduced Toxicity and Enhanced Antitumor Efficacy of Plumbagin Using Poly (Lactic‐Co‐Glycolic) Biodegradable Injectable Implant.” Indian Journal of Pharmacology
29, no. 3: 168–172.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Journal%20of%20Pharmacology&amp;title=Reduced%20Toxicity%20and%20Enhanced%20Antitumor%20Efficacy%20of%20Plumbagin%20Using%20Poly%20(Lactic%E2%80%90Co%E2%80%90Glycolic)%20Biodegradable%20Injectable%20Implant&amp;author=U.%20V.%20Singh&amp;author=K.%20S.%20Bisht&amp;author=S.%20Rao&amp;author=P.%20U.%20Devi&amp;author=N.%20Udupa&amp;volume=29&amp;issue=3&amp;publication_year=1997&amp;pages=168-172&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0117">
<cite>

Singh, U. V.
, and Udupa N.. 1997. “Reduced Toxicity and Enhanced Antitumor Efficacy of Betacyclodextrin Plumbagin Inclusion Complex in Mice Bearing Ehrich Ascites Carcinoma.” Indian Journal of Physiology and Pharmacology
41: 171–175.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9142565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Journal%20of%20Physiology%20and%20Pharmacology&amp;title=Reduced%20Toxicity%20and%20Enhanced%20Antitumor%20Efficacy%20of%20Betacyclodextrin%20Plumbagin%20Inclusion%20Complex%20in%20Mice%20Bearing%20Ehrich%20Ascites%20Carcinoma&amp;author=U.%20V.%20Singh&amp;author=N.%20Udupa&amp;volume=41&amp;publication_year=1997&amp;pages=171-175&amp;pmid=9142565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0118">
<cite>

Somasundaram, V.
, Hemalatha S. K., Pal K., et al. 2016. “Selective Mode of Action of Plumbagin Through BRCA1 Deficient Breast Cancer Stem Cells.” BMC Cancer
16: 1–16.</cite> [<a href="https://doi.org/10.1186/s12885-016-2372-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4882782/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27229859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Selective%20Mode%20of%20Action%20of%20Plumbagin%20Through%20BRCA1%20Deficient%20Breast%20Cancer%20Stem%20Cells&amp;author=V.%20Somasundaram&amp;author=S.%20K.%20Hemalatha&amp;author=K.%20Pal&amp;volume=16&amp;publication_year=2016&amp;pages=1-16&amp;pmid=27229859&amp;doi=10.1186/s12885-016-2372-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0119">
<cite>

Son, T. G.
, Camandola S., Arumugam T. V., et al. 2010. “Plumbagin, a Novel Nrf2/ARE Activator, Protects Against Cerebral Ischemia.” Journal of Neurochemistry
112, no. 5: 1316–1326.
</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2009.06552.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2819586/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20028456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurochemistry&amp;title=Plumbagin,%20a%20Novel%20Nrf2/ARE%20Activator,%20Protects%20Against%20Cerebral%20Ischemia&amp;author=T.%20G.%20Son&amp;author=S.%20Camandola&amp;author=T.%20V.%20Arumugam&amp;volume=112&amp;issue=5&amp;publication_year=2010&amp;pages=1316-1326&amp;pmid=20028456&amp;doi=10.1111/j.1471-4159.2009.06552.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0120">
<cite>

Sreelatha, T.
, Hymavathi A., Murthy J. M., Rani P. U., Rao J. M., and Babu K. S.. 2010. “Bioactivity‐Guided Isolation of Mosquitocidal Constituents From the Rhizomes of <em>Plumbago capensis</em> Thunb.” Bioorganic &amp; Medicinal Chemistry Letters
20, no. 9: 2974–2977.
</cite> [<a href="https://doi.org/10.1016/j.bmcl.2010.02.107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20347303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioorganic%20&amp;%20Medicinal%20Chemistry%20Letters&amp;title=Bioactivity%E2%80%90Guided%20Isolation%20of%20Mosquitocidal%20Constituents%20From%20the%20Rhizomes%20of%20Plumbago%20capensis%20Thunb&amp;author=T.%20Sreelatha&amp;author=A.%20Hymavathi&amp;author=J.%20M.%20Murthy&amp;author=P.%20U.%20Rani&amp;author=J.%20M.%20Rao&amp;volume=20&amp;issue=9&amp;publication_year=2010&amp;pages=2974-2977&amp;pmid=20347303&amp;doi=10.1016/j.bmcl.2010.02.107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0121">
<cite>

Srinivas, G.
, Annab L. A., Gopinath G., Banerji A., and Srinivas P.. 2004. “Antisense Blocking of BRCA1 Enhances Sensitivity to Plumbagin but Not Tamoxifen in BG‐1 Ovarian Cancer Cells.” Molecular Carcinogenesis
39, no. 1: 15–25.
</cite> [<a href="https://doi.org/10.1002/mc.10164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14694444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Carcinogenesis&amp;title=Antisense%20Blocking%20of%20BRCA1%20Enhances%20Sensitivity%20to%20Plumbagin%20but%20Not%20Tamoxifen%20in%20BG%E2%80%901%20Ovarian%20Cancer%20Cells&amp;author=G.%20Srinivas&amp;author=L.%20A.%20Annab&amp;author=G.%20Gopinath&amp;author=A.%20Banerji&amp;author=P.%20Srinivas&amp;volume=39&amp;issue=1&amp;publication_year=2004&amp;pages=15-25&amp;pmid=14694444&amp;doi=10.1002/mc.10164&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0122">
<cite>

Srinivas, P.
, Gopinath G., Banerji A., Dinakar A., and Srinivas G.. 2004. “Plumbagin Induces Reactive Oxygen Species, Which Mediate Apoptosis in Human Cervical Cancer Cells.” Molecular Carcinogenesis
40, no. 4: 201–211.
</cite> [<a href="https://doi.org/10.1002/mc.20031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15264212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Carcinogenesis&amp;title=Plumbagin%20Induces%20Reactive%20Oxygen%20Species,%20Which%20Mediate%20Apoptosis%20in%20Human%20Cervical%20Cancer%20Cells&amp;author=P.%20Srinivas&amp;author=G.%20Gopinath&amp;author=A.%20Banerji&amp;author=A.%20Dinakar&amp;author=G.%20Srinivas&amp;volume=40&amp;issue=4&amp;publication_year=2004&amp;pages=201-211&amp;pmid=15264212&amp;doi=10.1002/mc.20031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0123">
<cite>

Sukkasem, N.
, Chatuphonprasert W., Tatiya‐Aphiradee N., and Jarukamjorn K.. 2016. “Imbalance of the Antioxidative System by Plumbagin and <em>Plumbago indica</em> L. Extract Induces Hepatotoxicity in Mice.” Journal of Intercultural Ethnopharmacology
5, no. 2: 137.
</cite> [<a href="https://doi.org/10.5455/jice.20160301094913" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4835988/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27104034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Intercultural%20Ethnopharmacology&amp;title=Imbalance%20of%20the%20Antioxidative%20System%20by%20Plumbagin%20and%20Plumbago%20indica%20L.%20Extract%20Induces%20Hepatotoxicity%20in%20Mice&amp;author=N.%20Sukkasem&amp;author=W.%20Chatuphonprasert&amp;author=N.%20Tatiya%E2%80%90Aphiradee&amp;author=K.%20Jarukamjorn&amp;volume=5&amp;issue=2&amp;publication_year=2016&amp;pages=137&amp;pmid=27104034&amp;doi=10.5455/jice.20160301094913&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0124">
<cite>

Sumsakul, W.
, Plengsuriyakarn T., Chaijaroenkul W., Viyanant V., Karbwang J., and Na‐Bangchang K.. 2014. “Antimalarial Activity of Plumbagin In Vitro and in Animal Models.” BMC Complementary and Alternative Medicine
14: 1–6.
</cite> [<a href="https://doi.org/10.1186/1472-6882-14-15" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3897931/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24410949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Complementary%20and%20Alternative%20Medicine&amp;title=Antimalarial%20Activity%20of%20Plumbagin%20In%C2%A0Vitro%20and%20in%20Animal%20Models&amp;author=W.%20Sumsakul&amp;author=T.%20Plengsuriyakarn&amp;author=W.%20Chaijaroenkul&amp;author=V.%20Viyanant&amp;author=J.%20Karbwang&amp;volume=14&amp;publication_year=2014&amp;pages=1-6&amp;pmid=24410949&amp;doi=10.1186/1472-6882-14-15&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0125">
<cite>

Sun, D.
, Li X., Nie S., Liu J., and Wang S.. 2023. “Disorders of Cancer Metabolism: The Therapeutic Potential of Cannabinoids.” Biomedicine &amp; Pharmacotherapy
157: 113993.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2022.113993" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36379120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine%20&amp;%20Pharmacotherapy&amp;title=Disorders%20of%20Cancer%20Metabolism:%20The%20Therapeutic%20Potential%20of%20Cannabinoids&amp;author=D.%20Sun&amp;author=X.%20Li&amp;author=S.%20Nie&amp;author=J.%20Liu&amp;author=S.%20Wang&amp;volume=157&amp;publication_year=2023&amp;pages=113993&amp;pmid=36379120&amp;doi=10.1016/j.biopha.2022.113993&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0126">
<cite>

Sun, J.
, and McKallip R. J.. 2011. “Plumbagin Treatment Leads to Apoptosis in Human K562 Leukemia Cells Through Increased ROS and Elevated TRAIL Receptor Expression.” Leukemia Research
35, no. 10: 1402–1408.
</cite> [<a href="https://doi.org/10.1016/j.leukres.2011.06.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3163832/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21741707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia%20Research&amp;title=Plumbagin%20Treatment%20Leads%20to%20Apoptosis%20in%20Human%20K562%20Leukemia%20Cells%20Through%20Increased%20ROS%20and%20Elevated%20TRAIL%20Receptor%20Expression&amp;author=J.%20Sun&amp;author=R.%20J.%20McKallip&amp;volume=35&amp;issue=10&amp;publication_year=2011&amp;pages=1402-1408&amp;pmid=21741707&amp;doi=10.1016/j.leukres.2011.06.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0127">
<cite>

Sundari, B. K. R.
, Srivani T., Dwarakanath B. S., and Thyagarajan S. P.. 2017. “Cytotoxic and Antioxidant Effects in Various Tissue Extracts of <em>Plumbago zeylanica</em>: Implications for Anticancer Potential.” Pharmacognosy Journal
9, no. 5: 706–712.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacognosy%20Journal&amp;title=Cytotoxic%20and%20Antioxidant%20Effects%20in%20Various%20Tissue%20Extracts%20of%20Plumbago%20zeylanica:%20Implications%20for%20Anticancer%20Potential&amp;author=B.%20K.%20R.%20Sundari&amp;author=T.%20Srivani&amp;author=B.%20S.%20Dwarakanath&amp;author=S.%20P.%20Thyagarajan&amp;volume=9&amp;issue=5&amp;publication_year=2017&amp;pages=706-712&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0128">
<cite>

Sung, B.
, Oyajobi B., and Aggarwal B. B.. 2012. “Plumbagin Inhibits Osteoclastogenesis and Reduces Human Breast Cancer‐Induced Osteolytic Bone Metastasis in Mice Through Suppression of RANKL Signaling.” Molecular Cancer Therapeutics
11, no. 2: 350–359.
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-11-0731" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3277663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22090419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Cancer%20Therapeutics&amp;title=Plumbagin%20Inhibits%20Osteoclastogenesis%20and%20Reduces%20Human%20Breast%20Cancer%E2%80%90Induced%20Osteolytic%20Bone%20Metastasis%20in%20Mice%20Through%20Suppression%20of%20RANKL%20Signaling&amp;author=B.%20Sung&amp;author=B.%20Oyajobi&amp;author=B.%20B.%20Aggarwal&amp;volume=11&amp;issue=2&amp;publication_year=2012&amp;pages=350-359&amp;pmid=22090419&amp;doi=10.1158/1535-7163.MCT-11-0731&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0129">
<cite>

Sunil Kumar, M. R.
, Kiran Aithal B., Udupa N., et al. 2011. “Formulation of Plumbagin Loaded Long Circulating Pegylated Liposomes: In Vivo Evaluation in C57BL/6J Mice Bearing B16F1 Melanoma.” Drug Delivery
18, no. 7: 511–522.
</cite> [<a href="https://doi.org/10.3109/10717544.2011.595840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21793763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Delivery&amp;title=Formulation%20of%20Plumbagin%20Loaded%20Long%20Circulating%20Pegylated%20Liposomes:%20In%C2%A0Vivo%20Evaluation%20in%20C57BL/6J%20Mice%20Bearing%20B16F1%20Melanoma&amp;author=M.%20R.%20Sunil%20Kumar&amp;author=B.%20Kiran%20Aithal&amp;author=N.%20Udupa&amp;volume=18&amp;issue=7&amp;publication_year=2011&amp;pages=511-522&amp;pmid=21793763&amp;doi=10.3109/10717544.2011.595840&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0130">
<cite>

Susithra, E.
, Chamundeswari D., Srikanth P., Rajasekhar C., and Poornima B. S.. 2016. “Antiviral Effect of the Isolates From <em>Plumbago zeylanica</em> Roots Against HSV.” Journal of Ravishankar University
29, no. 1: 89.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Ravishankar%20University&amp;title=Antiviral%20Effect%20of%20the%20Isolates%20From%20Plumbago%20zeylanica%20Roots%20Against%20HSV&amp;author=E.%20Susithra&amp;author=D.%20Chamundeswari&amp;author=P.%20Srikanth&amp;author=C.%20Rajasekhar&amp;author=B.%20S.%20Poornima&amp;volume=29&amp;issue=1&amp;publication_year=2016&amp;pages=89&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0131">
<cite>

Thakor, N.
, and Janathia B.. 2022. “Plumbagin: A Potential Candidate for Future Research and Development.” Current Pharmaceutical Biotechnology
23, no. 15: 1800–1812.
</cite> [<a href="https://doi.org/10.2174/1389201023666211230113146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34967293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Pharmaceutical%20Biotechnology&amp;title=Plumbagin:%20A%20Potential%20Candidate%20for%20Future%20Research%20and%20Development&amp;author=N.%20Thakor&amp;author=B.%20Janathia&amp;volume=23&amp;issue=15&amp;publication_year=2022&amp;pages=1800-1812&amp;pmid=34967293&amp;doi=10.2174/1389201023666211230113146&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0132">
<cite>

Thasni, K. A.
, Rakesh S., Rojini G., Ratheeshkumar T., Srinivas G., and Priya S.. 2008. “Estrogen‐Dependent Cell Signaling and Apoptosis in BRCA1‐Blocked BG1 Ovarian Cancer Cells in Response to Plumbagin and Other Chemotherapeutic Agents.” Annals of Oncology
19, no. 4: 696–705.
</cite> [<a href="https://doi.org/10.1093/annonc/mdm557" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18187487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Oncology&amp;title=Estrogen%E2%80%90Dependent%20Cell%20Signaling%20and%20Apoptosis%20in%20BRCA1%E2%80%90Blocked%20BG1%20Ovarian%20Cancer%20Cells%20in%20Response%20to%20Plumbagin%20and%20Other%20Chemotherapeutic%20Agents&amp;author=K.%20A.%20Thasni&amp;author=S.%20Rakesh&amp;author=G.%20Rojini&amp;author=T.%20Ratheeshkumar&amp;author=G.%20Srinivas&amp;volume=19&amp;issue=4&amp;publication_year=2008&amp;pages=696-705&amp;pmid=18187487&amp;doi=10.1093/annonc/mdm557&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0133">
<cite>

Titiwattanakarn, T.
, Settacomkul R., Kasemsuk T., and Vivithanaporn P.. 2025. “Plumbagin Inhibits Cadmium‐Induced Interleukin‐6/STAT3 Signaling in the Triple‐Negative Breast Cancer Cell Line.” Asian Pacific Journal of Cancer Prevention
26, no. 2: 465–470.
</cite> [<a href="https://doi.org/10.31557/APJCP.2025.26.2.465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12118000/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40022690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Pacific%20Journal%20of%20Cancer%20Prevention&amp;title=Plumbagin%20Inhibits%20Cadmium%E2%80%90Induced%20Interleukin%E2%80%906/STAT3%20Signaling%20in%20the%20Triple%E2%80%90Negative%20Breast%20Cancer%20Cell%20Line&amp;author=T.%20Titiwattanakarn&amp;author=R.%20Settacomkul&amp;author=T.%20Kasemsuk&amp;author=P.%20Vivithanaporn&amp;volume=26&amp;issue=2&amp;publication_year=2025&amp;pages=465-470&amp;pmid=40022690&amp;doi=10.31557/APJCP.2025.26.2.465&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0134">
<cite>

Tiwari, S. B.
, Pai R. M., and Udupa N.. 2002. “Temperature Sensitive Liposomes of Plumbagin: Characterization and In Vivo Evaluation in Mice Bearing Melanoma B16F1.” Journal of Drug Targeting
10, no. 8: 585–591.
</cite> [<a href="https://doi.org/10.1080/1061186021000054924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12683662/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Drug%20Targeting&amp;title=Temperature%20Sensitive%20Liposomes%20of%20Plumbagin:%20Characterization%20and%20In%C2%A0Vivo%20Evaluation%20in%20Mice%20Bearing%20Melanoma%20B16F1&amp;author=S.%20B.%20Tiwari&amp;author=R.%20M.%20Pai&amp;author=N.%20Udupa&amp;volume=10&amp;issue=8&amp;publication_year=2002&amp;pages=585-591&amp;pmid=12683662&amp;doi=10.1080/1061186021000054924&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0135">
<cite>

Trepanier, C. H.
, and Milgram N. W.. 2010. “Neuroinflammation in Alzheimer's Disease: Are NSAIDs and Selective COX‐2 Inhibitors the Next Line of Therapy?” Journal of Alzheimer's Disease
21, no. 4: 1089–1099.</cite> [<a href="https://doi.org/10.3233/jad-2010-090667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21504126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Alzheimer's%20Disease&amp;title=Neuroinflammation%20in%20Alzheimer's%20Disease:%20Are%20NSAIDs%20and%20Selective%20COX%E2%80%902%20Inhibitors%20the%20Next%20Line%20of%20Therapy?&amp;author=C.%20H.%20Trepanier&amp;author=N.%20W.%20Milgram&amp;volume=21&amp;issue=4&amp;publication_year=2010&amp;pages=1089-1099&amp;pmid=21504126&amp;doi=10.3233/jad-2010-090667&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0136">
<cite>

Tripathi, C.
, Jain S. K., and Vengurlekar S.. 2025. “Extraction, Fractionation, and Characterization of Plumbagin From the Roots of <em>Plumbago zeylanica</em>
.” South Eastern European Journal of Public Health
2024: 4391–4401.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=South%20Eastern%20European%20Journal%20of%20Public%20Health&amp;title=Extraction,%20Fractionation,%20and%20Characterization%20of%20Plumbagin%20From%20the%20Roots%20of%20Plumbago%20zeylanica&amp;author=C.%20Tripathi&amp;author=S.%20K.%20Jain&amp;author=S.%20Vengurlekar&amp;volume=2024&amp;publication_year=2025&amp;pages=4391-4401&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0137">
<cite>

Uttarkar, S.
, Piontek T., Dukare S., et al. 2016. “Small‐Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells.” Molecular Cancer Therapeutics
15, no. 12: 2905–2915.
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-16-0185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27707899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Cancer%20Therapeutics&amp;title=Small%E2%80%90Molecule%20Disruption%20of%20the%20Myb/p300%20Cooperation%20Targets%20Acute%20Myeloid%20Leukemia%20Cells&amp;author=S.%20Uttarkar&amp;author=T.%20Piontek&amp;author=S.%20Dukare&amp;volume=15&amp;issue=12&amp;publication_year=2016&amp;pages=2905-2915&amp;pmid=27707899&amp;doi=10.1158/1535-7163.MCT-16-0185&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0138">
<cite>

Verma, A.
, and Goyal A.. 2024. “Unravelling the Potent Anti‐Oxidant and Anti‐Inflammatory Actions of Plumbagin: A Review of Preclinical Discoveries.” Pharmacological Research ‐ Modern Chinese Medicine
10: 100351.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacological%20Research%20%E2%80%90%20Modern%20Chinese%20Medicine&amp;title=Unravelling%20the%20Potent%20Anti%E2%80%90Oxidant%20and%20Anti%E2%80%90Inflammatory%20Actions%20of%20Plumbagin:%20A%20Review%20of%20Preclinical%20Discoveries&amp;author=A.%20Verma&amp;author=A.%20Goyal&amp;volume=10&amp;publication_year=2024&amp;pages=100351&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0139">
<cite>

Wang, C. C.
, Chiang Y. M., Sung S. C., Hsu Y. L., Chang J. K., and Kuo P. L.. 2008. “Plumbagin Induces Cell Cycle Arrest and Apoptosis Through Reactive Oxygen Species/c‐Jun N‐Terminal Kinase Pathways in Human Melanoma A375. S2 Cells.” Cancer Letters
259, no. 1: 82–98.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2007.10.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18023967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Letters&amp;title=Plumbagin%20Induces%20Cell%20Cycle%20Arrest%20and%20Apoptosis%20Through%20Reactive%20Oxygen%20Species/c%E2%80%90Jun%20N%E2%80%90Terminal%20Kinase%20Pathways%20in%20Human%20Melanoma%20A375.%20S2%20Cells&amp;author=C.%20C.%20Wang&amp;author=Y.%20M.%20Chiang&amp;author=S.%20C.%20Sung&amp;author=Y.%20L.%20Hsu&amp;author=J.%20K.%20Chang&amp;volume=259&amp;issue=1&amp;publication_year=2008&amp;pages=82-98&amp;pmid=18023967&amp;doi=10.1016/j.canlet.2007.10.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0140">
<cite>

Xie, Y.
, Shi X., Sheng K., et al. 2019. “PI3K/Akt Signaling Transduction Pathway, Erythropoiesis and Glycolysis in Hypoxia.” Molecular Medicine Reports
19, no. 2: 783–791.
</cite> [<a href="https://doi.org/10.3892/mmr.2018.9713" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6323245/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30535469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Medicine%20Reports&amp;title=PI3K/Akt%20Signaling%20Transduction%20Pathway,%20Erythropoiesis%20and%20Glycolysis%20in%20Hypoxia&amp;author=Y.%20Xie&amp;author=X.%20Shi&amp;author=K.%20Sheng&amp;volume=19&amp;issue=2&amp;publication_year=2019&amp;pages=783-791&amp;pmid=30535469&amp;doi=10.3892/mmr.2018.9713&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0141">
<cite>

Yan, W.
, Tu B., Liu Y. Y., et al. 2013. “Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down‐Regulation of Inflammatory Cytokine Expressions.” Bone Research
1, no. 1: 362–370.
</cite> [<a href="https://doi.org/10.4248/BR201304007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4472116/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26273514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bone%20Research&amp;title=Suppressive%20Effects%20of%20Plumbagin%20on%20Invasion%20and%20Migration%20of%20Breast%20Cancer%20Cells%20via%20the%20Inhibition%20of%20STAT3%20Signaling%20and%20Down%E2%80%90Regulation%20of%20Inflammatory%20Cytokine%20Expressions&amp;author=W.%20Yan&amp;author=B.%20Tu&amp;author=Y.%20Y.%20Liu&amp;volume=1&amp;issue=1&amp;publication_year=2013&amp;pages=362-370&amp;pmid=26273514&amp;doi=10.4248/BR201304007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0142">
<cite>

Yan, W.
, Wang T. Y., Fan Q. M., et al. 2014. “Plumbagin Attenuates Cancer Cell Growth and Osteoclast Formation in the Bone Microenvironment of Mice.” Acta Pharmacologica Sinica
35, no. 1: 124–134.
</cite> [<a href="https://doi.org/10.1038/aps.2013.152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4075744/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24384612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Pharmacologica%20Sinica&amp;title=Plumbagin%20Attenuates%20Cancer%20Cell%20Growth%20and%20Osteoclast%20Formation%20in%20the%20Bone%20Microenvironment%20of%20Mice&amp;author=W.%20Yan&amp;author=T.%20Y.%20Wang&amp;author=Q.%20M.%20Fan&amp;volume=35&amp;issue=1&amp;publication_year=2014&amp;pages=124-134&amp;pmid=24384612&amp;doi=10.1038/aps.2013.152&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0143">
<cite>

Yang, Y.
, Cong H., Han C., Yue L., Dong H., and Liu J.. 2015. “12‐Deoxyphorbol 13‐Palmitate Inhibits the Expression of VEGF and HIF‐1α in MCF‐7 Cells by Blocking the PI3K/Akt/mTOR Signaling Pathway.” Oncology Reports
34, no. 4: 1755–1760.
</cite> [<a href="https://doi.org/10.3892/or.2015.4166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26239613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncology%20Reports&amp;title=12%E2%80%90Deoxyphorbol%2013%E2%80%90Palmitate%20Inhibits%20the%20Expression%20of%20VEGF%20and%20HIF%E2%80%901%CE%B1%20in%20MCF%E2%80%907%20Cells%20by%20Blocking%20the%20PI3K/Akt/mTOR%20Signaling%20Pathway&amp;author=Y.%20Yang&amp;author=H.%20Cong&amp;author=C.%20Han&amp;author=L.%20Yue&amp;author=H.%20Dong&amp;volume=34&amp;issue=4&amp;publication_year=2015&amp;pages=1755-1760&amp;pmid=26239613&amp;doi=10.3892/or.2015.4166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0144">
<cite>

Yin, Z.
, Zhang J., Chen L., et al. 2020. “Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances.” BioMed Research International
2020, no. 1: 6940953.
</cite> [<a href="https://doi.org/10.1155/2020/6940953" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7725562/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33344645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioMed%20Research%20International&amp;title=Anticancer%20Effects%20and%20Mechanisms%20of%20Action%20of%20Plumbagin:%20Review%20of%20Research%20Advances&amp;author=Z.%20Yin&amp;author=J.%20Zhang&amp;author=L.%20Chen&amp;volume=2020&amp;issue=1&amp;publication_year=2020&amp;pages=6940953&amp;pmid=33344645&amp;doi=10.1155/2020/6940953&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0145">
<cite>

Yuan, J. H.
, Pan F., Chen J., et al. 2017. “Neuroprotection by Plumbagin Involves BDNF‐TrkB‐PI3K/Akt and ERK1/2/JNK Pathways in Isoflurane‐Induced Neonatal Rats.” Journal of Pharmacy and Pharmacology
69, no. 7: 896–906.
</cite> [<a href="https://doi.org/10.1111/jphp.12681" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28464236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacy%20and%20Pharmacology&amp;title=Neuroprotection%20by%20Plumbagin%20Involves%20BDNF%E2%80%90TrkB%E2%80%90PI3K/Akt%20and%20ERK1/2/JNK%20Pathways%20in%20Isoflurane%E2%80%90Induced%20Neonatal%20Rats&amp;author=J.%20H.%20Yuan&amp;author=F.%20Pan&amp;author=J.%20Chen&amp;volume=69&amp;issue=7&amp;publication_year=2017&amp;pages=896-906&amp;pmid=28464236&amp;doi=10.1111/jphp.12681&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0146">
<cite>

Yue, J.
, Lin Z., Wang D., Feng Y., and Sun H.. 1994. “Plumbasides A—C Three Naphthoquinone Derivatives From Ceratostigma Minus.” Phytochemistry
35, no. 4: 1023–1025.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Phytochemistry&amp;title=Plumbasides%20A%E2%80%94C%20Three%20Naphthoquinone%20Derivatives%20From%20Ceratostigma%20Minus&amp;author=J.%20Yue&amp;author=Z.%20Lin&amp;author=D.%20Wang&amp;author=Y.%20Feng&amp;author=H.%20Sun&amp;volume=35&amp;issue=4&amp;publication_year=1994&amp;pages=1023-1025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0147">
<cite>

Zenk, M. H.
, Fürbringer M., and Steglich W.. 1969. “Occurrence and Distribution of 7‐Methyljuglone and Plumbagin in the Droseraceae.” Phytochemistry
8, no. 11: 2199–2200.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Phytochemistry&amp;title=Occurrence%20and%20Distribution%20of%207%E2%80%90Methyljuglone%20and%20Plumbagin%20in%20the%20Droseraceae&amp;author=M.%20H.%20Zenk&amp;author=M.%20F%C3%BCrbringer&amp;author=W.%20Steglich&amp;volume=8&amp;issue=11&amp;publication_year=1969&amp;pages=2199-2200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0148">
<cite>

Zhang, J.
, Peng S., Li X., Liu R., Han X., and Fang J.. 2017. “Targeting Thioredoxin Reductase by Plumbagin Contributes to Inducing Apoptosis of HL‐60 Cells.” Archives of Biochemistry and Biophysics
619: 16–26.
</cite> [<a href="https://doi.org/10.1016/j.abb.2017.02.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28249720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Archives%20of%20Biochemistry%20and%20Biophysics&amp;title=Targeting%20Thioredoxin%20Reductase%20by%20Plumbagin%20Contributes%20to%20Inducing%20Apoptosis%20of%20HL%E2%80%9060%20Cells&amp;author=J.%20Zhang&amp;author=S.%20Peng&amp;author=X.%20Li&amp;author=R.%20Liu&amp;author=X.%20Han&amp;volume=619&amp;publication_year=2017&amp;pages=16-26&amp;pmid=28249720&amp;doi=10.1016/j.abb.2017.02.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0149">
<cite>

Zhang, W.
, Cheng L., Hou Y., Si M., Zhao Y. P., and Nie L.. 2015. “Plumbagin Protects Against Spinal Cord Injury‐Induced Oxidative Stress and Inflammation in Wistar Rats Through Nrf‐2 Upregulation.” Drug Research
65, no. 09: 495–499.
</cite> [<a href="https://doi.org/10.1055/s-0034-1389950" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25243650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Research&amp;title=Plumbagin%20Protects%20Against%20Spinal%20Cord%20Injury%E2%80%90Induced%20Oxidative%20Stress%20and%20Inflammation%20in%20Wistar%20Rats%20Through%20Nrf%E2%80%902%20Upregulation&amp;author=W.%20Zhang&amp;author=L.%20Cheng&amp;author=Y.%20Hou&amp;author=M.%20Si&amp;author=Y.%20P.%20Zhao&amp;volume=65&amp;issue=09&amp;publication_year=2015&amp;pages=495-499&amp;pmid=25243650&amp;doi=10.1055/s-0034-1389950&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0155">
<cite>

Zhang, X. Q.
, Yang C. Y., Rao X. F., and Xiong J. P.. 2016. “Plumbagin Shows Anti‐Cancer Activity in Human Breast Cancer Cells by the Upregulation of p53 and p21 and Suppression of G1 Cell Cycle Regulators.” European Journal of Gynaecological Oncology
37, no. 1: 30–35.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/27048106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Gynaecological%20Oncology&amp;title=Plumbagin%20Shows%20Anti%E2%80%90Cancer%20Activity%20in%20Human%20Breast%20Cancer%20Cells%20by%20the%20Upregulation%20of%20p53%20and%20p21%20and%20Suppression%20of%20G1%20Cell%20Cycle%20Regulators&amp;author=X.%20Q.%20Zhang&amp;author=C.%20Y.%20Yang&amp;author=X.%20F.%20Rao&amp;author=J.%20P.%20Xiong&amp;volume=37&amp;issue=1&amp;publication_year=2016&amp;pages=30-35&amp;pmid=27048106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0150">
<cite>

Zhao, Y. L.
, and Lu D. P.. 2006. “Effects of Plumbagin on the Human Acute Promyelocytic Leukemia Cells In Vitro.” Zhongguo Shi Yan Xue Ye Xue Za Zhi
14, no. 2: 208–211.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/16638181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Zhongguo%20Shi%20Yan%20Xue%20Ye%20Xue%20Za%20Zhi&amp;title=Effects%20of%20Plumbagin%20on%20the%20Human%20Acute%20Promyelocytic%20Leukemia%20Cells%20In%C2%A0Vitro&amp;author=Y.%20L.%20Zhao&amp;author=D.%20P.%20Lu&amp;volume=14&amp;issue=2&amp;publication_year=2006&amp;pages=208-211&amp;pmid=16638181&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="fsn370720-bib-0151">
<cite>

Zhou, Z. W.
, Li X. X., He Z. X., et al. 2015. “Induction of Apoptosis and Autophagy via sirtuin1‐and PI3K/Akt/mTOR‐Mediated Pathways by Plumbagin in Human Prostate Cancer Cells.” Drug Design, Development and Therapy
9: 1511–1554.
</cite> [<a href="https://doi.org/10.2147/DDDT.S75976" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4366042/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25834399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Design,%20Development%20and%20Therapy&amp;title=Induction%20of%20Apoptosis%20and%20Autophagy%20via%20sirtuin1%E2%80%90and%20PI3K/Akt/mTOR%E2%80%90Mediated%20Pathways%20by%20Plumbagin%20in%20Human%20Prostate%20Cancer%20Cells&amp;author=Z.%20W.%20Zhou&amp;author=X.%20X.%20Li&amp;author=Z.%20X.%20He&amp;volume=9&amp;publication_year=2015&amp;pages=1511-1554&amp;pmid=25834399&amp;doi=10.2147/DDDT.S75976&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="/articles/PMC9346404/" class="text-red">Retracted</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No new data were generated or analyzed in this review. Data supporting the findings of this study are available in the referenced works.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Food Science &amp; Nutrition are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/fsn3.70720"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/FSN3-13-e70720.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12365397/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12365397/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365397%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365397/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12365397/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12365397/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40842665/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12365397/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40842665/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12365397/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12365397/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="vaWzX7jm35WRoZNRGZ9kl62iBWSEyjcfExbTTUW32rAsZDrLecHkwoBEiQnAcsgF">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
